Quarterlytics / Industrials / Security & Protection Services / BIO-key International

BIO-key International

bkyi · NASDAQ Industrials
Claim this profile
Ticker bkyi
Exchange NASDAQ
Sector Industrials
Industry Security & Protection Services
Employees 11-50
← All annual reports
FY2013 Annual Report · BIO-key International
Sign in to download
Loading PDF…
SECURITIES & EXCHANGE COMMISSION EDGAR FILING

BIO KEY INTERNATIONAL INC

Form: 10-K 

Date Filed: 2014-03-31

Corporate Issuer CIK:   1019034
Symbol:

BKYI

© Copyright 2014, Issuer Direct Corporation. All Right Reserved. Distribution of this document is strictly prohibited, subject to the
terms of use.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2013
Commission File Number 1-13463
BIO-KEY INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)

DELAWARE
(State or other jurisdiction of
incorporation or organization)

41-1741861
(IRS Employer
Identification Number)

3349 HIGHWAY 138, BUILDING A, SUITE E, WALL, NJ 07719
(Address of principal executive offices) (Zip Code)
(732) 359-1100
Registrant’s telephone number, including area code.

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Common Stock, $0.0001 par value per share   
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   Yes  ☐   

   Name of Exchange on which Registered  
None

No  ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the

Act.   Yes  ☐    No  ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.   Yes  ☒   No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒   No  ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not

contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller

reporting company. See the definitions of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.:

Large accelerated filer  ☐

Non-accelerated filer  ☐

Accelerated filer  ☐

Smaller reporting company  ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The aggregate market value of the registrant’s voting and non-voting common equity held by non-affiliates computed by reference to
the price at which the common equity was last sold, as of the last business day of the registrant’s most recently completed second fiscal
quarter was $32,317,405.

As of March 25, 2014, the registrant had 115,995,974 shares of common stock outstanding.

Documents Incorporated by Reference: None

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
  
  
 
 
 
  
  
  
  
  
 
 
 
  
 
 
TABLE OF CONTENTS

PART I

Item 1. Description of Business
Item 1A Risk Factors
Item 2
Item 3
Item 4 Mine Safety Disclosures

Description of Property
Legal Proceedings

PART II

Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 8
Item 9
Item 9A Controls and Procedures
Item 9B Other Information

Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

PART III

Item 10 Directors, Executive Officers and Corporate Governance
Item 11 Executive Compensation
Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13 Certain Relationships and Related Transactions, and Director Independence
Item 14 Principal Accountant Fees and Services
Item 15 Exhibits

Signatures

PRIVATE SECURITIES LITIGATION REFORM ACT

1 
7 
12 
12 
12 

13 

13 
15 
23 
23 
23 
24 

25 
29 
34 
36 
37 
38 
63 

All statements other than statements of historical facts contained in this Annual Report on Form 10-K, including statements regarding our
future financial position, business strategy and plans and objectives of management for future operations, are forward-looking
statements. The words “anticipate,” “believe,” “estimate,” “will,” “may,” “future,” “plan,” “intend” and “expect” and similar expressions
generally identify forward-looking statements. Although we believe our plans, intentions and expectations reflected in the forward-looking
statements are reasonable, we cannot be sure they will be achieved. Actual results may differ materially from the forward-looking
statements contained herein due to a number of factors. Many of these factors are set forth under the caption “Risk Factors” in Item 1A of
this Annual Report and other filings with the Securities and Exchange Commission. These factors are not intended to represent a
complete list of the general or specific factors that may affect us. It should be recognized that other factors, including general economic
factors and business strategies, may be significant, presently or in the future. Except as required by law, we undertake no obligation to
update any forward-looking statement, whether as a result of new information, future events or otherwise.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
  
  
  
  
  
   
  
  
  
  
  
  
  
  
   
  
  
  
  
  
   
  
  
  
  
  
  
  
  
  
   
  
  
  
  
  
  
   
  
  
  
  
  
  
  
  
  
 
 
  
 
 
ITEM 1.

DESCRIPTION OF BUSINESS

PART I

BIO-key International, Inc., a Delaware corporation (the “Company,” “BIO-key,” “we,” or “us), was founded in 1993 to develop and
market advanced fingerprint biometric technology and related security software solutions. First incorporated as BBG Engineering, the
company was renamed SAC Technologies in 1994 and, again, renamed BIO-key International, Inc. in 2002.

We  develop  and  market  advanced  fingerprint  biometric  identification  and  identity  verification  technologies,  cryptographic
authentication-transaction security technologies, as well as related identity management and credentialing software solutions. We were
pioneers in developing automated, finger identification technology that supplements or compliments other methods of identification and
verification,  such  as  personal  inspection  identification,  passwords,  tokens,  smart  cards,  ID  cards,  PKI,  credit  card,  passports,  driver’s
licenses, OTP or other form of possession or knowledge-based credentialing. Additionally, advanced BIO-key® technology has been and
is used to improve both the accuracy and speed of competing finger-based biometrics.

We  have  developed  what  we  believe  is  the  most  discriminating  and  effective  commercially  available  finger-based  biometric
technology. Our primary focus is in marketing and selling this technology into commercial logical and physical privilege entitlement and
access  control  markets.  Example  primary  markets  include  mobile  payments  &  credentialing,  online  payments  and  credentialing,  and
healthcare  record  and  payment  data  security,  among  others.  Our  secondary  focus  includes  government  markets,  primarily  law
enforcement forensic investigation and the Department of Homeland Security. We continue to research and develop advancements in
our  capabilities,  as  well  as  exploring  and  developing  potential  strategic  relationships,  including  potential  business  combinations  and
acquisitions, which could help us leverage our capability to deliver our solutions. We have built a direct sales force of professionals, and
also team with resellers, integrators and partner networks with substantial experience in selling technology solutions to government and
corporate customers.

Products

Finger-based Biometric Identification and Personal Identity Verification

We  are  a  leader  in  finger-based  biometric  identification  and  personal  identity  verification,  as  well  as  authentication-transaction
security.  Stand-alone,  or  in  partnerships  with  OEMs,  integrators,  and  solution  providers,  we  provide  biometric  software  solutions  and
authentication-transaction  security  solutions  to  private  and  public  sector  customers.  We  help  customers  reduce  risk  by  providing  the
ability to control access to facilities and services, in either the logical or physical domain. Our capabilities positively identify individuals
and verify, or confirm, their identity before granting access to valuable corporate resources, privileged or subscribed data and services,
web portals, applications, physical locations or assets, among other things. Our capabilities are software based and both hardware and
operating-system agnostic.

We do not develop, manufacture or produce hardware components that are used in conjunction with our software. However, we do
sell  third-party  hardware  components  with  our  software  in  various  configurations  required  by  our  customers,  as  do  our  partners.  Our
products are interoperable with all major fingerprint reader and hardware manufacturers, enabling application developers, Value Added
Resellers  (“VARs”)  and  channel  partners  to  integrate  our  fingerprint  biometrics  into  their  application,  while  dramatically  reducing
maintenance,  upgrade  and  life-cycle  costs.  Our  core  technology  supports  interoperability  on  over  60  different  commercially  available
fingerprint readers. The technology is also interoperable across Windows and Linux, as well as Apple iOS and Android mobile operating
systems. This interoperability is unique in the industry and a key differentiator for our products in the biometric market and, in our opinion,
makes our technology more viable than competing technologies and expands the size of the overall market for our products.

Our biometric identification technology improves both the accuracy and speed of screening individuals, for identification purposes or
for personal identity verification, by extracting unique data from a fingerprint and comparing it to existing similar fingerprint data. These
comparisons are conducted to identify an individual, either in a forensic investigation, or to screen the individual upon the application for a
privilege, or to verify the individual’s identity upon such individuals request to access the previously entitled privilege. The technology has
been  built  to  be  completely  scalable  and  can  handle  databases  containing  millions  of  fingerprints.  We  achieve  the  highest  levels  of
discrimination  without  requiring  any  other  identifying  data  (multi-factor)  such  as  a  userID,  smart  ID  cards,  or  tokens,  although  our
technology can be used in conjunction with such additional factors.

- 1 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
We  support  industry  standards,  such  as  BioAPI,  and  have  received  National  Institute  of  Standards  and  Technology  independent
laboratory certification of our ability to support Homeland Security Presidential Directive #12 (HSPD-12) and ANSI/INCITS-378 templates,
as well as validation of our fingerprint match speed and accuracy in large database environments.

Our  finger  identification  algorithm—Vector  Segment  Technology  (VST™)  is  the  core  intellectual  property  behind  our  full  suite  of

biometric products that include:

•

•

•

•

Vector Segment Technology SDK (VST)—Our biometric software development kit (“SDK”) that provides developers the ability to
incorporate our biometric capabilities into their respective product offerings or infrastructure. VST is available as a low level SDK
for incorporation into any application architecture to increase security while not sacrificing convenience. VST runs on Windows
and Linux as well as within WEB-key® on iOS and Android systems.

Intelligent Image Indexing®—Our biometric identification solution that offers both large-scale one-to-many user identification.
This solution enables customers to perform false alias and fast entry checks, including preventing fraudulent access to systems
and privileges. Intelligent Image Indexing scales identification capabilities from thousands to millions of users. The solution runs
on commercially available hardware making it scalable for any size system.

Biometric Service Provider—We provide support for the BioAPI (a standards-based solution meeting worldwide needs) for a
compliant interface to applications using biometrics for verification and identification. We enhance the traditional use of BioAPI by
adding 64-bit support and other advanced features, supporting identification calls and also providing a single user interface for
multiple fingerprint readers.

ID Director™—Our Single Sign On (SSO) is a suite of solutions for integration with CA Technologies SiteMinder, Oracle’s Fusion
Middleware SSO, IBM Tivoli Access Manager and other solutions, utilizing the power and security of WEB-key. This solution
provides a simple to implement, custom authentication scheme for companies looking to enhance authentication. ID Director is
designed to add a level of security and convenience to the transaction level of any application.

Authentication Transaction Security

Our  authentication-transaction  security  technology,  WEB-key,  provides  the  ability  to  conduct  identification  and  identity  verification

transactions in potentially insecure environments, including the World Wide Web or in off-site cloud environments.

WEB-key makes cloud-based biometric user-authentication viable and eliminates technology constraints on online service providers,
who  are  otherwise  held  dependent  on  handset  provider  hardware  and  software  platform  decisions.  It  extends  all  features  and
functionalities  of  the  VST  algorithm  to  customers  looking  to  add  an  enhanced  level  of  security  to  their  thin  client  and  client/server
applications. WEB-key is currently supported by both Windows and Linux operating systems. Clients are available on Windows, iOS and
Android operating systems.

Intellectual Property Rights

We  develop  and  own  significant  intellectual  property  and  believe  that  our  intellectual  property  is  fundamental  to  our  biometric

operation:

Patents

We own patented technologies and trade secrets developed or acquired by us.

In May 2005, the U.S. Patent & Trademark Office issued patent 6,895,104 for our Vector Segment fingerprint technology (VST), BIO-
key’s core biometric analysis and identification technology. With the payment of all maintenance fees, this patent will expire on March 4,
2023.

On October 3, 2006, we announced that our patent for a biometric authentication security framework had been granted by the U.S.
Patent & Trademark Office. The patent No. 7,117,356 was issued to us for a biometric authentication security framework that enhances
commercial  and  civil  biometric  use.  Our  authentication  security  framework  protects  privacy  and  security  of  cloud  or  network  based
authentications while also facilitates ease of use of biometric systems. The technology that this patent is based on is the foundation for
the  authentication  security  incorporated  in  our  WEB-key  product  line.  WEB-key  is  a  mature  enterprise  authentication  solution  that
functions  in  a  wide  variety  of  application  environments.  The  solution  supports  a  variety  of  implementation  alternatives  including  card
technologies  for  “two-factor”  authentication  and  also  supports  “single-factor”  authentication.  Partners  and  customers  implementing  our
WEB-key  software  to  provide  convenient  and  secure  user  identity  include  a  number  of  institutions  including  the  Allscripts  Healthcare
Solutions, Computer Associates Site Minder, Oracle Access Manager and many other enterprise and solutions based systems. With the
payment of all maintenance fees, this patent will expire on May 20, 2023.

- 2 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
     
 
     
 
 
 
 
 
 
 
 
 
 
  
 
On December 26, 2006, we were issued US patent No. 7,155,040 covering our unique image processing technology, which is critical
for  enhancing  information  used  in  the  extraction  of  biometric  minutiae.  The  issued  patent  protects  a  critical  part  of  an  innovative  four-
phase image enhancement process developed by us. With the payment of all maintenance fees, this patent will expire on January 29,
2025.

On April 15, 2008, we were issued US patent No. 7,359,553 covering our image enhancement and data extraction core algorithm
components. The solution protected under this patent provides the capability to quickly and accurately transform a fingerprint image into
a computer image that can be analyzed to determine the critical data elements. With the payment of all maintenance fees, this patent will
expire on January 3, 2025.

On  August  19,  2008,  we  were  issued  US  patent  No.  7,415,605  for  our  “Biometric  Identification  Network  Security”  method.  The
solution  protected  under  this  patent  provides  a  defense  against  hackers  and  system  attacks,  while  leveraging  the  industry  standard
Trusted Platform Module (TPM) specification for encryption key management. With the payment of all maintenance fees, this patent will
expire on May 20, 2023.

On  November  18,  2008,  we  were  issued  US  patent  No.  7,454,624  for  our  “Match  Template  Protection  within  a  Biometric  Security
System” method. The solution protected under this patent limits the scope of enrollment templates usage and also eliminates the need for
revocation or encryption processes, which can be expensive and time consuming. With the payment of all maintenance fees, this patent
will expire on May 17, 2025.

On March 10, 2009, we were issued US patent No. 7,502,938 for our “Trusted Biometric Device” which covers a simple, yet secure
method of protecting a user’s biometric information. It covers the transmission of information from the point the information is collected at
the  biometric  reader  until  the  data  reaches  the  computer  or  device  that  is  authenticating  the  user’s  identity.  With  the  payment  of  all
maintenance fees, this patent will expire on October 25, 2025.

On  May  26,  2009,  we  were  issued  US  patent  No.  7,539,331  for  our  “Image  Identification  System”  method  for  improving  the
performance and reliability of image analysis within an image identification system. With the payment of all maintenance fees, this patent
will expire on March 22, 2022.

On  November  8,  2011,  we  were  issued  US  Patent  No  8,055,027  for  our  “Generation  of  Directional  Information  in  the  Context  of
Image Processing” method for image enhancement and processing. With the payment of all maintenance fees, this patent will expire on
October 10, 2027.

On July 3, 2012, we were issued US Patent No 8,214,652 for our “Biometric Identification Network Security”, an expanded method of
network  and  related  network  authentication  security  systems  utilizing  hardware  based  support  for  encryption  and  key  management  for
authentication purposes. With the payment of all maintenance fees, this patent will expire on April 24, 2024.

We  have  also  been  granted  parallel  patents  to  the  US  Patent  portfolio  to  certain  of  our  patents  in  many  foreign  countries  offering

protection of our intellectual property rights around the world.

Trademarks

We have registered our trademarks “BIO-key”, “True User Identification”, “Intelligent Image Indexing” and “WEB-key” with the U.S.
Patent & Trademark Office, as well as many foreign countries, protecting our companies name and key technology offering names world-
wide.

Copyrights and trade secrets

We  take  measures  to  ensure  copyright  and  license  protection  for  our  software  releases  prior  to  distribution.  When  possible,  the
software is licensed in an attempt to ensure that only licensed and activated software functions to its full potential. We also take measures
to protect the confidentiality of our trade secrets.

Markets

Identity Management, User Authentication, Privilege Entitlement and Access Control

Our products reduce risk of theft, fraud, loss and attack by limiting access to valuable assets, privileges, data, services, networks and
places, to only authorized individuals. Conversely, our products enhance the monetary value and/or viability of privileged assets, places
and services by ensuring only subscribers and otherwise entitled holders can enjoy full access to their privileges. In effect, our products
replace  traditional  credentialing  systems,  which  utilize  a  physical  or  electronic  credential  document  to  represent  the  holder’s  privilege
entitlement, and access control systems that guard access to such privileges. Examples of such privileges include, but are not limited to:
international  travel  and  immigration  privileges;  employment  ID,  campus  ID  and  corporate  ID  privileges;  healthcare  service  privileges;
citizen  entitlement  privileges  such  as  Medicare,  Medicaid  and  Social  Security;  and  bank,  credit  account  and  financial  transaction
privileges such as checking accounts, debit and credit cards, payments, online services and subscription privileges. Examples of access
points  include  doorways,  gates,  computers,  point-of-sale  terminals,  smart-phones  or  web-portals  and  automobiles.  In  our  opinion,  the
market  for  advanced  user  authentication,  including  fingerprint  biometrics,  is  conceptually  enormous,  represented  by  virtually  any
doorway, gate, computer network or internet end-point like smart-phones, desktops and laptops PCs and tablets, and compounded by the
number  of  individuals  privileged  to  access  something  guarded  by  those  access  points.  We  believe  the  market  opportunity  for  our

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
products is a massive upgrade cycle of global privilege entitlement and access control systems.

- 3 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

  
 
Historically, our largest market has been access control within highly regulated industries like healthcare. However, we believe the
mass  adoption  of  advanced  smart-phone  and  hand-held  wireless  devices  have  caused  commercial  demand  for  advanced  user
authentication to emerge as viable. The introduction of smart-phone capabilities, like mobile payments and credentialing, could effectively
require biometric user authentication on mobile devices to reduce risks of identity theft, payment fraud other forms of fraud in the mobile
or cellular based World Wide Web. As more services and payment functionalities, like mobile wallets and NFC, migrate to smart-phones,
the value and potential risk associated with such systems should grow substantially and drive demand and mass adoption of advanced
user authentication technologies, including fingerprint biometrics and our solutions.

We believe there is potential for significant market growth in three key areas:

•     Corporate network access control- corporate campuses, computer networks and applications.

•     Consumer mobile credentialing, including mobile payments- credit and payment card programs, data and application access and

commercial loyalty programs.

•     Government services and highly regulated industry- Medicare, Medicaid, Social Security, Drivers Licenses, Campus and School

ID, Passports/Visas.

Business Model

We  believe  the  most  viable  markets  for  our  products  involve  various  forms  of  computer  network  and  Internet  applications.  The
emergences  of  cloud  computing  and  mobile  computing  are  primary  drivers  of  commercial  and  consumer  adoption  of  advanced
authentication applications, including our authentication capabilities. As the value of assets, services and transactions increases on such
networks, we expect that security and user authentication demand will rise proportionately. We believe the nature of cloud and mobile
computing  requires  technology  interoperability  across  borders,  jurisdictions  and  networks.  Further,  government  and  highly  regulated
service  offerings  must  also  interoperate  across  borders,  jurisdictions  and  networks.  In  many  cases,  government  and  highly  regulated
service-related technologies are required to be interoperable and standards compliant. We have developed our technology and offerings
to  be  software-based,  standards  compliant,  universally  interoperable,  hardware  and  operating  system  agnostic,  and  scalable.  Our
technologies, products and platforms are designed to function on the Internet, in the cloud, in a traditional network environment, or stand-
alone.  We  believe  our  model  provides  the  strongest  opportunity  to  penetrate  the  global  biometric  authentication  market,  leverage  our
partners’ potentially large and resource rich sales channels, as well as produce the highest margin revenue.

We have built a two-tier sales channel to deliver our solutions. Channels include direct sales, integrator partners and VARs. We sell
stand-alone  software  licenses  for  our  products,  as  well  as  packaged  configurations  with  “commercial-off-the-shelf”  viable  third-party
hardware devices, like fingerprint readers and network technologies. We do not develop or produce proprietary hardware products. Our
technologies  also  work  with  a  variety  of  proprietary,  sole-source  technology  offerings  from  third-party  vendors.  We  believe  our
technologies can work within the constraints of any customer or partner system design. We are exploring a subscription or Software as a
Service (SaaS) model for our software.

Direct Sales, Licensing, Integrator and VAR Partnerships

Our products are software based and we typically license our software to end users directly, or through integrator and VAR partners.
Our primary sales and marketing focus is to integrate our software into the platform offerings of large technology infrastructure producers.
We employ dedicated staff to develop relationships with end-users and integrator partners. We further employ technical support staff that
helps customers integrate our technology into their applications, as well as support new strategic development efforts.

We have formed strategic relationships with large Internet and network infrastructure providers, including IBM, Oracle, Microsoft, CA
Technologies and Indigo, to provide enterprise-ready systems to large enterprise customers and stakeholders. We have also established
partnerships with leading technology integrators, including MorphoTrak, McKesson, LexisNexis, Allscripts, Epic, Caradigm, Identimetrics
and HealthCast.

- 4 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
 
  
 
On February 26, 2013, we entered into a strategic partnership with InterDigital Corporation to jointly develop and market biometric

authentication solutions for the mobile credentialing and payments markets.

Competition

In addition to companies that provide existing commonplace methods of restricting access to facilities and logical access points such
as pass cards, PIN numbers, passwords, locks and keys, there are numerous companies  involved  in  the  development,  manufacturing
and  marketing  of  fingerprint  biometrics  products  to  commercial,  government,  law  enforcement  and  prison  markets.  These  companies
include, but are not limited to, 3M (Cogent), NEC, and MorphoTrak.

The  majority  of  sales  for  automated  fingerprint  identification  products  in  the  market  to  date  have  been  deployed  for  government
agencies, healthcare facilities and law enforcement applications. The consumer and commercial markets represent areas of significant
growth potential for biometrics, led by the use of mobile devices.

The epidemic of security and data breaches reported over the past few years is one of the driving factors for identifying new methods
of  protecting  valuable  data.  After  attempting  to  create  a  more  sophisticated  password  or  more  efficient  token  or  PIN,  it’s  become
apparent that each of these methods is easily compromised and the downside risks are significant.

With  respect  to  competing  biometrics  technologies,  each  has  its  strengths  and  weaknesses  and  none  has  emerged  as  a  market

leader:

•     Fingerprint identification is generally viewed as very accurate, inexpensive and non-intrusive;

•     Palmvein scanning is expensive, technique-sensitive, and offers mobility challenges;

•     Iris scanning is viewed as accurate, but the hardware is significantly more expensive; and

•     Facial recognition can have accuracy limitations and is typically highly dependent on ambient lighting conditions, angle of view,

and other factors.

Research and Development

We  concentrate  our  research  and  development  efforts  on  enhancing  the  functionality,  reliability  and  integration  of  our  current
products as well as developing new and innovative products for biometrics. Although we believe that our identification technology is one
of the most advanced and discriminating fingerprint technologies available today, the markets in which we compete are characterized by
rapid technological change and evolving standards. In order to maintain our position in the market, we will continue to upgrade and refine
our existing technologies.

On  February  26,  2013,  we  announced  that  we  entered  into  a  Research  and  Development  Collaboration  Agreement  (the  “R&D
Collaboration”)  with  InterDigital  Communications,  Inc.,  a  subsidiary  of  InterDigital,  Inc.  (“InterDigital”),  a  wireless  research  and
development  company,  InterDigital  is  also  the  parent  company  of  DRNC  Holdings,  Inc.  ("DRNC"),  which  provided  debt  and  equity
financing  to  us  in  February  2013.  The  R&D  Collaboration  will  target  advanced  cloud  security  and  identity  and  access  management
solutions for the mobile market. The R&D Collaboration will bring together our innovative research and product development capabilities
in  fingerprint  biometrics  with  InterDigital’s  research  efforts  in  developing  identity  and  access  management  solutions  for  the  mobile
market. 

During the fiscal years ended December 31, 2013 and 2012, BIO-key spent approximately $1,344,000 and $947,000, respectively,
on its biometric segment’s research, development and engineering. BIO-key’s limited customer base during that time did not directly bear
these costs, which were principally funded through outside sources of equity and debt financing.

Government Regulations

BIO-key is not currently subject to direct regulation by any government agency, other than regulations generally applicable to
businesses or related to specific project requirements. In the event of any international sales, the company would be subject to various
domestic and foreign laws regulating such exports and export activities.

Environmental Regulations

As of the date of this report, BIO-key has not incurred any material expenses relating to our compliance with federal, state, or local

environmental laws and does not expect to incur any material expenses in the foreseeable future.

- 5 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Employees and Consultants

As of March 15, 2014, BIO-key employed seventeen (17) individuals on a full-time basis as follows - six (6) in engineering, customer
support, research and development; three (3) in finance and administration; and eight (8) in sales and marketing. BIO-key also uses the
services of five (5) consultants (full-time), who provide engineering and technical services, and one (1) part-time contracts administrator.

- 6 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
ITEM 1A. RISK FACTORS

Set forth below are the risks that we believe are material to our investors. This section contains forward-looking statements. You
should refer to the explanation of the qualifications and limitations on forward-looking statements appearing just before our Description of
Business section above.

Business and Financial Risks

Based on our lack of sufficient revenue since inception and recurring losses from operations, our auditors have included

an explanatory paragraph in their opinion as to the substantial doubt about our ability to continue as a going concern.

Due to, among other factors, our history of losses and limited revenue, our independent auditors have included an explanatory

paragraph in their opinion for the year ended December 31, 2013 as to the substantial doubt about our ability to continue as a going
concern. Our financial statements have been prepared in accordance with accounting principles generally accepted in the United States,
which contemplate that we will continue to operate as a going concern. Our financial statements do not contain any adjustments that
might result if we are unable to continue as a going concern.

Since our formation, we have historically not generated significant revenue and have sustained substantial operating

losses.

As of December 31, 2013, we had an accumulated deficit of approximately $54,871,000. Since our inception, we have focused
almost exclusively on developing our core technologies and, until the fourth quarter of 2004, had not generated any significant revenue.
In order to increase revenue, we have developed a direct sales force and anticipate the need to retain additional sales, marketing and
technical support personnel and may need to incur substantial expenses. We cannot assure you that we will be able to secure these
necessary resources, that a significant market for our technologies will develop, or that we will be able to achieve our targeted revenue. If
we are unable to achieve revenue or raise capital sufficient to cover our ongoing operating expenses, we will be required to scale back
operations, including marketing and research initiatives, or in the extreme case, discontinue operations.

Our biometric technology has yet to gain widespread market acceptance and we do not know how large of a market will

develop for our technology.

Biometric  technology  has  received  only  limited  market  acceptance,  particularly  in  the  private  sector.  Our  technology  represents  a
novel  security  solution  and  we  have  not  yet  generated  significant  sales.  Although  recent  security  concerns  relating  to  identification  of
individuals and appearance of biometric readers on popular consumer products, including the Apple iPhone 5S®, have increased interest
in  biometrics  generally,  it  remains  an  undeveloped,  evolving  market.  Biometric  based  solutions  compete  with  more  traditional  security
methods  including  keys,  cards,  personal  identification  numbers  and  security  personnel.  Acceptance  of  biometrics  as  an  alternative  to
such traditional methods depends upon a number of factors including:

      •     national or international events which may affect the need for or interest in biometric solutions;

      •     the performance and reliability of biometric solutions;

      •     marketing efforts and publicity regarding these solutions;

      •     public perception regarding privacy concerns;

      •     costs involved in adopting and integrating biometric solutions;

      •     proposed or enacted legislation related to privacy of information; and

      •     competition from non-biometric technologies that provide more affordable, but less robust, authentication (such as tokens and

smart cards).

For these reasons, we are uncertain whether our biometric technology will gain widespread acceptance in any commercial markets

or that demand will be sufficient to create a market large enough to produce significant revenue or earnings. Our future success
depends, in part, upon business customers adopting biometrics generally, and our solution specifically.

- 7 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Biometric technology is a new approach to Internet security which must be accepted in order for our WEB-key ® solution to

generate significant revenue.

Our WEB-key ® authentication initiative represents a new approach to Internet security which has been adopted on a limited basis

by companies which distribute goods, content or software applications over the Internet. The implementation of our WEB-key ® solution
requires the distribution and use of a finger scanning device and integration of database and server side software. Although we believe
our solutions provide a higher level of security for information transmitted over the Internet than existing traditional methods, unless
business and consumer markets embrace the use of a scanning device and believe the benefits of increased accuracy outweigh
implementation costs, our solution will not gain market acceptance.

Our software products may contain defects which will make it more difficult for us to establish and maintain customers.

Although we have completed the development of our core biometric technology, it has only been used by a limited number of
business customers. Despite extensive testing during development, our software may contain undetected design faults and software
errors, or “bugs” that are discovered only after it has been installed and used by a greater number of customers. Any such defect or error
in new or existing software or applications could cause delays in delivering our technology or require design modifications. These could
adversely affect our competitive position and cause us to lose potential customers or opportunities. Since our technologies are intended
to be utilized to secure physical and electronic access, the effect of any such bugs or delays will likely have a detrimental impact on us.
In addition, given that biometric technology generally, and our biometric technology specifically, has yet to gain widespread acceptance
in the market, any delays would likely have a more detrimental impact on our business than if we were a more established company.

While we have commenced a significant sales and marketing effort, we have only begun to develop a significant distribution channel

and may not have the resources or ability to sustain these efforts or generate any meaningful sales.

In order to generate revenue from our biometric products, we are dependent upon independent original equipment

manufacturers, system integrators and application developers, which we do not control. As a result, it may be more difficult to
generate sales.

We market our technology through licensing arrangements with:

       •     Original equipment manufacturers, system integrators and application developers which develop and market products and

applications which can then be sold to end users

       •     Companies which distribute goods, services or software applications over the Internet

As a technology licensing company, our success will depend upon the ability of these manufacturers and developers to effectively

integrate our technology into products and services which they market and sell. We have no control over these licensees and cannot
assure you that they have the financial, marketing or technical resources to successfully develop and distribute products or applications
acceptable to end users or generate any meaningful revenue for us. These third parties may also offer the products of our competitors to
end users.

We face intense competition and may not have the financial and human resources necessary to keep up with rapid

technological changes, which may result in our technology becoming obsolete.

The Internet, facility access control and information security markets are subject to rapid technological change and intense

competition. We compete with both established biometric companies and a significant number of startup enterprises as well as providers
of more traditional methods of access control. Most of our competitors have substantially greater financial and marketing resources than
we do and may independently develop superior technologies, which may result in our technology becoming less competitive or obsolete.
We may not be able to keep pace with this change. If we are unable to develop new applications or enhance our existing technology in a
timely manner in response to technological changes, we will be unable to compete in our chosen markets. In addition, if one or more
other biometric technologies such as voice, face, iris, hand geometry or blood vessel recognition are widely adopted, it would significantly
reduce the potential market for our fingerprint identification technology.

We depend on key employees and members of our management team, including our Chairman of the Board/ Chief

Executive Officer, in order to achieve our goals. We cannot assure you that we will be able to retain or attract such persons.

Our employment contracts with Michael W. DePasquale, our Chairman of the Board and Chief Executive Officer, and Mira LaCous,
our Chief Technology Officer, expire in each year, and renew automatically for successive one year periods unless notice of non-renewal
is provided by the Company. Although the contracts do not prevent them from resigning, they do contain confidentiality and non-compete
clauses which are intended to prevent them from working for a competitor within one year after leaving our Company. Our success
depends on our ability to attract, train and retain employees with expertise in developing, marketing and selling software solutions. In
order to successfully market our technology, we will need to retain additional engineering, technical support and marketing personnel.
The market for such persons remains highly competitive and our limited financial resources will make it more difficult for us to recruit and
retain qualified persons.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

- 8 -

 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
  
 
We cannot assure you that the intellectual property protection for our core technology provides a sustainable competitive

advantage or barrier to entry against our competitors.

Our success and ability to compete is dependent in part upon proprietary rights to our technology. We rely primarily on a combination

of patent, copyright and trademark laws, trade secrets and technical measures to protect our propriety rights. We have filed a patent
application relating to both the optic technology and biometrics solution components of our technology wherein several claims have been
allowed. Over the last few years, the U.S. Patent Office has issued us a series of patents for our Vector Segment fingerprint technology
(VST), and our other core biometric analysis and identification technologies. However, we cannot assure you that we will be able to
adequately protect our technology or other intellectual property from misappropriation in the U.S. and abroad. Any patent issued to us
could be challenged, invalidated or circumvented or rights granted thereunder may not provide a competitive advantage to us.
Furthermore, patent applications that we file may not result in issuance of a patent or, if a patent is issued, the patent may not be issued
in a form that is advantageous to us. Despite our efforts to protect our intellectual property rights, others may independently develop
similar products, duplicate our products or design around our patents and other rights. In addition, it is difficult to monitor compliance
with, and enforce, our intellectual property rights on a worldwide basis in a cost-effective manner. In jurisdictions where foreign laws
provide less intellectual property protection than afforded in the U.S. and abroad, our technology or other intellectual property may be
compromised, and our business would be materially adversely affected. If any of our proprietary rights are misappropriated or we are
forced to defend our intellectual property rights, we will have to incur substantial costs. Such litigation could result in substantial costs and
diversion of our resources, including diverting the time and effort of our senior management, and could disrupt our business, as well as
have a material adverse effect on our business, prospects, financial condition and results of operations. We can provide no assurance
that we will have the financial resources to oppose any actual or threatened infringement by any third party. Furthermore, any patent or
copyrights that we may be granted may be held by a court to infringe on the intellectual property rights of others and subject us to the
payment of damage awards.

We may be subject to claims with respect to the infringement of intellectual property rights of others, which could result in

substantial costs and diversion of our financial and management resources.

Third  parties  may  claim  that  we  are  infringing  on  their  intellectual  property  rights.  We  may  violate  the  rights  of  others  without  our
knowledge.  We  may  expose  ourselves  to  additional  liability  if  we  agree  to  indemnify  our  customers  against  third  party  infringement
claims. While we know of no basis for any claims of this type, the existence of and ownership of intellectual property can be difficult to
verify  and  we  have  not  made  an  exhaustive  search  of  all  patent  filings.  Additionally,  most  patent  applications  are  kept  confidential  for
twelve  to  eighteen  months,  or  longer,  and  we  would  not  be  aware  of  potentially  conflicting  claims  that  they  make.  We  may  become
subject  to  legal  proceedings  and  claims  from  time  to  time  relating  to  the  intellectual  property  of  others  in  the  ordinary  course  of  our
business.  If  we  are  found  to  have  violated  the  intellectual  property  rights  of  others,  we  may  be  enjoined  from  using  such  intellectual
property, and we may incur licensing fees or be forced to develop alternative technology or obtain other licenses. In addition, we may
incur substantial expenses in defending against these third party infringement claims and be diverted from devoting time to our business
and operational issues, regardless of the merits of any such claim.

In  addition,  in  the  event  that  we  recruit  employees  from  other  technology  companies,  including  certain  potential  competitors,  and
these employees are used in the development of portions of products which are similar to the development in which they were involved at
their former employers, we may become subject to claims that such employees have improperly used or disclosed trade secrets or other
proprietary information. If any such claims were to arise in the future, litigation or other dispute resolution procedures might be necessary
to  retain  our  ability  to  offer  our  current  and  future  services,  which  could  result  in  substantial  costs  and  diversion  of  our  financial  and
management resources. Successful infringement or licensing claims against us may result in substantial monetary damages, which may
materially  disrupt  the  conduct  of  our  business  and  have  a  material  adverse  effect  on  our  reputation,  business,  financial  condition  and
results  of  operations.  Even  if  intellectual  property  claims  brought  against  us  are  without  merit,  they  could  result  in  costly  and  time
consuming litigation, and may divert our management and key personnel from operating our business.

If we are unable to effectively protect our intellectual property rights on a worldwide basis, we may not be successful in the

international expansion of our business.

Access to worldwide markets depends in part on the strength of our intellectual property portfolio. There can be no assurance that,
as our business expands into new areas, we will be able to independently develop the technology, software or know-how necessary to
conduct our business or that we can do so without infringing the intellectual property rights of others. To the extent that we have to rely
on  licensed  technology  from  others,  there  can  be  no  assurance  that  we  will  be  able  to  obtain  licenses  at  all  or  on  terms  we  consider
reasonable. The lack of a necessary license could expose us to claims for damages and/or injunction from third parties, as well as claims
for  indemnification  by  our  customers  in  instances  where  we  have  a  contractual  or  other  legal  obligation  to  indemnify  them  against
damages  resulting  from  infringement  claims.  With  regard  to  our  own  intellectual  property,  we  actively  enforce  and  protect  our  rights.
However, there can be no assurance that our efforts will be adequate to prevent the misappropriation or improper use of our protected
technology in international markets.

- 9 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
   
 
We face inherent product liability or other liability risks that could result in large claims against us. 

We have inherent risk of exposure to product liability and other liability claims resulting from the use of our products, especially to the
extent customers may depend on our products in public safety situations that may involve physical harm or even death to individuals, as
well as exposure to potential loss or damage to property. Despite quality control systems and inspection, there remains an ever-present
risk of an accident resulting from a faulty manufacture or maintenance of products, or an act of an agent outside of our or our supplier’s
control. Even if our products perform properly, we may become subject to claims and costly litigation due to the catastrophic nature of the
potential  injury  and  loss.  A  product  liability  claim,  or  other  legal  claims  based  on  theories  including  personal  injury  or  wrongful  death,
made  against  us  could  adversely  affect  operations  and  financial  condition.  Although  we  may  have  insurance  to  cover  product  liability
claims, the amount of coverage may not be sufficient.

We expect that we will need to obtain additional financing to execute our business plan over the long-term, which may not

be available. If we are unable to raise additional capital or generate significant revenue, we may not be able to continue
operations.

Since  our  inception,  we  have  not  generated  sufficient  recurring  revenue  and  have  experienced  substantial  losses.  During  2013,  we
raised  additional  capital  before  expenses  of  approximately  $5,649,800  from  certain  private  investors  through  sales  of  our  equity
securities, less expenses of approximately $608,500. We believe that we have sufficient cash resources to fund operations for at least
the next twelve months. If we are unable to generate sufficient revenue to cover operating expenses and fund our business plan, we will
need to obtain additional third-party financing to (i) conduct the sales, marketing and technical support necessary to execute our plan to
substantially  grow  operations,  increase  revenue  and  serve  a  significant  customer  base;  and  (ii)  provide  working  capital.  We  may,
therefore, need to obtain additional financing through the issuance of debt or equity securities. We cannot assure you that we will ever be
able to secure any such additional financing on terms acceptable to us or at all. If we cannot obtain such financing, we will not be able to
execute our business plan, will be required to reduce operating expenses, and in the extreme case, discontinue operations.

We may not achieve sustainable profitability with respect to the biometric component of our business if we are unable to

maintain, improve and develop the wireless data services we offer.

We believe that our future business prospects depend in part on our ability to maintain and improve our current services and to
develop new ones on a timely basis. Our services will have to achieve market acceptance, maintain technological competitiveness, and
meet an expanding range of customer requirements. As a result of the complexities inherent in our service offerings, major new wireless
data services and service enhancements require long development and testing periods. We may experience difficulties that could delay
or prevent the successful development, introduction or marketing of new services and service enhancements. Additionally, our new
services and service enhancements may not achieve market acceptance. If we cannot effectively develop and improve services, we may
not be able to recover our fixed costs or otherwise become profitable.

If we fail to adequately manage our resources, it could have a severe negative impact on our financial results or stock

price.

We could be subject to fluctuations in technology spending by existing and potential customers. Accordingly, we will have to actively

manage expenses in a rapidly changing economic environment. This could require reducing costs during economic downturns and
selectively growing in periods of economic expansion. If we do not properly manage our resources in response to these conditions, our
results of operations could be negatively impacted.

Our business could be negatively impacted by security threats, including cybersecurity threats, and other disruptions.

As a technology company, we face various security threats, including cybersecurity threats to gain unauthorized access to sensitive
information. Although we utilize various procedures and controls to monitor these threats and mitigate our exposure to such threats, there
can be no assurance that these procedures and controls will be sufficient in preventing security threats from materializing. If any of these
events were to materialize, they could lead to losses of sensitive information, critical infrastructure, personnel or capabilities, essential to
our operations and could have a material adverse effect on our reputation, financial position, results of operations, or cash flows.

- 10 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
  
 
Cybersecurity attacks in particular are evolving and include but are not limited to, malicious software, attempts to gain unauthorized
access  to  data,  and  other  electronic  security  breaches  that  could  lead  to  disruptions  in  critical  systems,  unauthorized  release  of
confidential or otherwise protected information and corruption of data. These events could damage our reputation and lead to financial
losses from remedial actions, loss of business or potential liability.

Risks Related To Our Common Stock

We have issued a substantial number of securities that are convertible into shares of our common stock which could result

in substantial dilution to the ownership interests of our existing shareholders.

As of December 31, 2013, approximately 44,189,000 shares of our common stock were reserved for issuance upon exercise or

conversion of the following securities: 

•

•

44,060,000 shares upon exercise of outstanding stock options and warrants; and

129,000 shares upon exercise of options available for future grant under our existing option plans.

The exercise or conversion of these securities will result in a significant increase in the number of outstanding shares and

substantially dilute the ownership interests of our existing shareholders.

Applicable SEC Rules governing the trading of “penny stocks” limits the trading and liquidity of our common stock, which

may affect the trading price of our common stock.

Our common stock currently trades on the OTC Bulletin Board. Since our common stock continues to trade below $5.00 per share,

our common stock is considered a “penny stock” and is subject to SEC rules and regulations, which impose limitations upon the manner
in which our shares can be publicly traded. These regulations require the delivery, prior to any transaction involving a penny stock, of a
disclosure schedule explaining the penny stock market and the associated risks. Under these regulations, certain brokers who
recommend such securities to persons other than established customers or certain accredited investors must make a special written
suitability determination regarding such a purchaser and receive such purchaser’s written agreement to a transaction prior to sale. These
regulations have the effect of limiting the trading activity of our common stock and reducing the liquidity of an investment in our common
stock.

We  expect  to  raise  additional  funds  in  the  future  through  issuances  of  securities  and  such  additional  funding  may  be

dilutive to stockholders or impose operational restrictions.

We  expect  that  we  will  need  to  raise  additional  capital  in  the  future  to  help  fund  our  operations  through  sales  of  shares  of  our
common stock or securities convertible into shares of our common stock, as well as issuances of debt. Such additional financing may be
dilutive to our stockholders, and debt financing, if available, may involve restrictive covenants which may limit our operating flexibility. If
additional capital is raised through the issuance of shares of our common stock or securities convertible into shares of our common stock,
the  percentage  ownership  of  existing  stockholders  will  be  reduced.  These  stockholders  may  experience  additional  dilution  in  net  book
value  per  share  and  any  additional  equity  securities  may  have  rights,  preferences  and  privileges  senior  to  those  of  the  holders  of  our
common stock.

Because  we  do  not  expect  to  pay  dividends  for  the  foreseeable  future,  investors  seeking  cash  dividends  should  not

purchase shares of common stock.

We have never declared or paid any cash dividends on our common stock. We currently intend to retain future earnings, if any, to
finance  the  expansion  of  our  business.  As  a  result,  we  do  not  anticipate  paying  any  cash  dividends  in  the  foreseeable  future.  Our
payment of any future dividends will be at the discretion of our board of directors after taking into account various factors, including but
not limited to our financial condition, operating results, cash needs, growth plans and the terms of any credit agreements that we may be
a party to at the time. Accordingly, investors seeking cash dividends should not purchase our shares.

Provisions  of  our  certificate  of  incorporation,  bylaws  and  Delaware  law  may  make  a  contested  takeover  of  our  Company

more difficult.

Certain  provisions  of  our  certificate  of  incorporation,  bylaws  and  the  General  Corporation  Law  of  the  State  of  Delaware  ("DGCL")
could deter a change in our management or render more difficult an attempt to obtain control of us, even if such a proposal is favored by
a  majority  of  our  stockholders.  For  example,  we  are  subject  to  the  provisions  of  the  DGCL  that  prohibit  a  public  Delaware  corporation
from engaging in a broad range of business combinations with a person who, together with affiliates and associates, owns 15% or more
of  the  corporation’s  outstanding  voting  shares  (an  "interested  stockholder")  for  three  years  after  the  person  became  an  interested
stockholder,  unless  the  business  combination  is  approved  in  a  prescribed  manner.  Our  certificate  of  incorporation  also  includes
undesignated preferred stock, which may enable our board of directors to discourage an attempt to obtain control of us by means of a
tender offer, proxy contest, merger or otherwise. Finally, our bylaws include an advance notice procedure for stockholders to nominate
directors or submit proposals at a stockholders meeting. Delaware law and our charter may, therefore, inhibit a takeover.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

- 11 -

 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
  
 
EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

The trading price of our common stock may be volatile.

The trading price of our shares has from time to time fluctuated widely and in the future may be subject to similar fluctuations. The
trading price may be affected by a number of factors including the risk factors set forth in this prospectus as well as our operating results,
financial  condition,  announcements  of  innovations  or  new  products  by  us  or  our  competitors,  general  conditions  in  the  biometrics  and
access  control  industries,  and  other  events  or  factors.  Although  we  believe  that  approximately  15  registered  broker  dealers  currently
make a market in our common stock, we cannot assure you that any of these firms will continue to serve as market makers or have the
financial capability to stabilize or support our common stock. A reduction in the number of market makers or the financial capability of any
of  these  market  makers  could  also  result  in  a  decrease  in  the  trading  volume  of  and  price  of  our  shares.  In  recent  years  broad  stock
market  indices,  in  general,  and  the  securities  of  technology  companies,  in  particular,  have  experienced  substantial  price  fluctuations.
Such broad market fluctuations may adversely affect the future-trading price of our common stock.

ITEM 2.

DESCRIPTION OF PROPERTY

We do not own any real estate. We conduct operations from leased premises in Eagan, Minnesota (5,544 square feet), Wall, New
Jersey (4,517 square feet) and North Billerica, Massachusetts (shared services center). We believe our current facilities are adequate for
the foreseeable future.

ITEM 3.

LEGAL PROCEEDINGS

In the normal course of business, the Company periodically becomes involved in litigation. The Company is not a party to any

material pending litigation except as follows: 

On or about March 13, 2014, LifeSouth Community Blood Centers, Inc. filed a lawsuit  against the Company in the Superior
Court of Monmouth County, New Jersey based on an alleged breach of a license agreement seeking return of all amounts paid under the
license in the amount of $718,500. The Company has not been formally served and intends to vigorously defend the action and pursue all
available counterclaims.

ITEM 4.

MINE SAFETY DISCLOSURES

N/A

- 12 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
  
 
PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES

OF EQUITY SECURITIES

Our common stock currently trades on the OTCQB Marketplace under the symbol “BKYI”. The following table sets forth the range of

high and low bid prices per share of our common stock for each of the calendar quarters identified below as reported by the OTCQB
Marketplace. These quotations represent inter-dealer prices, without retail mark-up, markdown or commission, and may not represent
actual transactions.

2013:

High

Low

Quarter ended December 31, 2013
Quarter ended September 30, 2013
Quarter ended June 30, 2013
Quarter ended March 31, 2013

2012:

Quarter ended December 31, 2012
Quarter ended September 30, 2012
Quarter ended June 30, 2012
Quarter ended March 31, 2012

Holders

  $

  $

0.24    $
0.39     
0.40     
0.19     

High

Low

0.09    $
0.10     
0.11     
0.09     

0.15 
0.24 
0.16 
0.09 

0.06 
0.06 
0.06 
0.06 

As of March 26, 2014, the number of stockholders of record of our common stock was 174.

Dividends

We have not paid any cash dividends on our common stock to date, and have no intention of paying any cash dividends on our
common stock in the foreseeable future. The declaration and payment of dividends on our common stock is also subject to the discretion
of our Board of Directors and certain limitations imposed under the Delaware General Corporation Law. The timing, amount and form of
dividends, if any, will depend on, among other things, our results of operations, financial condition, cash requirements and other factors
deemed relevant by our Board of Directors.

Equity Compensation Plan Information

For information regarding our equity compensation plans, see Item 12 included in this Annual Report on Form 10-K.

Recent Sales of Unregistered Securities

a) On February 26, 2013, the Company issued an aggregate of 9,026,935 shares of common stock to DRNC, and certain private
investors for aggregate gross proceeds of approximately $902,693 in cash. The securities were issued and sold pursuant to an
exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, as transactions by an issuer not
involving any public offering.

b) On July 23, 2013, the Company issued an aggregate of 3,500,006 shares of common stock and warrants to purchase 3,500,006

shares of common stock at an amended exercise price of $0.25 per share to certain private investors for aggregate gross
proceeds of approximately $1,050,000 in cash. Each warrant is immediately exercisable and expires five years after the date of
grant. The securities were issued in a private placement transaction solely to a limited number of accredited investors pursuant to
the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D thereunder,
without engaging in any advertising or general solicitation of any kind and without payment of underwriting discounts or
commissions to any person.

c) On August 15, 2013, the Company issued warrants to purchase 300,000 shares of common stock at an exercise price of $0.10
per share to an independent contractor for work associated with the February 2013 common stock and note issuance. The
warrants have a term of three years and vest immediately. These securities were issued in a private placement transaction
exempt from the registration requirements of the Securities Act pursuant to Section 4(2) thereof directly by the Company without
engaging in any advertising or general solicitation of any kind and without payment of underwriting discounts or commissions to
any person.

- 13 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
   
 
 
     
       
 
   
   
   
 
 
   
 
 
     
       
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
d) On October 25, 2013 and November 8, 2013, the Company issued an aggregate of 24,647,337 shares of common stock and

warrants to purchase 24,647,337 share of common stock at an exercise price of $0.25 per share to certain private investors for
aggregate gross proceeds of approximately $3,697,100 in cash. Each warrant is immediately exercisable and expires three years
after the date of grant. The securities were issued in a private placement transaction solely to a limited number of accredited
investors pursuant to the exemption from registration provided by Section 4(2) of the Securities Act and/or Rule 506 of Regulation
D thereunder, without engaging in any advertising or general solicitation of any kind. Placement agency fees for the transaction
were 8% of gross proceeds, and the issuance of warrants to purchase common stock, as detailed below.

e) On November 8, 2013, the Company issued an aggregate of 412,066 shares of common stock to certain private investors for no

consideration, as a result of the anti-dilution rights granted to investors under the July 2013 common stock issuance. The
securities were issued and sold pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as
amended, as transactions by an issuer not involving any public offering.

f) On October 25, 2013 and November 8, 2013, the Company issued warrants to purchase a total of 1,971,786 shares of common

stock at an exercise price of $0.25 per share to the Placement Agent for work associated with the 2013 common stock issuances.
The warrants have a term of three years and vest immediately. These securities were issued in a private placement transaction
exempt from the registration requirements of the Securities Act pursuant to Section 4(2) thereof directly by the Company without
engaging in any advertising or general solicitation of any kind and without payment of underwriting discounts or commissions to
any person.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

- 14 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management’s Discussion And Analysis Of Financial Condition And Results Of Operations, and other parts of this Report
contain forward-looking statements that involve risks and uncertainties. All forward-looking statements included in this Report are based
on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements. Our
actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of factors,
including those set forth in the section captioned “RISK FACTORS” in Item 1A and elsewhere in this Report. The following should be
read in conjunction with our audited financial statements included elsewhere herein.

The following Management’s Discussion And Analysis Of Financial Condition And Results Of Operations (“MD&A”) is intended to help
you understand BIO-key International (the “Company”, “we”, “us” or “our”). MD&A is provided as a supplement to and should be read in
conjunction with our financial statements and the accompanying notes.

OVERVIEW

We  develop  and  market  advanced  fingerprint  biometric  identification  and  identity  verification  technologies,  cryptographic
authentication-transaction security technologies, as well as related identity management and credentialing software solutions. We were
pioneers in developing automated, finger identification technology that supplements or compliments other methods of identification and
verification,  such  as  personal  inspection  identification,  passwords,  tokens,  smart  cards,  ID  cards,  PKI,  credit  card,  passports,  driver’s
licenses, OTP or other form of possession or knowledge-based credentialing.  Advanced BIO-key® technology has been and is used to
improve both the accuracy and speed of competing finger-based biometrics.

In partnerships with OEMs, integrators, and solution providers, we provide biometric software solutions to private and public sector
customers.    We  provide  the  ability  to  positively  identify  and  authenticate  individuals  before  granting  access  to  valuable  corporate
resources, web portals or applications in seconds.  Powered by our patented Vector Segment Technology™ or VST™, WEB-key® and
BSP  development  kits  are  fingerprint  biometric  solutions  that  provide  interoperability  with  all  major  reader  manufacturers,  enabling
application developers and integrators to integrate fingerprint biometrics into their applications. 

We  have  developed  what  we  believe  is  the  most  discriminating  and  effective  commercially  available  finger-based  biometric
technology.  Our  primary  focus  is  in  marketing  and  selling  this  technology  into  commercial  logical  and  physical  privilege  entitlement  &
access  control  markets.    Our  primary  market  focus  includes,  among  others,  mobile  payments  &  credentialing,  online  payments  and
credentialing,  and  healthcare  record  and  payment  data  security.    Our  secondary  focus  includes  government  markets,  primarily  law
enforcement forensic investigation and Homeland Security.

STRATEGIC OUTLOOK AND RECENT DEVELOPMENTS

Historically, our largest market has been access control within highly regulated industries such as healthcare.  However, we believe
the  mass  adoption  of  advanced  smart-phone  and  hand-held  wireless  devices  have  caused  commercial  demand  for  advanced  user
authentication  to  emerge  as  viable.    The  introduction  of  smart-phone  capabilities,  like  mobile  payments  and  credentialing,  could
effectively require biometric user authentication on mobile devices to reduce risks of identity theft, payment fraud and other forms of fraud
in  the  mobile  or  cellular  based  world  wide  web.  As  more  services  and  payment  functionalities,  such  as  mobile  wallets  and  near  field
communication  (NFC),  migrate  to  smart-phones,  the  value  and  potential  risk  associated  with  such  systems  should  grow  and  drive
demand and adoption of advanced user authentication technologies, including fingerprint biometrics and BIO-key solutions.

In  October  2013,  Apple  Computer  Corporation  released  the  Apple  iPhone  5s  smartphone  (“5s”).  We  believe  the  5s  to  be  the  first
broadly distributed smartphone to incorporate fingerprint biometrics in the phone. Since that time, HTC Corporation has also released a
fingerprint  biometric  enabled  smartphone.  We  believe  other  smartphone,  tablet,  laptop  and  related  smart-device  manufacturers  will
additionally  make  fingerprint-enabled  smart  devices  available  for  consumer  applications.  As  devices  with  onboard  fingerprint  sensors
continue to deploy to consumers, we expect that third party application developers will demand the ability to authenticate users of their
respective applications (app’s) with the onboard fingerprint biometric. We further believe that authentication will occur on the device itself
for potentially low-value, and therefore low-risk, use-transactions and that user authentication for high-value transactions will migrate to
the  application  provider’s  authentication  server,  typically  located  within  their  supporting  technology  infrastructure,  or  Cloud.  We  have
developed our technology to enable, on-device authentication as well as network or cloud-based authentication and believe we may be
the only technology vendor capable of providing this flexibility and capability.

We believe there is potential for significant market growth in three key areas:

      •     corporate network access control, including corporate campuses, computer networks and applications;

- 15 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
  
 
 
  
 
      •     consumer mobile credentialing, including mobile payments, credit and payment card programs, data and application access, and

commercial loyalty programs; and.

      •     government services and highly regulated industries, including Medicare, Medicaid, Social Security, drivers licenses, campus and

school ID, passports/visas.

In  the  near-term,  we  expect  to  grow  our  business  within  government  services  and  highly-regulated  industries  in  which  we  have
historically  had  a  strong  presence,  such  as  the  healthcare  industry.    We  believe  that  continued  heightened  security  and  privacy
requirements in these industries will generate increased demand for security solutions, including biometrics.

Over  the  longer  term,  we  intend  to  expand  our  business  into  the  cloud  and  mobile  computing  industries.  The  emergence  of  cloud
computing  and  mobile  computing  are  primary  drivers  of  commercial  and  consumer  adoption  of  advanced  authentication  applications,
including  biometric  and  BIO-key  authentication  capabilities.    As  the  value  of  assets,  services  and  transactions  increases  on  such
networks,  we  expect  that  security  and  user  authentication  demand  should  rise  proportionately.  Our  integration  partners  include  major
web and network technology providers, who we believe will deliver our cloud-applicable solutions to interested service-providers. These
service-providers could include, but are not limited to, financial institutions, web-service providers, consumer payment service providers,
credit reporting services, consumer data service providers, healthcare providers and others. Additionally, our integration partners include
major technology component providers and OEM manufacturers, who we believe will deliver our device-applicable solutions to interested
hardware  manufacturers.  Such  manufacturers  could  include  cellular  handset  and  smartphone  manufacturers,  tablet  manufacturers,
laptop and PC manufacturers, among other hardware manufacturers. 

- 16 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
RESULTS OF OPERATIONS

Consolidated Results of Operations

Two Year % trend

Revenues
Services
License fees and other

Costs and other expenses
Cost of services
Cost of license fees and other

Gross Profit

Operating expenses
Selling, general and administrative
Research, development and engineering

Operating income (loss)

Other income (deductions)
Total other income (deductions)

Net income (loss)

Revenues and Costs of goods sold

Revenues
Service
License & other
Total Revenue

Cost of goods sold
Service
License & other
Total COGS

Revenues

Years ended December 31,

2013

2012

50%   
50%   
100%   

7%   
12%   
19%   
81%   

139%   
68%   
207%   
-127%   

-3%   
-130%   

29%
71%
100%

6%
9%
15%
85%

59%
25%
84%
1%

-1%
0%

2013

2012

$ Chg

% Chg

2013 - 2012

  $

  $

  $

  $

988,003    $
997,973     
1,985,976    $

1,094,731    $
2,741,162     
3,835,893    $

(106,728)    
(1,743,189)    
(1,849,917)    

145,702    $
241,326     
387,028    $

221,027    $
350,706     
571,733    $

(75,325)    
(109,380)    
(184,705)    

-10%
-64%
-48%

-34%
-31%
-32%

For the years ended December 31, 2013 and 2012, service revenues included approximately $326,000 and $407,000, respectively,
of  non-recurring  maintenance  and  support  revenue,  and  approximately  $662,000  and  $688,000,  respectively,  of  recurring  custom
services  revenue.    Recurring  service  revenue  decreased  4%  from  2012  to  2013  increasing  as  we  continued  to  bundle  maintenance
agreements to our expanding customer license base, offset by the delay in a large deployment renewal.

For  the  years  ended  December  31,  2013  and  2012,  license  and  other  revenue  (comprised  of  third  party  hardware  and  royalty)
decreased approximately 64% as a result of several contributing factors.  Software license revenue decreased approximately $1,589,000
or 76%.  During the years ended December 31, 2013 and 2012, we shipped orders from McKesson for their continued deployment of our
identification  technology  in  their  AccuDose®  product  line,  and  for  continued  expansion  of  biometric  ID  deployments  with  commercial
partners  LexisNexis,  Educational  Biometric  Technology,  and  Identimetrics.    Third-party  hardware  sales  decreased  by  approximately
$153,000  (28%),  as  a  result  smaller  healthcare  industry  deployments.    Royalty  income,  from  an  OEM  agreement,  for  the  year  ended
December 31, 2013, decreased 1% to approximately $115,000 from $116,000 during the corresponding period in 2012.

- 17 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
     
 
     
 
   
   
 
   
     
 
     
 
   
   
 
   
   
 
     
 
     
 
     
 
     
 
   
   
 
   
   
 
     
 
     
 
     
 
     
 
   
   
 
 
 
 
   
      
      
 
 
   
     
     
     
 
 
   
      
      
      
  
   
      
      
      
  
   
 
     
       
       
 
     
       
       
 
   
 
 
 
  
 
Costs of goods sold

For the year ended December 31, 2013, cost of service decreased approximately $75,000 primarily as a result of costs associated
with non-recurring custom services revenue. License and other costs for the year ended December 31, 2013 decreased approximately
$109,000 due to the decrease in third party hardware revenue.

Selling, general and administrative

2013

2012

$ Chg

      % Chg 

2013 - 2012

Total

  $ 2,776,559    $ 2,288,903    $

487,656     

21%

Selling, general and administrative expenses for the year ended December 31, 2013 increased 21% from the corresponding period in
2012.  Increases included, sales and marketing personnel, channel marketing expense, and the comparative reversal of the allowance for
doubtful accounts of approximately $377,000 in 2012 as the result of a payment received on an overdue contract.  The forgoing
increases were offset by a decrease in commissions related to reduced revenue, and reduced legal fees due to the settlement of the
Blue Spike litigation in 2012.

Research, development and engineering

2013

2012

$ Chg

      % Chg  

2013 - 2012

Total

  $ 1,344,070    $

947,371    $

396,699     

42%

For the year ended December 31, 2013, research, development and engineering costs increased 42% as we engaged temporary

outside services and hired additional personnel for specific projects.

Other income and expense

Interest income
Interest expense
Income tax
Gain on derivative liabilities

2013

2012

$ Chg

% Chg

2013 - 2012

  $

7    $
(136,484)    
(2,805)    
78,812     

7    $
(24,626)    
—     
—     

—     
(111,858)    
(2,805)  
78,812   

  $

(60,470)   $

(24,619)   $

(35,851)  

—%
454%
n/a 
n/a 

146%

The interest expense for the fiscal year ended 2013 was attributable to the related party note payable and the InterDigital Note, both
of which were repaid in full during the year. Interest expense in 2013 also includes the amortization of deferred costs with respect to the
issuance of the InterDigital Note in February 2013 in the amount of $107,203. As the note and all accumulated interest payable were
repaid by the Company in November 2013, the remaining deferred cost balance was expensed at that time. Interest expense for the 2012
period related solely to the related party note payable.

In 2013, the Company issued various equity securities that contained derivative liabilities. Such derivative liabilities are required to be

marked-to-market each reporting period.

- 18 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
   
 
   
 
 
 
   
   
 
 
     
       
       
       
 
 
 
        
 
   
      
      
 
 
   
     
     
 
   
      
      
      
  
 
 
  
 
 
    
    
 
 
 
   
   
   
 
 
     
       
       
       
 
   
   
   
 
   
      
      
    
  
 
  
 
  
 
LIQUIDITY AND CAPITAL RESOURCES

Operating activities overview

Net cash used for operations during the year ended December 31, 2013 was approximately $2,684,000. Items of note were as

follows:

•

•

•

Positive cash flows related to a decrease in accounts receivable of approximately $321,000 due to a large payment outstanding
in 2012 of approximately $293,000 being paid in the second quarter and approximately $187,000 in payments received from
factored receivables, less an overadvance repayment of approximately $49,000; and

Negative cash flows related to a decrease in accounts payable and accrued expenses of approximately $736,000 due to working
capital management, and an increase in prepaid expenses of approximately $48,000 due to prepaid trade shows, insurance and
software licensing; and

The Company recorded approximately $82,000 of charges in 2013 for the expense of issuing options to employees for services.

Investing activities overview

Net cash used for investing activities during the year ended December 31, 2013 was approximately $129,000 and were due to the

purchase of capital expenditures

Financing activities overview

Net cash provided by financing activities during the year ended December 31, 2013 was approximately $4,753,000 and attributable

primarily to the following activities:

•

•

Positive cash flows from the issuance of shares of common stock and warrants of approximately $5,650,000, and from the
issuance of the InterDigital Note in the principal amount of $497,307.

Negative cash flows of approximately $321,000 from the repayment of the related party note payable, $497,307 from the
repayment of the InterDigital Note, and approximately $576,000 for the one time transaction costs associated with the stock
issuances and the issuance of the InterDigital Note.

LIQUIDITY OUTLOOK

At December 31, 2013, our total cash and cash equivalents were approximately $2,023,000, as compared to approximately $84,000

at December 31, 2012.

As discussed above, we have historically financed our operations through access to the capital markets by issuing secured and
convertible debt securities, convertible preferred stock, common stock, and recently through factoring receivables. We currently require
approximately $400,000 per month to conduct our operations, a monthly amount that we have been unable to consistently achieve
through revenue generation.  During 2013, we generated approximately $1,985,000 of revenue, which is below our average monthly
requirements. We recently completed a private placement of our equity securities resulting in gross proceeds of approximately $3.7
million. As a result, we expect that we have sufficient capital resources to conduct operations for at least the next 6 months,

If we are unable to generate sufficient revenue to meet our goals over the longer term, we will need to obtain additional third-party

financing to (i) conduct the sales, marketing and technical support necessary to execute our plan to substantially grow operations,
increase revenue and serve a significant customer base; and (ii) provide working capital. Therefore, we may need to obtain additional
financing through the issuance of debt or equity securities, or to restructure our financial position through transactions similar to those
consummated during recent years and described above.

Due to several factors, including our history of losses and limited revenue, our independent auditors have included an explanatory
paragraph in their opinion related to our annual financial statements as to the substantial doubt about our ability to continue as a going
concern. Our long-term viability and growth will depend upon the successful commercialization of our technologies and our ability to
obtain adequate financing. To the extent that we require such additional financing, no assurance can be given that any form of additional
financing will be available on terms acceptable to us, that adequate financing will be obtained to meet our needs, or that such financing
would not be dilutive to existing stockholders. If available financing is insufficient or unavailable or we fail to continue to generate
sufficient revenue, we may be required to further reduce operating expenses, delay the expansion of operations, and be unable to pursue
merger or acquisition candidates, or continue as a going concern.

- 19 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
  
 
CAPITAL RESOURCES

Since our inception, our capital needs have been principally met through proceeds from the sale of equity and debt securities.  We
expect capital expenditures to be less than $100,000 during the next twelve months.  We do not currently maintain a line of credit or term
loan with any commercial bank or other financial institution.

The following sets forth our primary sources of capital during the previous two years:

Effective December 31, 2010, Thomas Colatosti (“Colatosti”), our Chairman of the Board agreed to exchange all of his outstanding

shares of Series D Convertible Preferred Stock, including all accrued and unpaid dividends thereon, and the 7% Convertible Promissory
Note dated as of December 28, 2009 in the original principal amount of $64,878, for a new non-convertible 7% Secured Promissory Note
in the original principal amount of $350,804 (the “Colatosti Note”).  In February 2013, the principal balance and accrued interest owing
under the Colatosti Note was repaid in full from the proceeds of the financing with InterDigital described below.

As of December 2011, we entered into a 24-month accounts receivable factoring arrangement with a financial institution (the

“Factor”). Pursuant to the terms of this arrangement, from time to time, we sell to the Factor certain of our accounts receivable balances
on a non-recourse basis for credit approved accounts. The Factor remits 75% of the accounts receivable balance to us (the “Advance
Amount”), with the remaining balance, less fees payable by us, once the Factor collects the full accounts receivable balance from the
customer. Factoring fees range from 2.75% to 15% of the face value of the invoice factored and are determined by the number of days
required for collection of the invoice. In April 2012, the terms were updated from monthly to quarterly, and the 24-month arrangement was
extended to August 1, 2014.  We expect to continue to use this factoring arrangement periodically to assist with our general working
capital requirements due to contractual requirements.

On  February  26,  2013,  we  issued  a  promissory  note  in  the  principal  amount  of  $497,307  (the  “InterDigital  Note”)  to  DRNC.    The
InterDigital  Note  accrues  interest  at  a  rate  of  7%  per  annum,  with  a  default  rate  of  9%  per  annum  while  a  nonpayment  default  is
continuing, matures on December 31, 2015, is secured by all of our tangible and intangible assets, and is subject to acceleration upon an
event of default.  A portion of the proceeds from the sale of the InterDigital Note was used to repay the Colatosti Note in full, and the
remaining  proceeds  were  used  for  general  corporate  purposes.    On  November  22,  2013,  we  repaid  in  full  the  $497,307  balance  due
under the InterDigital Note. In connection with the repayment, DRNC's security interest in all of our tangible and intangible assets was
terminated.

On February 26, 2013, we issued 4,026,935 shares of common stock to DRNC for an aggregate purchase price of $402,693.  

On February 26, 2013, we also issued 5,000,000 shares of common stock to a limited number of investors for an aggregate purchase

price of $500,000.

On July 23, 2013, we issued units to certain investors consisting of 3,500,006 shares of our common stock and warrants to purchase
an additional 3,500,006 shares of our common stock at a purchase price $0.30 per unit, for an aggregate purchase price of $1,050,000. 
The warrants are exercisable at $0.40 per share and expire five years after the date of the grant. On December 2, 2013, we agreed to
reduce the exercise price of the warrants to $0.25 per share.

On  October  25  and  November  8,  2013,  we  issued  an  aggregate  of  24,647,337  units  consisting  of  24,647,337  shares  of  common
stock and warrants to purchase an additional 24,647,337 shares of common stock at a purchase price $0.15 per unit for an aggregate
purchase price of $3,697,100 prior to deduction for placement agent fees and expenses. The warrants are exercisable at $0.25 per share
and  expire  three  years  after  the  date  of  the  grant.  Investors  in  this  offering  have  certain  anti-dilution  rights  which  require  us  to  issue
additional shares of common stock to the investors if within the nine months following November 8, 2013, we sell or issue any common
stock  or  common  stock  equivalents  (other  than  sales  or  issuances  to  directors,  officers,  employees  or  independent  contractors  in  the
ordinary  course  of  business  for  compensation  purposes  and  stock  splits  and  stock  dividends  payable  in  respect  our  common  stock)
having a purchase, exercise or conversion price per share of less than $0.15.

- 20 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
  
 
 
 
 
  
 
OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements that have, or are in the opinion of management reasonably likely to have, a

current or future effect on our financial condition or results of operations.

CRITICAL ACCOUNTING POLICIES

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. The
preparation of these financial statements requires that we make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of
revenue and expenses during the reporting periods. We base our estimates on historical experience and on various other assumptions
that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual
results may differ significantly from these estimates under different assumptions or conditions. There have been no material changes to
these estimates for the periods presented in this Annual Report on Form 10-K.

We believe that of our significant accounting policies, which are described in Note A of the notes to our consolidated financial
statements included in this Annual Report on Form 10-K, the following accounting policies involve a greater degree of judgment and
complexity. Accordingly, these are the policies we believe are the most critical to aid in fully understanding and evaluating our financial
condition and results of operations.

1. Revenue Recognition

Revenues from software licensing are recognized in accordance with ASC 985-605, “Software Revenue Recognition. Accordingly,
revenue from software licensing is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists,
delivery has occurred, the fee is fixed or determinable, and collectability is probable.

The Company intends to enter into arrangements with end users for items which may include software license fees, and services or

various combinations thereof. For each arrangement, revenues will be recognized when evidence of an agreement has been
documented, the fees are fixed or determinable, collection of fees is probable, delivery of the product has occurred and no other
significant obligations remain.

Multiple-Element Arrangements: For multiple-element arrangements, the Company applies the residual method in accordance with

ASC 985-605. The residual method requires that the portion of the total arrangement fee attributable to the undelivered elements be
deferred based on its VSOE of fair value and subsequently recognized as the service is delivered. The difference between the total
arrangement fee and the amount deferred for the undelivered elements is recognized as revenue related to the delivered elements, which
is generally the software license. VSOE of fair value for all elements in an arrangement is based upon the normal pricing for those
products and services when sold separately. VSOE of fair value for support services is additionally determined by the renewal rate in
customer contracts. The Company has established VSOE of fair value for support as well as consulting services.

License Revenues: Amounts allocated to license revenues are recognized at the time of delivery of the software and all other

revenue recognition criteria discussed above have been met.

Revenue from licensing software, which requires significant customization and modification, is recognized using the percentage of

completion method, based on the hours of effort incurred by the Company in relation to the total estimated hours to complete. In
instances where third party hardware, software or services form a significant portion of a customer’s contract, the Company recognizes
revenue for the element of software customization by the percentage of completion method described above. Otherwise, third party
hardware, software, and services are recognized upon shipment or acceptance as appropriate. If the Company makes different
judgments or utilizes different estimates of the total amount of work expected to be required to customize or modify the software, the
timing and revenue recognition, from period to period, and the margins on the project in the reporting period, may differ materially from
amounts reported. Anticipated contract losses are recognized as soon as they become known and are estimable.

Service Revenues: Revenues from services are comprised of maintenance and consulting and implementation services.
Maintenance revenues include providing for unspecified when-and-if available product updates and customer telephone support
services, and are recognized ratably over the term of the service period. Consulting services are generally sold on a time-and-materials
basis and include a range of services including installation of software and assisting in the design of interfaces to allow the software to
operate in customized environments. Services are generally separable from other elements under the arrangement since performance of
the services are not essential to the functionality of any other element of the transaction and are described in the contract such that the
total price of the arrangement would be expected to vary as the result of the inclusion or exclusion of the services. Revenues from
services are generally recognized as the services are performed.

- 21 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
The Company provides customers, free of charge or at a minimal cost, testing kits which potential licensing customers may use to

test compatibility/acceptance of the Company’s technology with the customer’s intended applications.

Costs and other expenses: Includes professional compensation and other direct contract expenses, as well as costs attributable to

the support of client service professional staff, depreciation and amortization costs related to assets used in revenue-generating
activities, and other costs attributable to serving the Company’s client base. Professional compensation consists of payroll costs and
related benefits including stock-based compensation and bonuses. Other direct contract expenses include costs directly attributable to
client engagements, such as out-of-pocket costs including travel and subsistence for client service professional staff, costs of hardware
and software and costs of subcontractors. The allocation of lease and facilities charges for occupied offices is included in costs of service.

The Company accounts for its warranties under the FASB ASC 450 “Contingencies.” The Company generally warrants that its

products are free from defects in material and workmanship for a period of one year from the date of initial delivery to our customers. The
warranty does not cover any losses or damage that occurs as a result of improper installation, misuse or neglect or repair or modification
by anyone other than the Company or its authorized repair agent. The Company’s policy is to accrue anticipated warranty costs based
upon historical percentages of items returned for repair within one year of the initial sale. The Company’s repair rate of products under
warranty has been minimal, and a historical percentage has not been established. The Company’s software license agreements
generally include certain provisions for indemnifying customers against liabilities if the Company’s software products infringe upon a third
party’s intellectual property rights. The Company has not provided for any reserves for warranty liabilities as it was determined to be
immaterial.

2. Impairment or Disposal of Long Lived Assets, including Intangible Assets

We review our long-lived assets, including intangible assets subject to amortization, whenever events or changes in circumstances
indicate that the carrying amount of such an asset may not be recoverable. Recoverability of these assets is measured by comparison of
their carrying amount to the future undiscounted cash flows the assets are expected to generate. If such assets are considered impaired,
the impairment to be recognized is equal to the amount by which the carrying value of the assets exceeds their fair value determined by
either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. In assessing recoverability, we
must make assumptions regarding estimated future cash flows and discount factors. If these estimates or related assumptions change in
the future, we may be required to record impairment charges. Intangible assets with determinable lives are amortized over their
estimated useful lives, based upon the pattern in which the expected benefits will be realized, or on a straight-line basis, whichever is
greater. We did not record any impairment charges in any of the years presented.

3. Research and Development Expenditures

Research and development expenses include costs directly attributable to the conduct of research and development programs
primarily related to the development of our software products and improving the efficiency and capabilities of our existing software. Such
costs include salaries, payroll taxes, employee benefit costs, materials, supplies, depreciation on research equipment, services provided
by outside contractors, and the allocable portions of facility costs, such as rent, utilities, insurance, repairs and maintenance, depreciation
and general support services. All costs associated with research and development are expensed as incurred.

4. Income Taxes

The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for
financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying
value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carryback,
carryforward period available under tax law. The Company evaluates, on a quarterly basis whether, based on all available evidence, if it
is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that
the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740-10, “Income Taxes,” includes the
consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with
reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income
exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent
an operating loss or tax credit carryforward from expiring unused. Because of the Companies historical performance and estimated future
taxable income a full valuation allowance has been established.

- 22 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
  
 
5. Accounting for Stock-Based Compensation

The Company accounts for share based compensation in accordance with the provisions of ASC 718-10, “Compensation — Stock
Compensation,” which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of
compensation over the service period for awards expected to vest. The majority of our share-based compensation arrangements vest
over either a three or four year vesting schedule. The Company expenses its share-based compensation under the ratable method,
which treats each vesting tranche as if it were an individual grant. The fair value of stock options is determined using the Black-Scholes
valuation model, and requires the input of highly subjective assumptions. These assumptions include estimating the length of time
employees will retain their vested stock options before exercising them (the “expected option term”), the estimated volatility of our
common stock price over the option’s expected term, the risk-free interest rate over the option’s expected term, and the Company’s
expected annual dividend yield. Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based
compensation and consequently, the related amount recognized as an expense in the consolidated statements of operations. As
required under the accounting rules, we review our valuation assumptions at each grant date and, as a result, are likely to change our
valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from using the Black-
Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals that will
ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant judgment.
We consider many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.
Actual results, and future changes in estimates, may differ substantially from our current estimates.

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

See financial statements appearing at pages 40-63 of this report

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

N/A

ITEM 9A.

CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the
effectiveness of our disclosure controls and procedures as of December 31, 2013. The term “disclosure controls and procedures,” as
defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls
and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports
that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the
SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that
information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and
communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow
timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures as of December 31,
2013, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable
assurance level.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is
defined in Exchange Act Rule 13a-15(f). Internal control over financial reporting cannot provide absolute assurance of achieving financial
reporting objectives because of its inherent limitations. Internal control over financial reporting is a process that involves human diligence
and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial
reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that
material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these
inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards
to reduce, though not eliminate, the risk. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.

Under the supervision and with the participation of our management, including our CEO and CFO, we have conducted an evaluation

of the effectiveness of our internal control over financial reporting as of December 31, 2013, based upon the framework in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this
evaluation, management has concluded that our internal control over financial reporting was effective as of December 31, 2013.

- 23 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control
over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant
to rules of the Securities and Exchange Commission that permit the company to provide only management’s report in this annual report.

Changes in Internal Control Over Financial Reporting

No change in our internal control over financial reporting occurred during the fiscal quarter ended December 31, 2013 that has

materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B.

OTHER INFORMATION

None.

- 24 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
 
 
ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The following sets forth certain information about each director and executive officer of the Company.

PART III

NAME
Michael W. DePasquale
Charles P. Romeo (a) (c)
John Schoenherr (b) 
Barbara Rivera (b)
Thomas E. Bush, III (c)
Thomas Gilley

Cecilia Welch
Mira K. LaCous
Renat Zhdanov
Scott Mahnken

AGE

POSITIONS HELD

59 
72 
61 
62 
61 
53 

54 
52 
51 
54 

Chairman of the Board of Directors and Chief Executive Officer
Director
Director
Director
Director
Director

Chief Financial Officer
Chief Technology Officer
Vice President, Chief Scientist
Vice President of Marketing

(a) From April 2004 to February 2005, Mr. Romeo was employed by the Company.

(b) Audit Committee Member

(c) Compensation Committee Member

The following is a brief summary of the business experience of each of the above-named individuals:

MICHAEL W. DEPASQUALE has served as the Chief Executive Officer and a Director of the Company since January 3, 2003, and
Chairman of the Board since January 29, 2014. He served as Co-Chief Executive Officer of the Company from July 2005 to August 2006.
Mr. DePasquale brings more than 27 years of executive management, sales and marketing experience to the Company. Prior to joining
us, Mr. DePasquale served as the President and Chief Executive Officer of Prism eSolutions, Inc., a Pennsylvania-based provider of
professional consulting services and online solutions for ISO-9001/14000 certification for customers in manufacturing, healthcare and
government markets, since February 2001. From December 1999 through December 2000, Mr. DePasquale served as Group Vice
President for WRC Media, a New York-based distributor of supplemental education products and software. From January 1996 until
December 1999, Mr. DePasquale served as Senior Vice President of Jostens Learning Corp., a California-based provider of multimedia
curriculum. Prior to Jostens, Mr. DePasquale held sales and marketing management positions with McGraw-Hill and Digital Equipment
Corporation. Mr. DePasquale earned a Bachelor of Science degree from the New Jersey Institute of Technology. He serves on the
Board of Directors and as Treasurer of the International Biometrics and Identification Industry Association. Mr. DePasquale provides the
Board with expert knowledge of the biometric industry, substantial general management experience in the technology sector, and
corporate governance expertise having served as a director for number of non-profit organizations and private companies.

CHARLES P. ROMEO has served as a director of the Company since February 28, 2005 and from January 29, 2003 to April 19,

2004. From April 2004 until February 2005, he served as our Vice President of Sales, Public Safety Division. From November 2005 to
November 2007, Mr. Romeo served as the Vice President of Sales and Marketing for UNICOM, a Rhode Island systems integrator. From
September 2002 until April 2004, Mr. Romeo was the President and Chief Executive Officer of FreedomBridge Technologies, Inc., a
Rhode Island-based consulting firm to technology companies in the homeland security industry specializing in implementing direct and
channel selling programs, strategic alliances and partnerships in the law enforcement market. Prior to founding FreedomBridge, Mr.
Romeo had a 33 year sales and marketing management career with Digital Equipment Corporation, Compaq Computer Corporation and
Hewlett Packard. During his career, Mr. Romeo served as Vice President of Service Sales for a $500 million business unit, and Director
of Public Sector Sales for a $275 million division of Hewlett Packard. Mr. Romeo authored The Sales Manager’s Troubleshooter, Prentice
Hall 1998, which was named as one of the “top 10 must reads” by Sales and Marketing Magazine. Mr. Romeo earned a Bachelor of
Science degree in Mathematics and Economics from the University of Massachusetts and an Executive MBA from Babson College. Mr.
Romeo has significant sales and marketing management experience in the infrastructure and computer hardware and software industries
which strengthens the Board's collective qualifications, skills and experience.

- 25 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
  
 
 
 
 
 
 
 
 
 
 
  
 
  
 
  
 
 
 
 
  
  
 
JOHN SCHOENHERR has served as a Director of the Company since December 30, 2004. Mr. Schoenherr served as Vice

President of Corporate Performance Management for Oracle Corporation from 1995 through 2006. Prior to Oracle he served as Senior
Vice President of Business Intelligence and Analytics at Information Resources, Inc. Mr. Schoenherr has over 25 years of experience in
the area of business intelligence and strategic planning. His career includes a number of product development and management
positions. Mr. Schoenherr has extensive product management and information services industry experience in both the large and small
enterprise sectors, which strengthens the Board's collective qualifications, skills and experience.

BARBARA RIVERA has served as a Director of the Company since January 29, 2014. Ms. Rivera has served as President &
General Manager of Experian Corporation’s U.S. Public Sector Division since April 2012. Prior to Experian, Ms. Rivera worked for SAS
Institute from 2009 through 2012. Ms. Rivera previously worked with firms including IBM, SAP and Oracle and also formed alliances with
system integrators and consulting organizations that work in the public sector. Ms. Rivera has an impressive 25-year track record of
developing and managing business with key federal, state and local organizations such as the Defense Department, the Department of
Justice, the Department of Education, New York City and State as well as the Centers for Medicare and Medicaid Services. Ms. Rivera
has particular knowledge and expertise in business development, technology security development, and executive management which
strengthens the Board's collective qualifications, skills and experience.

THOMAS E. BUSH, III has served as a Director of the Company since January 29, 2014. Since 2009, Mr. Bush has provided

business consulting services through his firm, Tom Bush Consulting. Prior to that, Mr. Bush served with the Federal Bureau of
Investigation for over 33 years. Mr. Bush joined the FBI in September 1975, ultimately becoming the Director of the CJIS division, with
over 2,500 employees and a budget of approximately one billion dollars. Mr. Bush is known for providing critical services in support of the
criminal justice community, with two significant IT projects; Next Generation Identification and N-Dex, were awarded by CJIS with early
increments delivered during his tenure at the FBI. He was the recipient of many awards during his tenure, most notably a Presidential
Rank Award for Meritorious Service in 2007. Mr. Bush's extensive experience in law enforcement, security matters, and the use of
biometric technologies in the government sector provides the Board with a unique perspective on security and public sector matters. 

THOMAS GILLEY has served as a Director of the Company since January 29, 2014. Mr. Gilley is an entrepreneur, hands on
technologist for mobile technologies, digital media, internet of things and social computing. Mr. Gilley served at Apple Computer, in the
Advance Technology Group and Portable Products Group.  Before and after Apple, Mr. Gilley founded several successful companies
including PicoStar, a Silicon Valley incubator-technology investment company where he has been CEO since 1996.  In New York City
Mr. Gilley served as a strategic advisor, investor and technology company founder. Most recently, Mr. Gilley sold his on-demand web
media company to Vignette and acted as CTO throughout the transaction and through the company's ultimate acquisition by OpenText.
Mr. Gilley’s substantial experience in starting, operating and financing technology companies provides the Board with a deep
knowledge of the sales and development cycles applicable to growth businesses in the technology industry.

CECILIA WELCH has served as Chief Financial Officer of the Company since December 21, 2009. Ms. Welch joined us in 2007 as

our Corporate Controller. Prior to joining us, from January 2006 to December 2006, she was the Controller for SavaJe Technologies
(acquired by Sun Microsystems), a developer of advanced mobile telephone software. From October 2004 to January 2006, she was
Controller for Crystal Systems, a manufacturer of sapphire crystals used for industrial, semiconductor, defense and medical applications.
From December 1988 to July 2004, she was the Controller for ATN Microwave (acquired by Agilent Technologies), a manufacturer of
automated test equipment. Ms. Welch has a Bachelor’s degree in Accounting from Franklin Pierce University.

MIRA K. LACOUS has served as Chief technology Officer of the Company since March 13, 2014. Prior to her appointment as Chief

Technology Officer she served as Vice President of Technology & Development of the Company since May 15, 2000. In 2012, Ms.
LaCous was promoted to Senior Vice President of Technology and Development. Ms. LaCous has over 28 years of product/project
management, solution architecture, software development, team leadership and customer relations experience with a background that
includes successfully bringing numerous technologies to market, including automated voice response systems, automated building
control systems, software piracy protection, intranet training materials and testing, page layout and design software, image scanning
software and systems, biometric security, biometric algorithms and more. Ms. LaCous is also the author of six US patented technologies,
multiple international patents, and other patent pending solutions. She has been an officer or director of two other companies; National
Computer Systems (NCS), and TEL-Line Systems. Ms. LaCous has a Bachelor’s in Computer Science from North Dakota State
University. Ms. LaCous also served on the Board of Directors of the Minnesota Sinfonia, a not-for-profit arts and education organization,
as well as its chairperson for two years.

RENAT Z. ZHDANOV has served as Chief Scientist of the Company since November 2001. He has over fifteen years of academic

experience in various fields of mathematics and physics; fifteen years of image processing, pattern recognition, and big data analysis
algorithm development experience and more than ten years of software development experience ranging from database programming to
statistical and analytical programming. Dr. Zhdanov is a recognized expert in mathematical physics and is the author of two books and
more than 130 papers published in leading mathematics and physics journals. Before joining us, he worked as Chief Mathematician and
Visiting Scientist in universities in Ukraine, Germany, Great Britain, Sweden and Spain. Dr. Zhdanov has two PhD degrees in
Mathematical Physics and Differential Equations from the Institute of Mathematics in Kiev, Ukraine. He serves as the member of the
Editorial Board of the “Journal of Applied Mathematics”.

SCOTT MAHNKEN has served as Vice President of Marketing since February 2011. He brings over 20 years of marketing

experience and success through strategic marketing and building dynamic relationships with channel partners. Prior to joining us, from
August 2009 until February 2011, he was President of Edge Marketing, a leading marketing consulting firm in the dental and medical
devices industries. From February 2008 until August 2009, Mr. Mahnken served as Director of Marketing at Milestone Scientific Inc., a
manufacturer of computer controlled anesthetic delivery medical devices. From August 2002 until January 2008, he served as Director of

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
Partnership Relations at ArcMesa Educators, an organization dedicated to providing accredited continuing education to medical and
dental providers. Prior to ArcMesa, Mr. Mahnken held a number of marketing roles with the Lanmark Group a leading healthcare
advertising agency. Mr. Mahnken is a graduate of the University of New Orleans, where he earned a Bachelor’s of Art degree in
Marketing.

- 26 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

  
 
Directors’ Terms of Office

Mr. DePasquale was initially elected as a director in 2003, and was re-elected in 2004. Mr. Schoenherr was initially elected as a
director in 2004. Mr. Romeo was initially elected as a director in 2005. Ms. Rivera, Mr. Bush and Mr. Gilley were all initially appointed as
directors in 2014. Each such director was elected to serve until the Company’s next annual meeting or until his or her successor is duly
elected and qualified in accordance with the By-laws of the Company.

Audit Committee

The Audit Committee is comprised of John Schoenherr and Barbara Rivera. The Board has determined that John Schoenherr is an

“audit committee financial expert” under the applicable rules adopted by the Securities and Exchange Commission. Additionally, the
Audit Committee has the ability on its own to retain independent accountants or consultants whenever it deems appropriate.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the U.S. Securities and Exchange Act of 1934, as amended (the “Exchange Act”), requires the Company’s officers

and directors and persons who own more than ten percent (10%) of the Company’s Common Stock to file with the Securities and
Exchange Commission (“SEC”) initial reports of ownership and reports of changes in ownership of the Company’s Common Stock. Such
officers, directors and ten percent (10%) stockholders are also required by applicable SEC rules to furnish the Company with copies of all
forms filed with the SEC pursuant to Section 16(a) of the Exchange Act. Based solely on its review of the copies of such forms received
by it, or written representations from such persons that no other reports were required for such persons, the Company believes that
during the fiscal year ended December 31, 2013, all Section 16(a) filing requirements applicable to the Company’s officers, directors and
ten percent (10%) stockholders were satisfied in a timely fashion, except for the following:

a) Thomas J. Colatosti — one late Form 4 filing with respect to the issuance of a total of 50,000 options on March 27, 2013.

b) Michael DePasquale — one late Form 4 filing with respect to the issuance of a total of 1,000,000 options on March 27, 2013.

c) Jeff May — one late Form 4 filing with respect to the issuance of a total of 50,000 options on March 27, 2013.

d) Charles Romeo — one late Form 4 filing with respect to the issuance of a total of 50,000 options on March 27, 2013.

e) John Schoenherr — one late Form 4 filing with respect to the issuance of a total of 50,000 options on March 27, 2013.

f) Cecilia Welch — one late Form 4 filing with respect to the issuance of a total of 150,000 options on March 27, 2013.

g) Mira LaCous — one late Form 4 filing with respect to the issuance of a total of 125,000 options on March 27, 2013.

- 27 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code of Ethics

We have adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer

or controller, or persons performing similar functions. Our Code of Ethics is designed to deter wrongdoing and promote: (i) honest and
ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
(ii) full, fair, accurate, timely and understandable disclosure in reports and documents that we file with, or submit to, the SEC and in our
other public communications; (iii) compliance with applicable governmental laws, rules, and regulations; (iv) the prompt internal reporting
of violations of the code to an appropriate person or persons identified in the code; and (v) accountability for adherence to the code.  The
Company intends to disclose amendments or waivers of the Code of Ethics on its website within four business days.  Any person may
obtain a copy of our Code of Ethics free of charge by sending a written request for such to the attention of the Chief Financial Officer of
the Company, 3349 Highway 138, Building A Suite E, Wall, NJ 07719.

Internet Address and SEC Reports

We maintain a website with the address www.BIO-key.com. We are not including the information contained on our website as a part

of, or incorporating it by reference into, this Annual Report on Form 10-K. We make available free of charge through our website our
Annual Reports on Form 10-K (and, where applicable, 10-KSB), Quarterly Reports on Form 10-Q (and, where applicable, 10-QSB) and
Current Reports on Form 8-K, and amendments to these reports, as soon as reasonably practicable after we electronically file such
material with, or furnish such material to, the SEC. Our SEC filings are also available over the Internet at the SEC’s website
www.sec.gov. Members of the public may read and copy any materials the Company files with the SEC at the SEC’s public reference
room at 100 F Street, NE, Washington, DC 20549. Information on the operation of the public reference room is available by calling the
SEC on 1-800-SEC-0330.

- 28 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
  
 
ITEM 11.

EXECUTIVE COMPENSATION

The following table sets forth a summary of the compensation paid to or accrued by our chief executive officer (principal executive
officer) and the two most highly compensated executive officers other than the principal executive officer, who were serving as executive
officers at the end of December 31, 2013, for the fiscal years ended December 31, 2013 and 2012:

Name

Michael W. DePasquale
Chief Executive Officer

Mira K. LaCous
Chief Technology Officer (2)

Scott Mahnken
Vice President Marketing

SUMMARY COMPENSATION TABLE

Fiscal
Year

Salary
($)

Option
Awards
($) 

All Other
Compensation
($)

Total
($)

2013   
2012   

2013   
2012   

2013   
2012   

257,815     
259,324     

148,800(1)    
— 

739     
739     

407,354 
260,063 

151,342     
142,092     

18,600(1)    
— 

545     
545     

170,487 
142,637 

144,292     
124,680     

11,160(1)    
— 

499     
499     

155,951 
125,179 

(1) The aggregate grant date fair value of the option awards was estimated using the Black-Scholes option pricing model, with the

assumptions listed in Note A to the Company’s financial statements. The amount shown in this column represents the grant date fair
value calculated under ASC 718.

(2) Ms. LaCous was appointed as our Chief Technology Officer on March 31, 2014. Prior to her appointment as our Chief Technology

Officer, she served as our Vice President of Technology & Development.

Narrative Disclosure to Summary Compensation Table

Compensation for BIO-key’s executives is comprised of three main components: base salary, annual performance-based cash bonus

and long-term equity awards. We do not target a specific weighting of these three components or use a prescribed formula to establish
pay levels. Rather, the board of directors and compensation committee considers changes in the business, external market factors and
our financial position each year when determining pay levels and allocating between long-term and current compensation for the named
executive officers.

Cash compensation is comprised of base salary and an annual performance-based cash bonus opportunity. The committee

generally seeks to set a named executive officer’s targeted total cash compensation opportunity within a range that is the average of the
applicable peer company and/or general industry compensation survey data, adjusted as appropriate for individual performance and
internal pay equity and labor market conditions.

In setting cash compensation levels, we favor a balance in which base salaries are generally targeted at slightly below the peer

average and a bonus opportunity that is targeted at slightly above the average. The committee believes that this higher emphasis on
performance-based cash bonuses places an appropriate linkage between a named executive officer’s pay, his or her individual
performance and the achievement of specific business goals by placing a higher proportion of annual cash compensation at risk, thereby
aligning executive opportunity with the interests of stockholders.

We include an equity component as part of our compensation package because we believe that equity-based compensation aligns

the long-term interests of our named executive officers with those of stockholders.

These cash and equity compensation components of pay are supplemented by various benefit plans that provide health, life,
accident, disability and severance benefits, most of which are the same as the benefits provided to all of our US based employees.

- 29 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
   
 
 
 
 
 
     
 
 
   
 
 
   
     
       
 
   
 
       
 
 
 
   
 
   
     
       
 
   
 
       
 
 
 
   
 
   
     
       
 
   
 
       
 
 
 
   
 
 
 
 
 
 
 
  
 
Employment Agreements

On March 26, 2010, the Company entered into an employment agreement, effective as of March 25, 2010, with Michael W.
DePasquale to serve as the Chief Executive Officer of the Company until March 24, 2011. The agreement automatically renews for
subsequent one-year terms, unless the employment relationship is terminated by either party, or modified in accordance with the terms
and conditions of the Agreement. Under the Agreement, Mr. DePasquale will be paid an annual base salary of $250,000, subject to
adjustment by the Board or Compensation Committee. In addition to the Base Salary, a “Performance Bonus” may be awarded to
Mr. DePasquale on the basis of the Company achieving certain corporate and strategic performance goals, as determined by the Board
in its sole discretion. The employment agreement contains standard and customary confidentiality, non-solicitation and “work made for
hire” provisions as well as a covenant not to compete which prohibits Mr. DePasquale from doing business with any current or
prospective customer of the Company or engaging in a business competitive with that of the Company during the term of his
employment and for the one year period thereafter. This agreement also contains a number of termination and change in control
provisions as described in “Termination and Change in Control Arrangements” in this Item.

On November 20, 2013, the Company renewed its one-year employment agreement with Mira K. LaCous to serve as the

Vice President of Technology & Development of the Company at an annual base salary of $147,420, subject to adjustment by the Board
or Compensation Committee. On March 13, 2014, in connection with her appointment as Chief Technology Officer, the Company
amended and restated Ms. LaCous’ employment agreement to increase Ms. LaCous’ annual base salary to $202,000. The employment
agreement contains standard and customary confidentiality, technical invention provisions, as well as a covenant not to compete which
prohibits Ms. LaCous from doing business with any current or prospective customer of the Company or engaging in a business
competitive with that of the Company during the term of her employment and for the one year period thereafter. This agreement also
contains a number of termination provisions as described in “Termination and Change in Control Arrangements” in this Item.

On May 15, 2013, the Company entered into an employment agreement with Cecilia Welch to serve as the Vice President Chief

Financial Officer of the Company until May, 2014. The agreement automatically renews for subsequent one-year terms, unless the
employment relationship is terminated by either party, or modified in accordance with the terms and conditions of the agreement. The
employment agreement contains standard and customary confidentiality, technical invention provisions, as well as a covenant not to
compete which prohibits Ms. Welch from doing business with any current or prospective customer of the Company or engaging in a
business competitive with that of the Company during the term of her employment and for the one year period thereafter. This agreement
also contains a number of termination provisions as described in “Termination and Change in Control Arrangements” in this Item.

Stock Option Grants

In the event of any change in the outstanding shares of our common stock by reason of a stock dividend, stock split, combination of

shares, recapitalization, merger, consolidation, transfer of assets, reorganization, conversion or what the board deems to be similar
circumstances, the number and kind of shares subject to outstanding options, and the exercise price of such options shall be
appropriately adjusted in a manner to be determined in the sole discretion of the board. Furthermore, these option agreements contain a
change of control provision as described in “Termination Arrangements” in this Item.

- 30 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
  
 
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END
DECEMBER 31, 2013

The following table sets forth for each named executive officer, information regarding outstanding equity awards as at December 31,

2013:

Option Awards

Number of
securities
underlying
unexercised
options
exercisable
(#)

Number of
securities
underlying
unexercised
options
unexercisable
(#)

Option
exercise
price
($)

Option
expiration
date

500,000     
—     

— 

1,000,000(2)    

75,000     
340,000     
49,999     
—     

— 
— 
25,001(1)    
125,000(2)    

—     
—     

33,334(1)    
75,000(2)    

0.087 
0.174 

0.180 
0.460 
0.140 
0.174 

0.140 
0.174 

2/27/2016
3/27/2020

8/13/2015
1/7/2017
5/11/2018
3/27/2020

5/11/2018
3/27/2020

Name

Michael W. DePasquale

Mira LaCous

Scott Mahnken

(1)
(2)

The options vest May 11, 2014
The options vest equally in three annual installments commencing March 27, 2014

- 31 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
   
 
 
 
 
 
   
 
 
 
 
     
       
 
     
   
   
   
 
   
 
     
       
 
     
   
   
   
 
   
   
 
   
 
   
 
     
       
 
     
   
   
 
   
 
  
 
Narrative Disclosure to Outstanding Equity Awards at Fiscal Year End Table

The following are the material terms of each agreement, contract, plan or arrangement that provide for payments to one or more of

our named executive officers at, following or pursuant to their resignation, retirement or termination, or in connection with a change in
control of the Company.

Termination Arrangements

Our  employment  agreement  with  Mr.  DePasquale  automatically  renews  for  subsequent  one-year  terms,  unless  the  employment
relationship is terminated by either party, or modified in accordance with the terms and conditions of the Agreement. We may terminate
the  Agreement  at  any  time  with  or  without  cause.  In  the  event  of  termination  by  us  without  cause,  we  will  continue  to  pay  Mr.
DePasquale  his  then  current  base  salary  for  the  greater  of  nine  months  from  the  date  of  such  termination  or  the  number  of  months
remaining until the end of the term of the Agreement.

We may terminate our employment agreement with Ms. LaCous at any time with or without cause. In the event of termination by us

without cause, we will continue to pay Ms. LaCous her then current base salary for nine months from the date of such termination.

Our  employment  agreement  with  Ms.  Welch  automatically  renews  for  subsequent  one-year  terms,  unless  the  employment
relationship is terminated by either party, or modified in accordance with the terms and conditions of the Agreement. We may terminate
our employment agreement with Ms. Welch at any time with or without cause. In the event of termination by us without cause, we will
continue to pay Ms. Welch her then current base salary for the greater of six months from the date of such termination or the number of
months remaining until the end of the term of the Agreement.

Change in Control Provisions

The Company’s 1999 Stock Option Plan and 2004 Stock Incentive Plan (the “1999 Plan” and together with the 2004 Plan, the

“Plans”) provide for the acceleration of the vesting of unvested options upon a “Change in Control” of the Company. A Change in Control
is defined in the Plans to include (i) a sale or transfer of substantially all of the Company’s assets; (ii) the dissolution or liquidation of the
Company; (iii) a merger or consolidation to which the Company is a party and after which the prior shareholders of the Company hold
less than 50% of the combined voting power of the surviving corporation’s outstanding securities; (iv) the incumbent directors cease to
constitute at least a majority of the Board of Directors; or (v) a change in control of the Company which would otherwise be reportable
under Section 13 or 15(d) of the Exchange Act.

In the event of a “Change In Control” each Plan provides for the immediate vesting of all options issued thereunder. The 1999 Plan

provides for the Company to deliver written notice to each optionee under the 1999 Plan fifteen (15) days prior to the occurrence of a
Change in Control during which all options issued under the 1999 Plan may be exercised. Thereafter, all options issued under the 1999
Plan which are neither assumed nor substituted in connection with such transaction, automatically expire unless otherwise determined by
the Board. The 2004 Plan enables the Board to provide that all outstanding options be assumed, or equivalent options be substituted by
the acquiring or succeeding corporation upon the occurrence of a “Reorganization Event” as defined. If such Reorganization Event also
constitutes a Change In Control, then such assumed or substituted options shall be immediately exercisable in full. If the acquiring or
succeeding corporation does not agree to assume, or substitute for such options, then the Board, upon written notice to the Participants,
may provide that all unexercised options become exercisable in full as of a specified time prior to the Reorganization Event and terminate
prior to the consummation of the Reorganization Event. Alternatively, if under the terms and conditions of the Reorganization Event,
holders of common stock will receive a cash payment for their shares, then the Board may provide that all Participants receive a cash
payment equal to the difference between the Acquisition Price and the Option Price multiplied by the number of options held by such
Participants.

Options issued to executive officers outside of the Plans contain change in control provisions substantially similar to those contained

in the 1999 Plan.

Our employment agreement with Mr. DePasquale contains a change in control provision that is triggered if Mr. DePasquale is not
offered  continued  employment  with  us  or  any  successor,  or  within  five  years  following  such  Change  of  Control,  we  or  any  successor
terminates Mr. DePasquale’s employment without cause. If this occurs, then we will pay Mr. DePasquale his base salary and benefits
earned but unpaid through the date of termination, and any prorated bonus earned during the then current bonus year, plus two times his
then current base salary.

- 32 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
  
 
DIRECTOR COMPENSATION FOR THE FISCAL YEAR ENDED
DECEMBER 31, 2013

The following table sets forth for each director, information regarding their compensation for the year ended December 31, 2013:

Name
Thomas J. Colatosti
Michael W. DePasquale (1)
Jeffrey J. May
Charles P. Romeo
John Schoenherr

Option
Awards
($) (2)

Total
($)

7,404     
—     
7,404     
7,404     
7,404     

7,404 
— 
7,404 
7,404 
7,404 

(1)

(2)

Refer to Narrative Disclosure to Summary Compensation Table for information pertaining to Mr. DePasquale’s employment
agreement.

The aggregate grant date fair value of the option awards was estimated using the Black-Scholes option pricing model, with the
assumptions listed in Note A to the Company’s financial statements. The amount shown in this column represents the grant date
fair value calculated under ASC 718

Narrative Disclosure to Director Compensation Table

Prior to 2014, the Company’s policy was to issue options to purchase 50,000 shares of common stock to each non-employee director

on an annual basis. The Chair of the Audit Committee typically receives options to purchase an additional 50,000 shares of common
stock on an annual basis. Effective 2014, the Company adopted a policy to pay a cash fee to each non-employee director of $3,000 per
board meeting and $1,000 per telephonic board meeting attended and make an annual grant of options in the discretion of the Board
upon recommendation of the Compensation Committee.

We reimburse each of our non-employee directors for their reasonable expenses incurred in connection with attending meetings of

the board of directors and related committees.

- 33 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
   
 
   
   
   
   
   
  
 
 
 
 
 
 
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS

The following table sets forth, as of March 25, 2014 information with respect to the securities holdings of all persons which the
Company, pursuant to filings with the Securities and Exchange Commission, has reason to believe may be deemed the beneficial
owners of more than five percent (5%) of the Company’s outstanding common stock. The following table also sets forth, as of such date,
the beneficial ownership of the Company’s common stock by all officers and directors, individually and as a group. Unless otherwise
indicated, the address of each person listed below is c/o BIO-key International, Inc., 3349 Highway 138, Building A, Suite E, Wall, NJ
07719.

Name and Address of Beneficial Owner

Michael W. DePasquale
Mira LaCous
John Schoenherr
Renat Zhdanov
Cecilia Welch
Charles P. Romeo
Scott Mahnken

Amount and
Nature
of Beneficial
Ownership(1)

Percentage of
Class(1)

883,333 (2)   
506,665 (3)   
215,596 (4)   
186,666 (5)   
169,999 (6)   
149,286 (7)   
25,000 (8)   

* 
* 
* 
* 
* 
* 
* 

All officers and directors as a group (7) persons

2,136,545 

1.8%

*

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

Less than 1%

The securities “beneficially owned” by an individual are determined in accordance with the definition of “beneficial ownership” set
forth in the regulations promulgated under the Securities Exchange Act of 1934 and, accordingly, may include securities owned
by or for, among others, the spouse and/or minor children of an individual and any other relative who has the same home as such
individual, as well as, other securities as to which the individual has or shares voting or investment power or which each person
has the right to acquire within 60 days through the exercise of options or otherwise. Beneficial ownership may be disclaimed as to
certain of the securities. This table has been prepared based on 115,995,974 shares of common stock outstanding as of March
25, 2014.

Includes 833,333 issuable on exercise of options and 50,000 shares of common stock. Does not include 1,166,667 shares
issuable upon exercise of options subject to vesting.

Consists of 506,665 shares issuable upon exercise of options. Does not include 408,335 shares issuable upon exercise of options
subject to vesting.

Consists of 215,596 shares issuable upon exercise of options. Does not include 108,334 shares issuable upon exercise of options
subject to vesting.

Consists of 186,666 shares issuable upon exercise of options. Does not include 183,334 shares issuable upon exercise of options
subject to vesting.

Consists of 169,999 shares issuable upon exercise of options. Does not include 450,001 shares issuable upon exercise of options
subject to vesting.

Consists of 149,286 shares issuable upon exercise of options. Does not include 108,334 shares issuable upon exercise of options
subject to vesting.

Consists of 25,000 shares issuable upon exercise of options. Does not include 283,334 shares issuable upon exercise of options
subject to vesting.

- 34 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
     
 
     
 
   
   
   
   
   
   
   
 
     
 
     
 
   
   
  
 
 
 
 
 
 
 
 
  
 
The following table sets forth, as of December 31, 2013, information with respect to securities authorized for issuance under equity

compensation plans.

EQUITY COMPENSATION PLAN INFORMATION

Number of
securities
remaining
available for
future issuance
under
equity
compensation
plans
(excluding
securities
reflected in
column (a))
(c)

Number of
securities to be
issued
upon exercise
of outstanding
options,
warrants and
rights
(a)

Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)

Equity compensation plans approved by security holders
Equity compensation plans not approved by security holders
Total

—     
5,390,607    $
5,390,607    $

—     
0.17     
0.17     

— 
129,395 
129,395 

The Company’s 1999 Stock Option Plan (the “1999 Plan”) was adopted by the Board of Directors of the Company on or about

August 31, 1999. The material terms of the 1999 Plan are summarized below.

The 1999 Plan is currently administered by the Board of Directors of the Company (the “Plan Administrator”). The Plan Administrator
is authorized to construe the 1999 Plan and any option issued under the 1999 Plan, select the persons to whom options may be granted,
and determine the number of shares to be covered by any option, the exercise price, vesting schedule and other material terms of such
option. Under the 1999 Plan 2,000,000 shares of common stock were reserved for issuance to officers, employees, directors and
consultants of the Company at exercise prices not less than 85% of the last sale price of the Company’s common stock as reported on
the OTC Bulletin Board on the date of grant. Options have terms of not more than 10 years from the date of grant, are subject to vesting
as determined by the Plan Administrator and are not transferable without the permission of the Company except by will or the laws of
descent and distribution or pursuant to a domestic relations order. Options terminate three (3) months after termination of employment or
other association with the Company or one (1) year after termination due to disability, death or retirement. In the event that termination of
employment or association is for a cause, as that term is defined in the 1999 Plan, options terminate immediately upon such termination.
The Plan Administrator has the discretion to extend options for up to three years from the date of termination or disassociation with the
Company.

The 1999 Plan provides for the immediate vesting of all options in the event of a “Change In Control” of the Company. In the event of
a Change In Control, the Company is required to deliver written notice to each optionee under the 1999 Plan fifteen (15) days prior to the
occurrence of a Change in Control, during which time all options issued under 1999 Plan may be exercised. Thereafter, all options issued
under the 1999 Plan which are neither assumed nor substituted in connection with such transaction, automatically expire, unless
otherwise determined by the Board. Under the 1999 Plan, a “Change In Control” is defined to include (i) a sale or transfer of substantially
all of the Company’s assets; (ii) the dissolution or liquidation of the Company; (iii) a merger or consolidation to which the Company is a
party and after which the prior shareholders of the Company hold less than 50% of the combined voting power of the surviving
corporation’s outstanding securities; (iv) the incumbent directors cease to constitute at least a majority of the Board of Directors; or (v) a
change in control of the Company which would otherwise be reportable under Section 13 or 15(d) of the Exchange Act. The 1999 Plan
expired in August 2009.

As of December 31, 2013, there were outstanding options under the 1999 Plan to purchase 500,000 shares of common stock, and no

shares were available for future grants.

On October 12, 2004, the Board of Directors of the Company approved the 2004 Stock Option Plan (the 2004 Plan). The 2004 Plan

has not yet been presented to stockholders for approval and thus incentive stock options are not available under this plan. Under the
terms of this plan, 4,000,000 shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the
Company at exercise prices which may not be below 85% of fair market value. The term of stock options granted may not exceed ten
years. Options issued under the 2004 Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a
change in control, as defined, all options outstanding vest immediately. The 2004 Plan expires in October 2014.

As of December 31, 2013, there were outstanding options under the 2004 Plan to purchase 3,690,607 shares of common stock, and

options to purchase an aggregate of 129,395 shares were available for future grants.

In addition to options issued under the 1999 and 2004 Plans, the Company has issued options to employees, officers, directors and

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
  
 
 
 
 
   
   
 
   
   
   
 
 
 
 
 
 
 
 
consultants to purchase common stock under the non-plan. As of December 2013, there were outstanding options under the non-plan to
purchase 1,200,000 shares of common stock. The terms of outstanding options under the non-plan are substantially similar to the
provisions of the 1999 Plan and options issued thereunder.

- 35 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

  
 
ITEM 13. 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Employment Arrangements

The Company has entered into employment agreements with Michael W. DePasquale, and Mira LaCous. See “EXECUTIVE

COMPENSATION—Employment Agreements.”

Consulting Arrangement with Thomas J. Colatosti

In connection with his appointment to the Board of Directors in September 2002, and as acting Chief Financial Officer from

November 2008 to December 2009, the Company had entered into a number of consulting arrangements with Thomas Colatosti. Under
the most recent arrangement, which was entered into on January 12, 2010, Mr. Colatosti provided services to the Company and its
subsidiaries and affiliates for the two-year term ended December 31, 2011 at a rate of $5,000 per month. At December 31, 2013 and
December 31, 2012, Mr. Colatosti is owed $50,000. The balance owed to Colatosti is included in accounts payable.

Repayment of Note Payable to Thomas J. Colatosti

Effective as of December 31, 2010, we entered into a Securities Exchange Agreement with Thomas J. Colatosti, pursuant to which
Mr. Colastosti agreed to exchange all of his outstanding shares of Series D Convertible Preferred Stock, including all accrued and unpaid
dividends  thereon,  and  the  7%  Convertible  Promissory  Notes  dated  as  of  December  28,  2009  issued  to  Mr.  Colatosti  in  the  original
principal amount of $64,878 for a new non-convertible 7% Secured Promissory Note in the original principal amount of $350,804. The 7%
Secured  Promissory  Note  was  due  on  December  31,  2012.  Pursuant  to  a  Note  Amendment  and  Extension  Agreement  effective  as  of
December 31, 2012, the maturity date of the 7% Convertible Promissory Note was extended to March 31, 2013. In February 2013, the
principal balance and accrued interest owing under the 7% Convertible Promissory Note was repaid from the proceeds of our February
2013 private offering with InterDigital.

Director Independence

The Board applies the definition of independent director as set forth in NASDAQ Stock Market Rule 4200 (a)(15), as well as

Rule 10A-3 under the Securities Exchange Act of 1934, as amended.

In accordance with this guidance, the Board considers Mr. Schoenherr, Mr. Romeo, Ms. Rivera, Mr. Bush and Mr. Gilley, to be
independent. Mr. Schoenherr and Ms. Rivera are the members of the Company’s Audit Committee, while Mr. Schoenherr, Mr. Romeo,
and Mr. Bush are the members of the Company’s Compensation Committee.

- 36 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
  
 
ITEM 14.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

The following table shows fees for professional services and quarterly audit fees billed to us by Rotenberg Meril Solomon Bertiger &
Guttilla, P.C. (“RMSBG”) for the audit of our annual consolidated financial statements for the years ended December 31, 2013 and 2012:

Audit Fees
Audit-Related Fees
Tax Fees

Total Fees

2013

2012

  $

  $

72,000    $
7,534     
20,000     

99,534    $

72,000 
0 
20,000 

92,000 

Audit Fees consist of fees billed for professional services rendered for the audit of our financial statements and review of the interim

financial statements included in quarterly reports and services that are normally provided by our auditors in connection with statutory and
regulatory filings or engagements. Audit fees also include fees for services provided in connection with registration of securities, comfort
letters, and review of documents filed with the SEC.

Audit-Related Fees consist of fees billed for assurance and related services that are reasonably related to the performance of the

audit or review of our financial statements and which are not reported under audit fees. These services relate primarily to the due
diligence related to registration statements filed by the Company.

Tax Fees consist of fees billed for professional services for tax compliance assistance rendered during the fiscal year.

Audit Committee Pre-Approval Procedures

The Audit Committee of our Board of Directors consisted of John Schoenherr and Jeff May in 2013. Barbara Rivera was appointed to

the Audit Committee in March 2014 to replace Mr. May. The Audit Committee approves the engagement of our independent auditors to
render audit and non-audit services before they are engaged. All of the fees for 2013 and 2012 shown above were pre-approved by the
Audit Committee.

The Audit Committee pre-approves all audit and other permitted non-audit services provided by our independent auditors. Pre-
approval is generally provided for up to one year, is detailed as to the particular category of services and is subject to a monetary limit.
Our independent auditors and senior management periodically report to the Audit Committee the extent of services provided by the
independent auditors in accordance with the pre-approval, and the fees for the services performed to date. The Audit Committee may
also pre-approve particular services on a case-by-case basis.

Our audit committee will not approve engagements of our independent registered public accounting firm to perform non-audit

services for us if doing so will cause our independent registered public accounting firm to cease to be independent within the meaning of
applicable SEC rules. In other circumstances, our audit committee considers, among other things, whether our independent registered
public accounting firm is able to provide the required services in a more or less effective and efficient manner than other available service
providers.

- 37 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
   
 
 
     
       
 
   
   
 
     
       
 
 
 
 
 
 
 
 
 
 
ITEM 15.

EXHIBITS

(a)      The following documents are filed as part of this Report. Portions of Item 15 are submitted as separate sections of this Report:

(1) Financial statements filed as part of this Report:

Reports of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as at December 31, 2013 and 2012

Consolidated Statements of Operations—Years ended December 31, 2013 and 2012

Consolidated Statement of Stockholders’ Equity (Deficit) —Years ended December 31, 2013 and 2012

Consolidated Statements of Cash Flows—Years ended December 31, 2013 and 2012

Notes to Consolidated Financial Statements—December 31, 2013 and 2012

(b)      The exhibits listed in the Exhibits Index immediately preceding such exhibits are filed as part of this Report

- 38 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
 
 
ITEM 8—FINANCIAL STATEMENTS

The following financial statements of BIO-key International, Inc. are included herein at the indicated page numbers:

Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as at December 31, 2013 and 2012
Consolidated Statements of Operations—Years ended December 31, 2013 and 2012
Consolidated Statements of Stockholders’ Equity (Deficit) —Years ended December 31, 2013 and 2012
Consolidated Statements of Cash Flows—Years ended December 31, 2013 and 2012
Notes to the Consolidated Financial Statements—December 31, 2013 and 2012

40
41
42
43
44
45

- 39 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
  
 
Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders
BIO-key International, Inc.
North Billerica, MA

We have audited the accompanying consolidated balance sheets of BIO-key International, Inc. and Subsidiary (the “Company”) as of
December 31, 2013 and 2012, and the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows for the
years then ended. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to
express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial
statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the
accounting principles used and significant estimates made by management as well as evaluating the overall consolidated financial
statement presentation. We believe our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of BIO-
key International, Inc. and Subsidiary as of December 31, 2013 and 2012, and the consolidated results of its operations and its cash
flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
As disclosed in the consolidated financial statements, the Company has suffered substantial net losses in recent years, has an
accumulated deficit at December 31, 2013 and is dependent on debt and equity financing to fund its operations, all of which raise
substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are
disclosed in Note A. The consolidated financial statements do not include any adjustments that might result from the outcome of this
uncertainty.

/s/ Rotenberg Meril Solomon Bertiger & Guttilla, P.C.

ROTENBERG MERIL SOLOMON BERTIGER & GUTTILLA, P.C.
Saddle Brook, New Jersey
March 31, 2014

- 40 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
  
  
  
 
 
BIO-key International, Inc. and Subsidiary
CONSOLIDATED BALANCE SHEETS

ASSETS

Cash and cash equivalents
Accounts receivable, net
Due from factor
Inventory
Prepaid expenses and other
Total current assets
Equipment and leasehold improvements, net
Deposits and other assets
Intangible assets—less accumulated amortization
Total non-current assets

TOTAL ASSETS

LIABILITIES

Accounts payable
Accrued liabilities
Deferred revenue
Note payable – related party
Total current liabilities
Warrant liabilities
TOTAL LIABILITIES

Commitments

  $

  $

  $

December 31,

2013

2012

2,023,349    $
284,025     
2,449     
9,376     
73,482     
2,392,681     
125,062     
8,712     
174,950     
308,724     
2,701,405    $

540,912    $
338,321     
528,160     
-     
1,407,393     
243,077     
1,650,470     

83,989 
604,784 
189,904 
4,186 
25,088 
907,951 
24,267 
8,712 
195,911 
228,890 
1,136,841 

931,276 
593,599 
508,520 
321,428 
2,354,823 
- 
2,354,823 

STOCKHOLDERS’ EQUIY (DEFICIT)

Common stock — authorized, 170,000,000 shares; issued and outstanding; 115,842,315 and

78,155,413 of $.0001 par value at December 31, 2013 and December 31, 2012,
respectively

Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

11,584     
55,909,923     
(54,870,572)    
1,050,935     
2,701,405    $

7,815 
51,062,624 
(52,288,421)
(1,217,982)
1,136,841 

  $

The accompanying notes are an integral part of these statements.

- 41 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
   
 
   
 
     
 
 
   
   
   
   
   
   
   
   
   
 
     
       
 
   
 
     
 
 
   
   
   
   
   
   
 
     
       
 
     
       
 
 
     
       
 
   
 
     
 
 
   
   
   
   
 
 
 
 
 
BIO-key International, Inc. and Subsidiary
CONSOLIDATED STATEMENTS OF OPERATIONS

Revenues
Services
License fees and other

Costs and other expenses
Cost of services
Cost of license fees and other

Gross Profit

Operating expenses
Selling, general and administrative
Research, development and engineering

Operating (loss) income

Other income (deductions)
Interest income
Interest expense
Gain on derivative liabilities
Income taxes

Net (loss) income

Basic and Diluted (Loss) Income per Common Share:

Weighted Average Shares Outstanding:
Basic and Diluted

Years ended December 31,

2013

2012

988,003    $
997,973     
1,985,976     

145,702     
241,326     
387,028     
1,598,948     

2,776,559     
1,344,070     
4,120,629     
(2,521,681)    

7     
(136,484)    
78,812     
(2,805)    
(60,470)    
(2,582,151)   $

1,094,731 
2,741,162 
3,835,893 

221,027 
350,706 
571,733 
3,264,160 

2,288,903 
947,371 
3,236,274 
27,886 

7 
(24,626)
- 
- 
(24,619)
3,267 

(0.03)   $

0.00 

91,791,690     

78,155,413 

  $

  $

  $

The accompanying notes are an integral part of these statements. 

- 42 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
   
 
 
     
       
 
     
       
 
   
 
   
     
       
 
   
   
 
   
   
 
     
       
 
     
       
 
   
   
 
   
   
 
     
       
 
     
       
 
   
   
   
   
 
   
 
     
       
 
 
     
       
 
     
       
 
   
 
 
 
 
BIO-key International, Inc. and Subsidiary
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

Balance as of December 31, 2011

Share-based compensation
Net income

Common Stock

    Additional
    Contributed     Accumulated     

Shares
    78,155,413    $

Amount

Capital

Deficit

Total

7,815    $ 51,012,782    $ (52,291,688)   $ (1,271,091)

—     
—     

—     
—     

49,842     
—     

—     
3,267     

49,842 
3,267 

Balance as of December 31, 2012

    78,155,413    $

7,815    $ 51,062,624    $ (52,288,421)   $ (1,217,982)

Issuance of common stock and warrants pursuant to

security purchase agreements

    37,174,277     

3,718     

5,646,076     

—     

5,649,794 

Issuance of common stock pursuant to anti-dilution

rights

Issuance of common stock in exchange for options

exercised

Derivative liabilities associated with security purchase

agreements

Stock issuance costs
Share-based compensation
Reclassification of derivative liability
Net loss

412,067     

100,558     

41     

10     

(41)    

(10)    

—     

—     

— 

— 

 ---     

—     
—     
---     
—     

 ---     

 (346,214)    

 ---     

 (346,214) 

—     
—     
----     
—     

(648,116)    
81,642     
113,962     
—     

—     
—     
---     
(2,582,151)    

(648,116)
81,642 
113,962 
(2,582,151)

Balance as of December 31, 2013

    115,842,315    $

11,584    $ 55,909,923    $ (54,870,572)   $ 1,050,935 

The accompanying notes are an integral part of these statements.

- 43 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
   
 
     
 
     
 
     
 
 
 
 
 
 
 
 
   
   
   
   
 
 
     
       
       
       
       
 
   
   
 
     
       
       
       
       
 
 
     
       
       
       
       
 
   
   
   
   
   
   
   
 
     
       
       
       
       
 
 
 
 
BIO-key International, Inc. and Subsidiary
CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31,

2013

2012

CASH FLOW FROM OPERATING ACTIVITIES:
Net (loss) income
Adjustments to reconcile net (loss) income to cash (used for) provided by operating

  $

(2,582,151)   $

3,267 

activities:

Allowance for doubtful accounts
Depreciation
Amortization:
Intangible assets
Deferred costs
Share-based compensation
Gain on derivative liabilities
Change in assets and liabilities:
Accounts receivable trade
Due from factor
Inventory
Prepaid expenses and other
Accounts payable
Accrued liabilities
Deferred revenue
Net cash (used for) provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures
Net cash used for investing activities
CASH FLOW FROM FINANCING ACTIVITIES:
Issuances of common stock
Repayment of notes payable – related party
Proceeds from issuance of Note Payable
Repayment of Note Payable
Costs to issue common stock and Note Payable
Net cash provided by (used for) financing activities
NET INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR
CASH AND CASH EQUIVALENTS, END OF YEAR

SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION

Cash paid for:
Interest
Income taxes

Noncash investing and financing activities:
Issuance of warrants for deferred financing costs and equity raise
Unpaid costs to issue common stock
Reclassification of derivative liability to additional paid-in capital

-     
28,618     

(377,000)
28,603 

20,961     
107,203     
81,642     
(78,812)    

320,759     
187,455     
(5,190)    
(48,394)    
(480,364)    
(255,278)    
19,640     
(2,683,911)    

(129,413)    
(129,413)    

5,649,793     
(321,428)    
497,307     
(497,307)    
(575,681)    
4,752,684     
1,939,360     
83,989     
2,023,349    $

11,269 
- 
49,842 
- 

359,562 
(189,904)
4,051 
33,833 
243,835 
(82,234)
(19,572)
65,552 

- 
- 

- 
(25,000)
- 
- 
- 
(25,000)
40,552 
43,437 
83,989 

Years ended December 31,

2013

2012

77,216    $
—     

— 
41,169 

89,637    $
90,000     
113,962     

— 
— 
— 

  $

  $

  $

The accompanying notes are an integral part of these statements. 

- 44 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
   
 
 
     
       
 
     
       
 
     
       
 
   
   
     
       
 
   
   
   
   
     
       
 
   
   
   
   
   
   
   
   
     
       
 
   
   
     
       
 
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
 
     
       
 
     
       
 
   
 
     
       
 
     
       
 
   
   
 
 
   
 
BIO-key International, Inc. and Subsidiary
NOTES TO THE FINANCIAL STATEMENTS
December 31, 2013 and 2012

NOTE A —THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

The Company, founded in 1993, develops and markets proprietary fingerprint identification biometric technology and software

solutions. We also deliver advanced identification solutions and information services to law enforcement departments, public safety
agencies and other government and private sector customers. Our mobile wireless technology provides first responders with critical,
reliable, real-time data and images from local, state and national databases.

Basis of Presentation

We have incurred significant losses to date, and at December 31, 2013, we had an accumulated deficit of approximately $55 million.

In addition, broad commercial acceptance of our technology is critical to the Company’s success and ability to generate future
revenues. At December 31, 2013, our total cash and cash equivalents were approximately $2,023,000, as compared to approximately
$84,000 at December 31, 2012.

As discussed below, the Company has financed itself in the past through access to the capital markets by issuing secured and
convertible debt securities, convertible preferred stock, common stock, and recently through factoring receivables. We currently require
approximately $400,000 per month to conduct our operations, a monthly amount that we have been unable to achieve through revenue
generation.

If the Company is unable to generate sufficient revenue to meet our goals, we will need to obtain additional third-party financing to

(i) conduct the sales, marketing and technical support necessary to execute our plan to substantially grow operations, increase revenue
and serve a significant customer base; and (ii) provide working capital. No assurance can be given that any form of additional financing
will be available on terms acceptable to the Company, that adequate financing will be obtained by the Company in order to meet its
needs, or that such financing would not be dilutive to existing shareholders.

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the

United States of America ("GAAP"), which contemplate continuation of the Company as a going concern, and assumes continuity of
operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The matters
described in the preceding paragraphs raise substantial doubt about the Company’s ability to continue as a going concern. Recoverability
of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company’s ability to
meet its financing requirements on a continuing basis, and become profitable in its future operations. The accompanying consolidated
financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the amounts and
classification of liabilities that might be necessary should the Company be unable to continue in existence.

Summary of Significant Accounting Policies

A summary of the significant accounting policies consistently applied in the preparation of the accompanying consolidated financial

statements follows:

1.  Basis of Consolidation

The accompanying consolidated financial statements include the accounts of BIO-key International, Inc. and its wholly-owned

subsidiary (collectively, the “Company”). Intercompany accounts and transactions have been eliminated in consolidation.

2. Use of Estimates

Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards

Board’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable
guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain
estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable
based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates,
judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as
the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between
these estimates, judgments or assumptions and actual results, our consolidated financial statements will be affected. In many cases, the
accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its
application. There are also areas in which management’s judgment in selecting among available alternatives would not produce a
materially different result.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

- 45 -

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3. Revenue Recognition

Revenues from software licensing are recognized in accordance with ASC 985-605, "Software Revenue Recognition." Accordingly,
revenue from software licensing is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists,
delivery has occurred, the fee is fixed or determinable, and collectability is probable.

The Company intends to enter into arrangements with end users for items which may include software license fees, and services or

various combinations thereof. For each arrangement, revenues will be recognized when evidence of an agreement has been
documented, the fees are fixed or determinable, collection of fees is probable, delivery of the product has occurred and no other
significant obligations remain.

Multiple-Element Arrangements: For multiple-element arrangements, the Company applies the residual method in accordance with

ASC 985-605. The residual method requires that the portion of the total arrangement fee attributable to the undelivered elements be
deferred based on its vendor-specific objective evidence ("VSOE") of fair value and subsequently recognized as the service is delivered.
The difference between the total arrangement fee and the amount deferred for the undelivered elements is recognized as revenue
related to the delivered elements, which is generally the software license. VSOE of fair value for all elements in an arrangement is based
upon the normal pricing for those products and services when sold separately. VSOE of fair value for support services is additionally
determined by the renewal rate in customer contracts. The Company has established VSOE of fair value for support as well as consulting
services.

License Revenues: Amounts allocated to license revenues are recognized at the time of delivery of the software and all other

revenue recognition criteria discussed above have been met.

Revenue from licensing software, which requires significant customization and modification, is recognized using the percentage of

completion method, based on the hours of effort incurred by the Company in relation to the total estimated hours to complete. In
instances where third party hardware, software or services form a significant portion of a customer’s contract, the Company recognizes
revenue for the element of software customization by the percentage of completion method described above. Otherwise, third party
hardware, software, and services are recognized upon shipment or acceptance as appropriate. If the Company makes different
judgments or utilizes different estimates of the total amount of work expected to be required to customize or modify the software, the
timing and revenue recognition, from period to period, and the margins on the project in the reporting period, may differ materially from
amounts reported. Anticipated contract losses are recognized as soon as they become known and are estimable.

Service Revenues: Revenues from services are comprised of maintenance and consulting and implementation services.
Maintenance revenues include providing for unspecified when-and-if available product updates and customer telephone support
services, and are recognized ratably over the term of the service period. Consulting services are generally sold on a time-and-materials
basis and include a range of services including installation of software and assisting in the design of interfaces to allow the software to
operate in customized environments. Services are generally separable from other elements under the arrangement since performance of
the services are not essential to the functionality of any other element of the transaction and are described in the contract such that the
total price of the arrangement would be expected to vary as the result of the inclusion or exclusion of the services. Revenues from
services are generally recognized as the services are performed.

The Company provides customers, free of charge or at a minimal cost, testing kits which potential licensing customers may use to

test compatibility/acceptance of the Company’s technology with the customer’s intended applications.

Costs and other expenses: Includes professional compensation and other direct contract expenses, as well as costs attributable to

the support of client service professional staff, depreciation and amortization costs related to assets used in revenue-generating
activities, and other costs attributable to serving the Company’s client base. Professional compensation consists of payroll costs and
related benefits including stock-based compensation and bonuses. Other direct contract expenses include costs directly attributable to
client engagements, such as out-of-pocket costs including travel and subsistence for client service professional staff, costs of hardware
and software and costs of subcontractors. The allocation of lease and facilities charges for occupied offices is included in costs of service.

The Company accounts for its warranties under the FASB ASC 450 “Contingencies.” The Company generally warrants that its

products are free from defects in material and workmanship for a period of one year from the date of initial receipt by our customers. The
warranty does not cover any losses or damage that occurs as a result of improper installation, misuse or neglect or repair or modification
by anyone other than the Company or its authorized repair agent. The Company’s policy is to accrue anticipated warranty costs based
upon historical percentages of items returned for repair within one year of the initial sale. The Company’s repair rate of products under
warranty has been minimal, and a historical percentage has not been established. The Company’s software license agreements
generally include certain provisions for indemnifying customers against liabilities if the Company’s software products infringe upon a third
party’s intellectual property rights. The Company has not provided for any reserves for warranty liabilities as it was determined to be
immaterial.

- 46 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
    
 
 
 
 
 
 
 
 
 
  
 
4.  Cash Equivalents

Cash equivalents consist of liquid investments with original maturities of three months or less.  At December 31, 2013 and 2012,

cash equivalents consisted of a money market account.

5. Accounts Receivable

Accounts receivable are carried at original amount less an estimate made for doubtful receivables based on a review of all
outstanding amounts on a monthly basis. Management determines the allowance for doubtful receivables by regularly evaluating
individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions.
Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded
when received. Accounts receivable at December 31, 2013 and 2012 consisted of the following:

Accounts receivable
Allowance for doubtful accounts

Accounts receivable, net allowances for doubtful accounts

December 31,

2013

2012

  $

  $

304,551    $
(20,526)    

625,310 
(20,526)

284,025    $

604,784 

The allowance for doubtful accounts for the years ended December 31, 2013 and 2012 is as follows:

Year Ended December 31, 2013
Allowance for Doubtful Accounts
Year Ended December 31, 2012
Allowance for Doubtful Accounts

Balance at
Beginning of
Year

Charged to Costs
and Expenses

Deductions
From
Reserves

Balance at
End of Year  

  $

20,526    $

-    $

-    $

20,526 

  $

397,526    $

-    $

377,000    $

20,526 

The allowance at January 1, 2012 was primarily for one customer whose payments under a contract were behind schedule. $400,000

was collected from the customer in 2012, and subsequently, $150,000 was collected in 2013.

6. Equipment and Leasehold Improvements, Intangible Assets and Depreciation and Amortization

Equipment and leasehold improvements are stated at cost.  Depreciation is provided for in amounts sufficient to relate the cost of

depreciable assets to operations over the estimated service lives, principally using straight-line methods. Leasehold improvements are
amortized over the shorter of the life of the improvement or the lease term, using the straight-line method.

The estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:

Equipment and leasehold improvements
Equipment (years)
Furniture and fixtures (years)
Software (years)
Leasehold improvements

 3 - 5
 3 - 5
3
life or lease term  

Intangible assets consist of patents.  Patent costs are capitalized until patents are awarded. Upon award, such costs are amortized
using the straight-line method over their respective economic lives. If a patent is denied, all costs are charged to operations in that year.

- 47 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
     
       
 
   
 
     
       
 
 
 
 
 
 
   
   
   
     
     
 
       
       
 
     
     
 
       
       
 
 
 
 
 
 
   
 
 
 
 
 
 
 
   
  
 
 
  
 
7. Impairment or Disposal of Long Lived Assets, including Intangible Assets

We review our long-lived assets, including intangible assets subject to amortization, whenever events or changes in circumstances
indicate that the carrying amount of such an asset may not be recoverable. Recoverability of these assets is measured by comparison of
their carrying amount to the future undiscounted cash flows the assets are expected to generate. If such assets are considered impaired,
the impairment to be recognized is equal to the amount by which the carrying value of the assets exceeds their fair value determined by
either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. In assessing recoverability, we
must make assumptions regarding estimated future cash flows and discount factors. If these estimates or related assumptions change in
the future, we may be required to record impairment charges. Intangible assets with determinable lives are amortized over their
estimated useful lives, based upon the pattern in which the expected benefits will be realized, or on a straight-line basis, whichever is
greater. We did not record any impairment charges in any of the years presented.

8. Advertising Expense

The Company expenses the costs of advertising as incurred. Advertising expenses for the years ended December 31, 2013 and

2012 were approximately $178,000 and $114,000, respectively.

9. Deferred Revenue

Deferred revenue includes customer advances and amounts that have been billed per the contractual terms but have not been
recognized as revenue. The majority of these amounts are related to maintenance contracts for which the revenue is recognized ratably
over the applicable term, which generally is 12 months from the date the customer is delivered the products.

10. Research and Development Expenditures

Research and development expenses include costs directly attributable to the conduct of research and development programs
primarily related to the development of our software products and improving the efficiency and capabilities of our existing software. Such
costs include salaries, payroll taxes, employee benefit costs, materials, supplies, depreciation on research equipment, services provided
by outside contractors, and the allocable portions of facility costs, such as rent, utilities, insurance, repairs and maintenance, depreciation
and general support services. All costs associated with research and development are expensed as incurred.

11. Earnings Per Share of Common Stock (“EPS”)

The Company’s EPS is calculated by dividing net income (loss) applicable to common stockholders by the weighted-average number

of common shares outstanding during the reporting period. Diluted EPS includes the effect from potential issuances of common stock,
such as stock issuable pursuant to the exercise of stock options and warrants, when the effect of their inclusion is dilutive. See Note Q
- Earnings Per Share “EPS”, for additional information.

12. Accounting for Stock-Based Compensation

The Company accounts for share based compensation in accordance with the provisions of ASC 718-10, “Compensation — Stock
Compensation,” which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of
compensation over the service period for awards expected to vest. The majority of our share-based compensation arrangements vest
over either a three or four year vesting schedule. The Company expenses its share-based compensation under the ratable method,
which treats each vesting tranche as if it were an individual grant. The fair value of stock options is determined using the Black-Scholes
valuation model, and requires the input of highly subjective assumptions. These assumptions include estimating the length of time
employees will retain their vested stock options before exercising them (the “expected option term”), the estimated volatility of our
common stock price over the option’s expected term, the risk-free interest rate over the option’s expected term, and the Company’s
expected annual dividend yield. Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based
compensation and consequently, the related amount recognized as an expense in the consolidated statements of operations. As
required under the accounting rules, we review our valuation assumptions at each grant date and, as a result, are likely to change our
valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from using the Black-
Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals that will
ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant judgment.
We consider many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.
Actual results, and future changes in estimates, may differ substantially from our current estimates.

The compensation expense recognized under ASC 718 amounted to $81,642 and $49,842 for the years ended December 31, 2013

and 2012 respectively.

- 48 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
The following table presents share-based compensation expenses for continuing operations included in the Company’s consolidated

statements of operations:

Selling, general and administrative
Research, development and engineering

Valuation Assumptions for Stock Options

Year ended
December 31,

2013

2012

  $

  $

60,151    $
21,491     
81,642    $

22,502 
27,340 
49,842 

For the years ended December 31, 2013 and 2012, 2,350,000 and 600,000 stock options were granted, respectively. The fair value

of each option was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk free interest rate
Expected life of options (in years)
Expected dividends
Volatility of stock price

Year ended
December 31,

2013

2012

0.68%   
4.50 

0%   
139%   

0.80%
4.48 

0%
114%

The stock volatility for each grant is determined based on the review of the experience of the weighted average of historical daily
price changes of the Company’s common stock over the expected option term. The expected term was determined using the simplified
method for estimating expected option life, which qualify as “plain-vanilla” options; and the risk-free rate is based on the U.S. Treasury
yield curve in effect at the time of grant for periods corresponding with the expected life of the option.

13. Derivative Liabilities

In connection with the issuances of equity instruments or debt, the Company may issue options or warrants to purchase common stock.
In certain circumstances, these options or warrants may be classified as liabilities, rather than as equity. In addition, the equity instrument
or debt may contain embedded derivative instruments, such as conversion options or listing requirements, which in certain
circumstances may be required to be bifurcated from the associated host instrument and accounted for separately as a derivative liability
instrument. The Company accounts for derivative liability instruments under the provisions of FASB ASC 815, “Derivatives and Hedging.”

14. Deferred Costs

Costs incurred with obtaining and executing debt arrangements are capitalized and amortized to interest expense using the effective
interest method over the term of the related debt.

15. Income Taxes

The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for
financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying
value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carryback,
carryforward period available under tax law. The Company evaluates, on a quarterly basis whether, based on all available evidence, if it
is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that
the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740-10, “Income Taxes,” includes the
consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with
reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income
exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent
an operating loss or tax credit carryforward from expiring unused. Because of the Company’s historical performance and estimated future
taxable income, a full valuation allowance has been established.

The Company accounts for uncertain tax provisions in accordance with ASC 740-10-05 “Accounting for Uncertainty in Income
Taxes.” The ASC clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. The ASC
prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties,
accounting in interim periods, disclosure and transition.

- 49 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
   
 
 
     
       
 
   
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
  
 
16. Recent Accounting Pronouncements

On  July  18,  2013,  the  FASB  issued  Accounting  Standards  Update  No.  2013-11,  “Income  Taxes  (Topic  740):  Presentation  of  an
Unrecognized  Tax  Benefit  When  a  Net  Operating  Loss  Carryforward,  a  Similar  Tax  Loss,  or  a  Tax  Credit  Carryforward  Exists”  (“ASU
2013-11”).  ASU  2013-11  is  expected  to  reduce  diversity  in  practice  by  providing  guidance  on  the  presentation  of  unrecognized  tax
benefits and will better reflect the manner in which  an  entity  would  settle  at  the  reporting  date  any  additional  income  taxes  that  would
result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist.
The amendments in this update should be applied prospectively for annual and interim periods beginning after December 15, 2013. The
Company is currently evaluating the impact of its pending adoption of ASU 2013-11 on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standard if currently adopted would

have a material effect on the accompanying consolidated financial statements.

NOTE B—FACTORING

Due from factor consisted of the following as of December 31:

Year Ended December 31, 2013
Factored accounts receivable
Year Ended December 31, 2012
Factored accounts receivable

Original Invoice
Value

Factored
Amount

Factored
Balance due

  $

  $

9,795    $

7,346    $

2,449 

744,315    $

554,411    $

189,904 

As of December 2011, the Company entered into a 24 month accounts receivable factoring arrangement with a financial institution
(the “Factor”). Pursuant to the terms of the arrangement, the Company, from time to time shall sell to the Factor certain of its accounts
receivable balances on a non-recourse basis for credit approved accounts. The Factor shall then remit 75% of the accounts receivable
balance to the Company (the “Advance Amount”), with the remaining balance, less fees to be forwarded to the Company once the Factor
collects the full accounts receivable balance from the customer. Factoring fees range from 2.75% to 15% of the face value of the invoice
factored, and are determined by the number of days required for collection of the invoice. In April 2012, the terms were updated from
monthly to quarterly, and the 24-month arrangement was extended to August 1, 2014.  

NOTE C—FAIR VALUES OF FINANCIAL INSTRUMENTS

Cash and cash equivalents, accounts receivable, due from factor, accounts payable, accrued liabilities, and notes payable - related

party, are carried at, or approximate, fair value because of their short-term nature.

The fair value of the warrant liabilities and derivative liabilities are measured at fair value using the following assumptions:

Risk free interest rate
Expected term
Expected dividends
Volatility of stock price

    0.07% - 1.38%
    0.25% - 4.65%
  0
    78.0% - 136.2%

For the anti-dilution features, the Company utilized the Monte Carlo simulation. The stock volatility for each grant is determined

based on the review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the
expected term and the risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with
the expected term of the derivative.

The warrant liabilities and derivative liabilities are considered Level 3 liabilities on the fair value hierarchy as the determination of fair
value includes various assumptions about of future activities and the Company’s stock prices and historical volatility as inputs.

- 50 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
 
 
   
   
 
     
       
       
 
     
       
       
 
 
 
 
 
 
 
 
   
 
 
 
   
 
 
 
  
 
The table below provides a reconciliation of the beginning and ending balances for the liabilities measured at fair value using significant
unobservable inputs (Level 3). There were no assets as of or during the year ended December 31, 2013 and no assets or liabilities as of
or during the year ended December 31, 2012 measured using significant unobservable inputs.

Fair Value Measurements Using

Significant Unobservable Inputs (Level 3):

Balance, January 1, 2013

Compensatory Warrant (Note M3)
 Fair value at issuance
 Gain on derivative

 Value at December 31, 2013

Warrants issued Under PI SPA (Note M2c)
 Fair value at issuance
 Gain on derivative

 Value at December 31, 2013

Anti-Dilution Features From July Private Investor SPA (Note M2b)
 Fair value at issuance
 Loss on derivative
 Reclassification to additional paid-in capital

 Value at December 31, 2013

  $

- 

89,637 
(53,267)

36,370 

325,891 
(119,184)

206,707 

20,323 
93,639 
(113,962)

- 

Balance, December 31, 2013

  $

243,077 

NOTE D—CONCENTRATION OF RISK

Financial instruments which potentially subject the Company to risk primarily consist of cash and accounts receivables.

The  Company  maintains  its  cash  and  cash  equivalents  with  various  financial  institutions,  which,  at  times  may  exceed  the  amounts
insured by the Federal Deposit Insurance Corporation. The exposure to the Company is solely dependent upon daily bank balances and
the respective strength of the financial institutions. The Company has not incurred any losses on these accounts. At December 31, 2013
and 2012, amounts in excess of insured limits were $1,534,815 and $0, respectively.

The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to

perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where
appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness
when evaluating the adequacy of the allowances.

- 51 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
  
 
  
     
 
     
 
   
   
  
     
 
   
  
     
 
     
 
   
   
  
     
 
   
  
     
 
     
 
   
   
   
  
     
 
   
  
     
 
  
     
 
 
 
 
 
 
 
 
  
 
The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, as

follows:

Customer A
Customer B

Years Ended December 31,

2013

2012

19%   
15%   

31%
*%

*      Less than 10% of total revenue

The Company had certain customers whose accounts receivable balances individually represented 10% or more of the Company’s

total accounts receivable, as follows:

As of December 31,

2013

2012

50%   
*%   

74%
14%

Customer C
Customer D

*      Less than 10% of total accounts receivable

NOTE E—EQUIPMENT AND LEASEHOLD IMPROVEMENTS

Equipment and leasehold improvements consisted of the following as of December 31:

Equipment
Furniture and fixtures
Software
Leasehold improvements

Less accumulated depreciation and amortization

Total

  $

2013

2012

378,074    $
138,618     
28,624     
53,948     
599,264     

302,052 
99,199 
28,624 
39,975 
469,850 

(474,202)    

(445,583)

  $

125,062    $

24,267 

Depreciation and amortization were $28,618 and $28,603 for the periods ending December 31, 2013 and 2012, respectively.

NOTE F—INTANGIBLE ASSETS

Intangible assets consisted of the following as of December 31:

2013

2012

Gross
Carrying
Amount    

Accumulated
Amortization   

Net
Carrying
Amount    

Gross
Carrying
Amount    

Accumulated
Amortization   

Net
Carrying
Amount  

Patents and patents pending

  $ 287,248    $

(112,298)   $ 174,950    $ 287,248    $

(91,337)   $ 195,911 

Total

  $ 287,248    $

(112,298)   $ 174,950    $ 287,248    $

(91,337)   $ 195,911 

Aggregate amortization expense for the years ended December 31, 2013 and 2012, was $20,961 and $11,269 respectively. The
estimated aggregate amortization expense of intangible assets for the years following December 31, 2014 is approximately $21,000 per
year for 2014 through 2018, and approximately $70,000 thereafter.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

- 52 -

 
 
 
 
 
 
 
 
 
 
 
 
     
 
     
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
     
 
     
 
   
   
 
 
 
 
 
 
 
   
 
 
     
       
 
   
   
   
 
   
 
     
       
 
   
 
     
       
 
 
 
 
 
 
 
 
   
 
 
 
 
     
       
       
       
     
 
       
 
 
     
       
       
       
     
 
       
 
 
   
 
NOTE G—ACCRUED LIABILITIES

Accrued liabilities consisted of the following as of December 31:

Compensation
Compensated absences
Dividends payable
Interest payable – related party
Accrued legal and accounting fees
Sales tax payable
Other

Total

  $

2013

2012

11,102    $
112,609     
3,435     
-     
84,609     
54,382     
72,184     

243,049 
133,535 
3,435 
47,935 
84,954 
53,043 
27,648 

  $

338,321    $

593,599 

NOTE H—RELATED PARTY

Consulting Arrangement with Thomas J. Colatosti (“Colatosti”)

In connection with his appointment to the Board of Directors in September 2002, and as acting Chief Financial Officer from November

2008 to December 2009, the Company had entered into a number of consulting arrangements with Mr. Colatosti. Under the most recent
arrangement, which expired on December 31, 2011, Mr. Colatosti provided services to the Company and its subsidiary for the two-year
term at a rate of $5,000 per month. At December 31, 2013 and December 31, 2012, Mr. Colatosti is owed $50,000. The balance owed to
Colatosti is included in accounts payable.

NOTE I—DEFERRED REVENUE

The components of deferred revenue are as follows as of December 31:

Maintenance contracts
Customer deposit

Total

2013

2012

  $

  $

528,160    $
-     

496,055 
12,465 

528,160    $

508,520 

Maintenance contracts include provisions for unspecified when-and-if available product updates and customer telephone support

services, and are recognized ratably over the term of the service period.

NOTE J—NOTES PAYABLE

The 2010 Exchange Agreement

Effective as of December 31, 2010, the Company entered into a Securities Exchange Agreement (the “2010 Exchange Agreement”)

with Colatosti. Pursuant to the 2010 Exchange Agreement, Mr. Colatosti agreed to exchange all of his outstanding shares of Series D
Convertible Preferred Stock, including all accrued and unpaid dividends thereon, and the 7% Convertible Promissory Note dated as of
December 28, 2009 issued by the Company to Mr. Colatosti in the original principal amount of $64,878 for a new non-convertible 7%
Secured Promissory Note in the original principal amount of $350,804 (the “Colatosti Note”).

The principal and interest under the Colatosti Note was scheduled to be repaid by the Company in cash on December 31, 2012.
Pursuant to a Note Amendment and Extension Agreement effective as of December 31, 2012, the maturity date of the Colatosti Note
was extended to March 31, 2013. In February 2013, the principal balance and accrued interest owing under the Colatosti Note was
repaid from the proceeds of the February 2013 financing (see Note M2a).  At December 31, 2013 and December 31, 2012, the amount
payable under the Colatosti Note was $0 and $321,428, respectively. Accrued interest owed amounted to $0 and $47,935 at December
31, 2013 and 2012, respectively, and was included in accrued liabilities (see Note G).

- 53 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
   
 
 
     
       
 
   
   
   
   
   
   
 
     
       
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
     
       
 
   
 
     
       
 
 
 
 
 
 
 
  
 
The 2013 Note Purchase Agreement

Pursuant to a Note Purchase Agreement (the “InterDigital NPA”) dated February 26, 2013 by and between the Company and DRNC

Holdings, Inc. (“DRNC”), the Company issued to DRNC a promissory note in the principal amount of $497,307 (the “InterDigital Note”),
which accrued interest at a rate of 7% per annum, with a default rate of 9% per annum while a nonpayment default was continuing.

The InterDigital Note was to mature on December 31, 2015, was secured by a security interest in all of the tangible and intangible

assets of the Company, and was subject to acceleration upon an event of default. A portion of the proceeds from the sale of the
InterDigital Note were used to repay the Colatosti Note in full, with the remaining proceeds to be used for other general corporate
purposes.   

On November 22, 2013, the Company repaid in full the $497,307 principal balance and accumulated interest payable due under the
InterDigital Note. In connection with the repayment, DRNC's security interest in all of our tangible and intangible assets was terminated. 

In connection with the InterDigital NPA and InterDigital Note, the Company incurred costs totaling $57,202.  Such costs were

capitalized and were being amortized over the initial expected term of the InterDigital Note using the effective interest method. Once the
InterDigital Note was repaid, the remaining balance of capitalized costs was written off to interest expense.

NOTE K—SEGMENT INFORMATION

The Company has determined that its continuing operations are one discrete segment consisting of Biometric products.

Geographically, North American sales accounted for approximately 97% and 93% of the Company’s total sales for fiscal years 2013 and
2012, respectively.

NOTE L—COMMITMENTS

Operating Leases

The Company does not own any real estate but conducts operations from three leased premises. These non-cancelable operating
leases expire at various dates through 2018. In addition to base rent, the Company pays for property taxes, maintenance, insurance and
other occupancy expenses according to the terms of the individual leases.

Future minimum rental commitments of non-cancelable operating leases are approximately as follows:

Years ending December 31,

2014
2015
2016
2017
2018

  $

142,944 
143,745 
147,726 
152,359 
103,825 

  $

690,599 

Rental expense was approximately $159,000 and $169,000 during 2013 and 2012, respectively.

NOTE M— EQUITY

1. Redeemable Preferred Stock

Within the limits and restrictions provided in the Company’s Certificate of Incorporation, the Board of Directors has the authority,
without further action by the shareholders, to issue up to 5,000,000 shares of preferred stock, $.0001 par value per share, in one or more
series, and to fix, as to any such series, any dividend rate, redemption price, preference on liquidation or dissolution, sinking fund terms,
conversion rights, voting rights, and any other preference or special rights and qualifications.

2. Common Stock

The Company is authorized to issue 170,000,000 shares of common stock, $.0001 par value per share, of which 115,842,315 and

78,155,413 were outstanding as of December 31, 2013 and 2012, respectively.

- 54 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
   
   
   
   
 
     
 
 
 
 
 
 
 
 
  
 
Holders of common stock have equal rights to receive dividends when, as and if declared by the Board of Directors, out of funds
legally available therefor. Holders of common stock have one vote for each share held of record and do not have cumulative voting rights.

Holders of common stock are entitled, upon liquidation of the Company, to share ratably in the net assets available for distribution,
subject to the rights, if any, of holders of any preferred stock then outstanding. Shares of common stock are not redeemable and have no
preemptive or similar rights. All outstanding shares of common stock are fully paid and nonassessable.

Issuances of Common Stock

a) Securities Purchase Agreements dated February 26, 2013

Pursuant to a Securities Purchase Agreement dated February 26, 2013 by and between the Company and DRNC (the “InterDigital

SPA”), the Company issued to DRNC 4,026,935 shares of its common stock at a purchase price $0.10 per share, for an aggregate
purchase price of $402,693. DRNC had anti-dilution rights under the InterDigital SPA that required the Company to issue additional
shares to DRNC on a full-ratchet basis if the Company, within the nine months following February 26, 2013, sold or issued any common
stock or common stock equivalents (other than sales or issuances to directors, officers, employees or independent contractors in the
ordinary course of business for compensation purposes and stock splits and stock dividends payable in respect of the Company’s
common stock) having a purchase, exercise or conversion price per share of less than $0.10.  No shares were issued under the anti-
dilution rights due to subsequent issuances.

Concurrently with the closing of the transactions described above, the Company closed an equity financing with a number of private
investors pursuant to a Securities Purchase Agreement (the “Private Investor SPA”). Pursuant to the Private Investor SPA, the Company
issued to such investors 5,000,000 shares of its common stock at a purchase price $0.10 per share, for an aggregate purchase price of
$500,000.

In connection with the share issuances described above, the Company incurred costs of $46,176, which were offset against

additional paid-in capital.

The shares of common stock were subject to registration clauses.  The Company filed a registration statement on

November 22, 2013 and such registration was declared effective on December 31, 2013.  See Note M2d.

b) Securities Purchase Agreement dated July 23, 2013

Pursuant to a Securities Purchase Agreement, dated July 23, 2013, by and between the Company and a number of private and

institutional investors (the “July Private Investor SPA”), the Company issued units to such investors consisting of 3,500,006 shares of
common stock and 3,500,006 warrants to purchase additional shares of common stock, at a purchase price of $0.30 per unit for an
aggregate purchase price of $1,050,000. The Investors have anti-dilution rights under the July Private Investors SPA that require the
Company to issue additional shares to Investors on an average-weighted basis if the Company, within the six months following July 23,
2013, sells or issues any common stock or common stock equivalents (other than sales or issuances to directors, officers, employees or
independent contractors in the ordinary course of business for compensation purposes and stock splits and stock dividends payable in
respect of the Company’s common stock) having a purchase, exercise or conversion price per share of less than $0.30 (see Note
M2c below where the anti-dilution rights were triggered). The warrants are immediately exercisable at an exercise price of $0.40 per
share and have a term of five years. Effective November 22, 2013, the Company agreed to reduce the exercise price of the warrants to
$0.25 per share.

In connection with the share issuances described above, the Company incurred costs of $135,594, including filing costs for the
associated Registration Statement filed with the SEC pursuant to the registration rights clause in the July 2013 Private Investors SPA,
which were offset against additional paid-in capital.

The shares of common stock and the shares of common stock underlying the warrants were subject to a registration
clause.  The Company filed a registration statement on November 22, 2013 and such registration was declared effective on
December 31, 2013.  See Note M2d.

Based on an evaluation as discussed in FASB ASC 815-15, “Embedded Derivatives” and FASB ASC 815-40-15, “Contracts in
Entity’s Own Equity - Scope and Scope Exceptions,” the Company determined that the anti-dilution feature in the common stock issued
was not considered indexed to its own stock because neither the occurrence of a sale of equity securities by the issuer at market nor the
issuance of another equity contract with a lower strike price is an input to the fair value of a fixed-for-fixed option or forward on equity
shares.  As such, the anti-dilution feature should be bifurcated from the common stock and accounted for as a derivative liability.

The  Company  recorded  derivative  liabilities  equal  to  their  estimated  fair  value  of  $20,323.  Such  amount  was  also  recorded  as  a
reduction  of  additional  paid-in  capital.  As  discussed  in  Item  c)  below,  the  down  round  feature  was  triggered.  As  such,  the  Company
marked-to-market  the  derivative  liabilities  at  the  date  of  issuances.  In  addition,  the  Company  was  required  to  mark-to-market  the
derivative liabilities at December 31, 2013. For the year ended December 31, 2013, the Company recorded a loss on the change in fair
value of the anti-dilution rights of $93,639. The Company did not value the derivative liability at December 31, 2013.  At such date, the
Company determined that it was still highly unlikely that an equity financing would occur prior to January 23, 2014, the expiration date of

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the down round feature.  Such conclusion was based upon the discussion noted in Note M2c below.

- 55 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
As discussed above, the Company agreed to reduce the exercise price of the warrants. Under GAAP, the warrants have to be
revalued and a charge recorded if the value of the warrants under the new terms exceeds the value of the warrants under the old terms
on the day before the change. No charge was recorded as the value of the “new” warrants was less than the value of the “old” warrants.

c) Securities Purchase Agreements dated October 25, 2013 and November 8, 2013

Pursuant  to  a  series  of  Private  Investors  Securities  Purchase  Agreements  (the  “PI  SPA”),  on  October  25,  2013  and  November  8,
2013,  the  Company  issued  to  certain  private  investors  an  aggregate  of  24,647,337  units  consisting  of  24,647,337  shares  of  common
stock (the “Shares”) and warrants to purchase an additional 24,647,337 shares of our common stock (the “Warrants”) for an aggregate
purchase  price  of  $3,697,100.  Each  unit  had  a  purchase  price  of  $0.15  and  consisted  of  one  share  of  common  stock  and  one
Warrant.  The  Warrants  are  immediately  exercisable  at  an  exercise  price  of  $0.25  per  share,  have  a  term  of  three  years,  and  are
exercisable  on  a  cashless  basis  if  at  any  time  following  the  nine  month  anniversary  of  the  issuance  date,  there  is  not  an  effective
registration statement covering the public resale of the shares of Common Stock underlying the Warrants.

In connection with the share issuances described above, the Company incurred costs of $466,346, including filing costs for the
associated Registration Statement filed with the SEC pursuant to the registration rights clause in the October and November 2013
Private Investors SPA, which were offset against additional paid-in capital.

Investors in the PI SPA have certain anti-dilution rights which require the Company to issue additional shares of common stock to the
investors  if  within  the  nine  months  following  November  8,  2013,  the  Company,  sells  or  issues  any  common  stock  or  common  stock
equivalents (other than sales or issuances to directors, officers, employees or independent contractors in the ordinary course of business
for compensation purposes and stock splits and stock dividends payable in respect of the Company’s common stock) having a purchase,
exercise or conversion price per share of less than $0.15.

Based on an evaluation as discussed in FASB ASC 815-15, “Embedded Derivatives” and FASB ASC 815-40-15, “Contracts in
Entity’s Own Equity - Scope and Scope Exceptions,” the Company determined that the anti-dilution features in the common stock issued
were not considered indexed to its own stock because neither the occurrence of a sale of equity securities by the issuer at market nor the
issuance of another equity contract with a lower strike price is an input to the fair value of a fixed-for-fixed option or forward on equity
shares.  As such, the anti-dilution features should be bifurcated from the common stock and accounted for as a derivative liability.

The Company did not value the derivative liability.  One of the key determinants of the Company’s decision to not value the derivative
liability was the high likelihood that a future financing would not occur that would trigger the down round feature.  Whether a future equity
financing would occur would be determined by the cash needs of the Company and management’s willingness to trigger the down round
feature. The Company’s reasons were as follows:

1. The Company’s cash position after the completion of the PI SPA.
2. The stock price of the Company’s common stock.
3. The lack of enough available authorized shares to complete a large offering.

Under GAAP, the Company is required to mark-to-market the derivative liability at the end of each reporting period. The Company did
not  value  the  derivative  liability  at  December  31,  2013.    At  such  date,  the  Company  determined  that  it  was  still  highly  unlikely  that  an
equity financing would occur prior to July 8, 2014, the expiration date of the down round feature.  Such conclusion was based upon the
discussion noted above.

The Shares and shares of common stock underlying the Warrants were subject to a registration rights agreement.  The Company
filed  a  registration  statement  on  November  22,  2013  and  such  registration  was  declared  effective  on  December  31,  2013.    See  Note
M2d.

Pursuant  to  a  placement  agency  letter  agreement,  the  Company  paid  the  placement  agent  cash  commissions  equal  to  8%  of  the
gross proceeds of the offering, reimbursed the placement agent for its reasonable out of pocket expenses, and issued to the placement
agent warrants (the “Placement Agent Warrants”) to purchase an aggregate of 1,971,786 shares of common stock. The Placement Agent
Warrants  have  substantially  the  same  terms  as  the  Warrants  issued  to  the  investors,  except  the  Placement  Agent  Warrants  are
immediately exercisable on a cashless basis. 

- 56 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
  
  
 
 
 
 
 
 
  
 
The  cashless  exercise  features  contained  in  the  warrants  are  considered  to  be  derivatives  and  the  Company  recorded  warrant
liabilities on the consolidated balance sheet. The Company recorded the warrant liabilities equal to their estimated fair value of $325,891.
Such  amount  was  also  recorded  as  a  reduction  of  additional  paid-in  capital.  The  Company  is  required  to  mark-to-market  the  warrant
liabilities at the end of each reporting period. For the year ended December 31, 2013, the Company recorded a gain on the change in fair
value of the cashless exercise features of $119,184, and as of December 31, 2013, the fair value of the cashless exercise features was
$206,707.

The  sales  of  securities  in  this  offering  triggered  the  anti-dilution  rights  set  forth  in  the  July  Private  Investor  SPA.  As  a  result,  in
connection with the October 25, 2013 closing, the per  share  purchase  price  set  forth  in  the  July  Private  Investor  SPA  was  reduced  to
$0.2722 resulting in the issuance of 357,452 additional shares of common stock. In connection with the November 8, 2013 closing, the
per share purchase price set forth in the July Private Investor SPA was further reduced to $0.2684 resulting in the issuance of 54,614
additional shares of common stock.

d) Registration Statement

The Company filed a registration statement on Form S-1 with the SEC to register the public resale of 65,733,688 shares of its

common stock from the above 2013 Securities Purchase Agreements, comprised of:

•
•
•
•

•
•

9,026,935 shares of common stock issued in the February 2013 private offering
3,500,006 shares of common stock issued in the July 2013 private offering
3,500,006 shares of common stock underlying warrants issued in the July 2013 private offering
412,067 shares of common stock issued pursuant to certain anti-dilution rights held by certain investors in the July 2013
private offering
24,647,337 shares of common stock issued in the October 2013 and November 2013 private offerings
24,647,337 shares of common stock underlying warrants issued in the October 2013 and November 2013 private offerings

The registration statement was declared effective on December 31, 2013.

e) Employees’ exercise options

During the year ended December 31, 2013, 179,998 stock options were exercised resulting in the cashless issuance of 100,558

shares of common stock.

- 57 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
3. Warrants

The Company has issued warrants to certain creditors, investors, investment bankers and consultants. A summary of warrant activity

is as follows:

Total

Warrants    

Weighted
average
exercise
price

Weighted
average
remaining
life
(in years)

Aggregate
intrinsic
value

Outstanding, as of December 31, 2011

8,250,000    $

0.30     

Granted
Exercised
Forfeited
Expired
Outstanding, as of December 31, 2012

Granted
Exercised
Forfeited
Expired
Outstanding, as of December 31, 2013
Vested or expected to vest at December 31, 2013
Exercisable at December 31, 2013

—     
—     
—     
—     
8,250,000    $

30,419,129     
—     
—     
—     
38,669,129    $
38,669,129    $
38,669,129    $

—     
—     
—     
—     
0.30     

0.25     
—     
—     
—     
0.26     
0.26     
0.26     

2.97     

2.79     
2.79     
2.79     

— 
— 
— 

On August 15, 2013, the Company issued a warrant to purchase 300,000 shares of the Company’s common stock to an independent

contractor for work associated with the InterDigital Note and InterDigital SPA as additional compensation. The warrant has an exercise
price of $0.10 per share and term of three years. The warrant also contains a cashless exercise feature. The Company valued the
warrant using the following assumptions: risk free rate of 0.70%, stock price of $0.34, and 134.2% volatility for a total valuation of
$89,637. Approximately $50,000 of the value of the warrant was allocated to the InterDigital NPA as deferred financing costs (the balance
of which was written off in November 2013 on repayment of the InterDigital Note), and approximately $39,600 was allocated to
additional-paid-in-capital for the InterDigital SPA.

The cashless exercise feature contained in the warrant is considered to be a derivative and the Company recorded a warrant liability
on the consolidated balance sheet. The Company recorded the warrant liability equal to its estimated fair value of $89,637. The Company
is  required  to  mark-to-market  the  warrant  liabilities  at  the  end  of  each  reporting  period.  For  the  year  ended  December  31,  2013,  the
Company recorded a gain on the change in fair value of the cashless exercise feature of $53,267, and as of December 31, 2013, the fair
value of the cashless exercise feature was $36,370. On March 11, 2014, the 300,000 warrants were exercised resulting in the cashless
issuance of 153,659 shares of common stock.

On January 27, 2014, the Company repurchased a warrant for the purchase of 8,000,000 shares of common stock from the Shaar

Fund Ltd. at a purchase price of $150,000.   The warrant was exercisable at a strike price of $0.30 per share through December 31,
2015.   

NOTE N—STOCK OPTIONS

1999 Stock Option Plan
During 1999, the Board of Directors of the Company adopted the 1999 Stock Option Plan (the 1999 Plan). The 1999 Plan was not
presented to stockholders for approval and thus incentive stock options are not available under the plan. Under the 1999 Plan, 2,000,000
shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices
which may not be below 85% of fair market value. The term of nonstatutory stock options granted may not exceed ten years. Options
issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, as
defined, all options outstanding vest immediately. The 1999 Plan expired in August 2009.

- 58 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
   
   
 
 
     
     
 
       
     
 
 
   
      
  
 
     
     
 
       
     
 
 
   
      
  
   
      
  
   
      
  
   
      
  
   
  
 
     
     
 
       
     
 
 
   
      
  
   
      
  
   
      
  
   
      
  
   
   
   
 
 
 
 
 
 
 
  
 
2004 Stock Option Plan
On October 12, 2004, the Board of Directors of the Company approved the 2004 Stock Option Plan (the 2004 Plan). The 2004 Plan

has not yet been presented to stockholders for approval and thus incentive stock options are not available under this plan. Under the
terms of this plan, 4,000,000 shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the
Company at exercise prices which may not be below 85% of fair market value. The term of stock options granted may not exceed ten
years. Options issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change
in control, as defined, all options outstanding vest immediately. The Plan expires in October 2014.

Non-Plan Stock Options
Periodically, the Company has granted options outside of the 1999 and 2004 Plans to various employees and consultants. In the

event of change in control, as defined, certain of the non-plan options outstanding vest immediately.

Stock Option Activity
Information summarizing option activity is as follows:

Number of Options

  1999 Plan    2004 Plan     Non Plan    

Total

price

Outstanding, as of December 31,
2011

Granted
Exercised
Forfeited
Expired
Outstanding, as of December 31,
2012

    500,000      2,831,836      1,072,576      4,404,412    $

0.22     

—     
—     
—     
—     

600,000     
—     
(164,623)    
(504,941)    

600,000     
—     
—     
—     
(365,378)    
(530,001)    
(707,198)     (1,212,139)    

0.09     
—     
0.09     
0.30     

    500,000      2,762,272     

—      3,262,272    $

0.16     

Weighted
average
exercise    

Weighted
average
remaining
life
    (in years)    

Aggregate
intrinsic  
value

Granted
Exercised
Forfeited
Expired
Outstanding, as of December 31,
2013
Vested or expected to vest at
December 31, 2013
Exercisable at December 31, 2013    

—      1,150,000      1,200,000      2,350,000     
(179,998)    
—     
(41,667)    
—     
—     
—     

(179,998)    
(41,667)    
—     

—     
—     
—     

    500,000      3,690,607      1,200,000      5,390,607    $ 

0.17     
0.13     
0.16     
—     

0.17     

4.48    $ 136,787 

       4,526,934    $
       2,495,595    $ 

0.17     
0.17     

4.17    $ 130,993 
2.74    $ 105,496 

The options outstanding and exercisable at December 31, 2013 were in the following exercise price ranges:

Range of exercise prices

Number of
shares

Options Outstanding
Weighted
average
exercise
price

Weighted
average
remaining 
life (in years)

$ 0.08  - 0.21
 0.22  - 0.40
 0.41  - 0.68
$ 0.07  - 0.68

4,980,607  $
70,000  
340,000  
5,390,607   

0.14  
0.40  
0.46  

4.60 
3.02 
3.02 

Options Exercisable

Weighted
average
exercise
price

0.12  
0.40  
0.46  

Number
exercisable

2,085,595  $
70,000  
340,000  
2,495,595   

The aggregate intrinsic value in the table above represents the total intrinsic value, based on the Company’s closing stock price of
$0.16 as of December 31, 2013, which would have been received by the option holders had all option holders exercised their options as
of that date. The total number of in-the-money options exercisable as of December 31, 2013 was 1,820,595.

- 59 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
  
 
 
 
   
   
 
   
 
 
     
       
       
       
     
 
       
       
 
      
  
 
     
       
       
       
     
 
       
       
 
   
      
  
   
      
  
   
      
  
   
      
  
      
  
 
     
       
       
       
     
 
       
       
 
   
      
  
   
      
  
   
      
  
   
      
  
   
      
      
      
      
 
 
 
 
 
 
  
 
  
  
 
  
  
 
 
 
 
 
 
 
 
    
 
  
 
  
 
The weighted average fair value of options granted during the years ended December 31, 2013 and 2012 was $0.15 and $0.05 per
share, respectively. The total intrinsic value of options exercised during the years ended December 31, 2013 and 2012 was $31,643, and
$0, respectively. The total fair value of shares vested during the years ended December 31, 2013 and 2012 was $42,058 and $70,026
respectively.

As of December 31, 2013 future compensation cost related to nonvested stock options is $335,020 and will be recognized over an

estimated weighted average period of 2.10 years.

On March 13, 2014, the Board of Directors granted options to purchase 3,420,000 shares of the Company’s common stock to certain

employees and members of the Board of Directors. The terms of the options include the following:

Exercise price - $0.205 per share
Vesting period – Three years
Expiration date – March 21, 2021

- 60 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
NOTE O—INCOME TAXES

There was no provision for federal or state taxes as at December 31, 2013.  

The Company has deferred taxes due to income tax credits, net operating loss carryforwards, and the effect of temporary differences

between the carrying values of certain assets and liabilities for financial reporting and income tax purposes. Significant components of
deferred taxes are as follows at December 31:

Current asset:
Accrued compensation
Accounts receivable allowance
Non-current asset (liability):
Stock-based compensation
Basis differences in fixed assets
Basis differences in intangible assets
Net operating loss and credit carryforwards
Valuation allowances

2013

2012

  $

49,000    $
8,000     

128,000 
8,000 

205,000     
(19,000)    
(69,000)    
17,217,000     
(17,391,000)    

336,000 
(10,000)
(77,000)
16,143,000 
(16,528,000)

  $

—    $

— 

The Company has a valuation allowance against the full amount of its net deferred taxes due to the uncertainty of realization of the

deferred tax assets due to operating loss history of the Company. The Company currently provides a valuation allowance against
deferred taxes when it is more likely than not that some portion, or all of its deferred tax assets will not be realized. The valuation
allowance could be reduced or eliminated based on future earnings and future estimates of taxable income. Similarly, income tax benefits
related to stock options exercised have not been recognized in the financial statements.

As of December 31, 2013, the Company has federal net operating loss carryforwards of approximately $47,600,000 subject to
expiration between 2019 and 2033.  These net operating loss carryforwards are subject to the limitations under Section 382 of the
Internal Revenue Code due to changes in the equity ownership of the Company.

A reconciliation of the effective income tax rate on operations reflected in the Statements of Operations to the US Federal statutory

income tax rate is presented below.

US Federal statutory income tax rate
Permanent differences
Effect of net operating loss

Effective tax rate

2013

2012

34%   
(3)    
(31)    

—%   

34%

831 
(865)

—%

The Company has not been audited by the Internal Revenue Service (“IRS”) or any states in connection with income taxes. The
Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The periods from 2010 through 2013
remain open to examination by the IRS and state jurisdictions. The Company believes it is not subject to any tax audit risk beyond those
periods. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of
income tax expense. The Company does not have any accrued interest or penalties associated with any unrecognized tax benefits, nor
was any significant interest expense recognized during the years ended December 31, 2013 and 2012.

- 61 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
  
 
 
 
   
 
 
     
       
 
     
       
 
   
     
       
 
   
   
   
   
   
 
     
       
 
 
 
 
 
 
 
 
 
 
 
 
     
 
     
 
   
   
   
 
     
 
     
 
   
 
 
  
 
NOTE P—PROFIT SHARING PLAN

The Company has established a savings plan under section 401(k) of the Internal Revenue Code. All employees of the Company,
after completing one day of service are eligible to enroll in the 401(k) plan. Participating employees may elect to defer a portion of their
salary on a pre-tax basis up to the limits as provided by the IRS Code. The Company is not required to match employee contributions but
may do so at its discretion. The Company made no contributions during the years ended December 31, 2013 and 2012.

NOTE Q—EARNINGS PER SHARE (EPS)

The Company’s basic EPS is calculated using net income (loss) available to common shareholders and the weighted-average

number of shares outstanding during the reporting period. Diluted EPS includes the effect from potential issuance of common stock, such
as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes and preferred
stock.

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of
including these potential shares was antidilutive even though the exercise price was less than the average market price of the common
shares.

Stock Options
Warrants

Potentially dilutive securities

Years ended December 31,

2013

2012

1,844,530     
166,690     

2,011,220     

— 
— 

— 

Items excluded from the diluted per share calculation because the exercise price was greater than the average market price of the

common shares:

Stock options
Warrants

Total

Years ended December 31,

2013

2012

410,000     
38,369,129     

3,262,272 
8,250,000 

38,779,129     

11,512,272 

NOTE R—SUBSEQUENT EVENTS

The Company has reviewed subsequent events through the date of this filing.

On or about March 13, 2014, LifeSouth Community Blood Centers, Inc. filed a lawsuit against the Company in the Superior
Court of Monmouth County, New Jersey based on an alleged breach of a license agreement seeking return of all amounts paid
under the license in the amount of $718,500. The Company has not been formally served and intends to vigorously defend the
action and pursue all available counterclaims.

- 62 -

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
   
 
 
     
       
 
   
   
 
     
       
 
   
 
 
 
 
 
 
 
   
 
 
     
       
 
   
   
 
     
       
 
   
 
 
 
 
 
 
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this

report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 31, 2014

BIO-KEY INTERNATIONAL, INC.

By:

/s/  MICHAEL W. DEPASQUALE
Michael W. DePasquale
CHIEF EXECUTIVE OFFICER
(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on

behalf of the Registrant and in the capacities on the dates indicated.

Signature

Title

Date

/s/  MICHAEL W. DEPASQUALE    Chairman of the Board of Directors, Chief Executive Officer

March 31, 2014

and Director (Principal Executive Officer)

Michael W. DePasquale

/s/  CECILIA WELCH
Cecilia Welch

   Chief Financial Officer (Principal Accounting Officer)

March 31, 2014

/s/  JOHN SCHOENHERR
John Schoenherr

   Director

/s/  CHARLES P. ROMEO
Charles P. Romeo

   Director

/s/  BARBARA RIVERA
Barbara Rivera

   Director

/s/  THOMAS E. BUSH III
Thomas E. Bush

   Director

/s/  THOMAS GILLEY
Thomas Gilley

   Director

- 63 -

March 31, 2014

March 31, 2014

March 31, 2014

March 31, 2014

March 31, 2014

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
  
  
  
  
  
  
  
 
 
EXHIBIT INDEX

Description

   Certificate of Incorporation of BIO-key International, Inc., a Delaware corporation
   By-Laws of BIO-key International, Inc., a Delaware corporation
   Certificate of Amendment of Certificate of Incorporation of BIO-key International, Inc., a Delaware corporation
   Specimen certificates for shares of BIO-key International, Inc. common stock
   SAC Technologies, Inc. 1999 Stock Option Plan
   Employment Agreement by and between BIO-key International, Inc. and Mira LaCous dated November 20, 2001
   BIO-key International, Inc. 2004 Stock Incentive Plan
   Options to Purchase 50,000 and 65,241 Shares of Common Stock issued to Thomas J. Colatosti
   Options to Purchase 100,000 and 130,481 Shares of Common Stock issued to Jeff May
   Options to Purchase 50,000 and 32,620 Shares of Common Stock issued to Charles Romeo
   Options to Purchase 50,000 and 48,930 Shares of Common Stock issued to John Schoenherr
   Option to Purchase 500,000 Shares of Common Stock issued to Michael W. DePasquale
   Option to Purchase 50,000 Shares of Common Stock issued to Thomas J. Colatosti
   Options to Purchase 50,000 and 25,000 Shares of Common Stock issued to Jeff May
   Option to Purchase 50,000 Shares of Common Stock issued to Charles Romeo
   Option to Purchase 100,000 Shares of Common Stock issued to John Schoenherr
   Warrant to purchase 250,000 shares of Common Stock issued to Thomas J. Colatosti on December 28, 2009
   Convertible Note, dated as of December 28, 2009, by and between the Company and The Shaar Fund Ltd.
   Convertible Note, dated as of December 28, 2009, by and between the Company and Thomas J. Colatosti
   Compensation Agreement, dated January 12, 2010, by and between the Company and Mr. Colatosti
   Employment Agreement, effective March 25, 2010, by and between the Company and Michael W. DePasquale

Omnibus Amendment and Waiver Agreement, dated as of December 30, 2010, by and between the Company and
InterAct911 Mobile Systems, Inc., and SilkRoad Equity, LLC
Securities Exchange Agreement, dated as of December 31, 2010, by and between the Company and The Shaar Fund
Ltd., and Thomas J. Colatosti
Security and Subordination Agreement, dated as of December 31, 2010, by and between the Company and The Shaar
Fund Ltd., and Thomas J. Colatosti

   Warrant to purchase 8,000,000 shares of Common Stock issued to The Shaar Fund Ltd. on December 31, 2010
   Secured Note, dated as of December 31, 2010, by and between the Company and The Shaar Fund Ltd.
   Secured Note, dated as of December 31, 2010, by and between the Company and Thomas J. Colatosti

Note Amendment and Extension Agreement, effective as of December 31, 2012, by and between the Company and
Thomas J. Colatosti

  Note Purchase Agreement, dated February 26, 2013, by and between the Company and DRNC Holdings, Inc.

Senior Secured Term Promissory Note, dated February 26, 2013 by and between the Company and DRNC Holdings,
Inc.

  Securities Purchase Agreement, dated February 26, 2013, by and between the Company and DRNC Holdings, Inc.
  Form of Securities Purchase Agreement, dated February 26, 2013, by and between the Company and certain investors
  Form of Securities Purchase Agreement, dated July 23, 2013, by and between the Company and certain investors
  Form of Warrant, dated July 23, 2013, by and between the Company and certain investors

Form of Securities Purchase Agreement by and between the Company and certain investors dated October 25, 2013
and November 8, 2013
Form of Investor Warrant, by and between the Company and certain investors dated October 25, 2013 and November 8,
2013
Form of Registration Rights Agreement by and between the Company and certain investors dated October 25, 2013 and
November 8, 2013
Form of Supplement to Securities Purchase Agreement by and between the Company and certain investors dated
November 8, 2013
Options to Purchase 50,000 Shares of Common Stock issued to Charles Romeo 
Options to Purchase 50,000 Shares of Common Stock issued to John Schoenherr 
Option to Purchase 1,000,000 Shares of Common Stock issued to Michael W. DePasquale 
Options to Purchase 50,000 Shares of Common Stock issued to Jeff May 
Options to Purchase 50,000 Shares of Common Stock issued to Thomas J. Colatosti 
Option to Purchase 125,000 Shares of Common Stock issued to Mira LaCous 

Exhibit No.
3.1 (1)
3.2 (1)
3.3 (1)
4.1 (2)
10.1 (3)
10.2 (4)
10.3 (5)
10.4 (6)
10.5 (6)
10.6 (6)
10.7 (6)
10.8 (6)
10.9 (6)
10.10 (6)
10.11 (6)
10.12 (6)
10.13 (7)
10.14 (7)
10.15 (7)
10.16 (7)
10.17 (7)
10.18 (9)

10.19 (9)

10.20 (9)

10.21 (9)
10.22 (9)
10.23 (9)
10.24 (11)

10.25 (12)
10.26 (12)

10.27 (12)
10.28 (12)
10.29 (13)
10.30 (13)
10.31 (14)

10.32 (14)

10.33 (14)

10.34 (14)

10.35 (8)
10.36 (8)
10.37 (8)
10.38 (8)
10.39 (8)
10.40 (8)

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
  
  
  
  
  
 
 
 
 
 
 
 
 
10.41 (8)
10.42 (8)
10.43 (8) 

10.44 (8)

  Option to Purchase 150,000 Shares of Common Stock issued to Cecilia Welch
  Employment Agreement by and between BIO-key International, Inc. and Cecilia Welch dated May 15, 2013

Third Amendment to Lease Agreement by and between BIO-key International, Inc. and Victor AOP, Inc. dated June 30,
2013
First Amendment to Lease Agreement by and between BIO-key International, Inc. and BRE/DP MN LLC dated
September 12, 2013

   List of subsidiaries of BIO-key International, Inc.
   Consent of RMSBG
   Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   XBRL Instance Document

21.1 (10)
23.1 (8)
31.1 (8)
31.2 (8)
32.1 (8)
32.2 (8)
101.INS (8)
101.SCH (8)    XBRL Taxonomy Extension Schema Document
101.CAL (8)
101.DEF (8)    XBRL Taxonomy Extension Definition Linkbase Document
101.LAB (8)
101.PRE (8)    XBRL Taxonomy Extension Presentation Linkbase Document

   XBRL Taxonomy Extension Calculation Linkbase Document

   XBRL Taxonomy Extension Label Linkbase Document

(1) Filed as an exhibit to the registrant’s current report on Form 8-K filed with the Securities and Exchange Commission on January 5,

2005 and incorporated herein by reference.

(2) Filed as an exhibit to the registrant’s registration statement on Form SB-2, File No. 333-16451 dated February 14, 1997 and

incorporated herein by reference.

(3) Filed as an exhibit to the registrant’s annual report on Form 10-KSB filed with the Securities and Exchange Commission on April 14,

2000 and incorporated herein by reference.

(4) Filed as an exhibit to the registrant’s current report on Form 8-K filed with the Securities and Exchange Commission on

November 26, 2001 and incorporated herein by reference.

(5) Filed as an exhibit to the registrant’s registration statement on Form SB-2, File No. 333-120104 dated October 29, 2004 and

incorporated herein by reference.

(6) Filed as an exhibit to the registrant’s annual report on Form 10-K filed with the Securities and Exchange Commission on March 11,

2009 and incorporated herein by reference.

(7) Filed as an exhibit to the registrant’s annual report on Form 10-K filed with the Securities and Exchange Commission on March 26,

2010 and incorporated herein by reference.

(8) Filed herewith.

(9) Filed as an exhibit to the registrant’s annual report on Form 10-K filed with the Securities and Exchange Commission on March 23,

2011 and incorporated herein by reference.

(10)Previously filed

(11)Filed as an exhibit to the registrant’s annual report on Form 10-K filed with the Securities and Exchange Commission on April 1, 2013

and incorporated herein by reference.

(12)Filed as an exhibit to the registrant’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on May 15,

2013 and incorporated herein by reference.

(13)Filed as an exhibit to the registrant’s registration statement on Form S-1, File No. 333-190200 dated July 26, 2013 and incorporated

herein by reference.

(14)Filed as an exhibit to the registrant’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November

14, 2013 and incorporated herein by reference.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE WITH RULE 144, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF
THESE SECURITIES, REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER,
ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SUCH ACT.

Exhibit 10.35

OPTION TO PURCHASE COMMON STOCK
OF
BIO-key International, Inc.
Void after March 27, 2020

This  certifies  that,  for  value  received, Charles Romeo  ("Holder"),  is  entitled,  subject  to  the  terms  set  forth  below,  to  purchase
from BIO-key International, Inc., a Delaware corporation (the "Company"), shares of the common stock, $.0001 par value per share, of
the Company ("Common Stock"), as constituted on the date hereof (the "Option Issue Date"), with the Notice of Exercise attached hereto
duly executed, and simultaneous payment therefor in lawful money of the United States or as otherwise provided in Section 3 hereof, at
the  Exercise  Price  then  in  effect.  The  number,  character  and  Exercise  Price  of  the  shares  of  Common  Stock  issuable  upon  exercise
hereof are subject to adjustment as provided herein.

1 .             Term of Option. Subject to compliance with the vesting provisions identified at Section 2.3 hereof, this Option shall be
exercisable, in whole or in part, during the term commencing on the Option Issue Date and ending at 5:00 p.m. EST on March 27, 2020
(the "Option Expiration Date") and shall be void thereafter.

2.             Number of Shares, Exercise Price and Vesting Provisions.

2 . 1        Number of Shares. The number of shares of Common Stock which may be purchased pursuant to this Option

shall be 50,000 shares (the "Shares"), subject, however, to adjustment pursuant to Section 11 hereof.

2.2        Exercise Price. The Exercise Price at which this Option, or portion thereof, may be exercised shall be $0.17 per

Share, subject, however, to adjustment pursuant to Section 11 hereof.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
2.3        Vesting.      This Option shall vest in accordance with the following schedule:

(i)

16,666 Shares shall vest on March 27, 2014;

(ii)

16,666 Shares shall vest on March 27, 2015; and

(iii)

16,667 Shares shall vest on March 27, 2016.

3.             Exercise of Option.

3.1        Payment of Exercise Price.      Subject to the terms hereof, the purchase rights represented by this Option are
exercisable by the Holder in whole or in part, at any time, or from time to time, by the surrender of this Option and the Notice of Exercise
annexed hereto duly completed and executed on behalf of the Holder, at the office of the Company (or such other office or agency of the
Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company)
accompanied by payment of the Exercise Price in full (i) in cash or by bank or certified check for the Shares with respect to which this
Option is exercised; (ii) by delivery to the Company of shares of the Company's Common Stock having a Fair Market Value (as defined
below)  equal  to  the  aggregate  Exercise  Price  of  the  Shares  being  purchased  which  Holder  is  the  record  and  beneficial  owner  of  and
which  have  been  held  by  the  Holder  for  at  least  six  (6)  months;  (iii)  if  the  Shares  are  eligible  for  public  resale,  by  delivering  to  the
Company a Notice of Exercise together with an irrevocable direction to a broker-dealer registered under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), to sell a sufficient portion of the Shares and deliver the sales proceeds directly to the Company
to pay the Exercise Price; or (iv) by any combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 3.1.

3 . 2        Fair Market Value.  If  previously  owned  shares  of  Common  Stock  are  tendered  as  payment  of  the  Exercise
Price, the value of such shares shall be the "Fair Market Value" of such shares on the trading date immediately preceding the date of
exercise. For the purpose of this Agreement, the "Fair Market Value" shall be:

(a)     If the Common Stock is admitted to quotation on the National Association of Securities Dealers Automated
Quotation System ("NASDAQ"), the Fair Market Value on any given date shall be the average of the highest bid and lowest asked prices
of the Common Stock as reported for such date or, if no bid and asked prices were reported for such date, for the last day preceding such
date for which such prices were reported;

(b)     If the Common Stock is admitted to trading on a United States securities exchange or the NASDAQ National
Market  System,  the  Fair  Market  Value  on  any  date  shall  be  the  closing  price  reported  for  the  Common  Stock  on  such  exchange  or
system for such date or, if no sales were reported for such date, for the last day preceding such date for which a sale was reported;

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
(c)     If the Common Stock is traded in the over-the-counter market and not on any national securities exchange
nor in the NASDAQ Reporting System, the Fair Market Value shall be the average of the mean between the last bid and ask prices per
share, as reported by the National Quotation Bureau, Inc., or an equivalent generally accepted reporting service, or if not so reported, the
average  of  the  closing  bid  and  asked  prices  for  a  share  as  furnished  to  the  Company  by  any  member  of  the  National  Association  of
Securities Dealers, Inc., selected by the Company for that purpose; or

(d)     If the Fair Market Value of the Common Stock cannot be determined on the basis previously set forth in this
definition on the date that the Fair Market Value is to be determined, the Board of Directors of the Company shall in good faith determine
the Fair Market Value of the Common Stock on such date.

If the tender of previously owned shares would result in an issuance of a whole number of Shares and a fractional Share of Common
Stock, the value of such fractional share shall be paid to the Company in cash or by check by the Holder.

3.3        Termination of Employment; Death.

(a)     If Holder shall cease to be employed by the Company, all Options to which Holder is then entitled to exercise
may be exercised only within ninety (90) days after the termination of employment and prior to the Option Termination Date or, if such
termination was due to disability or retirement (as hereinafter defined), within one (1) year after termination of employment and prior to
the Option Termination Date. Notwithstanding the foregoing, in the event that any termination of employment shall be for Cause as that
term is defined in the Company’s 1999 Stock Option Plan, then this Option shall forthwith terminate. 

(b)     If Holder shall die while employed by the Company and prior to the Option Termination Date, any Options
then exercisable may be exercised only within one (1) year after Holder's death, prior to the Option Termination Date and only by the
Holder's personal representative or persons entitled thereto under the Holder's will or the laws of descent and distribution. 

(c)     This Option may not be exercised for more Shares (subject to adjustment as provided in Section 11 hereof)
after the termination of the Holder's employment or death, as the case may be, than the Holder was entitled to purchase thereunder at
the time of the termination of the Holder's employment or death. 

3 . 4        Exercise  Date;  Delivery  of  Certificates.      This Option shall be deemed to have been exercised immediately
prior to the close of business on the date of its surrender for exercise as provided above, and Holder shall be treated for all purposes as
the holder of record of such Shares as of the close of business on such date. As promptly as practicable on or after such date and in any
event within ten (10) days thereafter, the Company at its expense shall issue and deliver to the Holder a certificate or certificates for the
number of Shares issuable upon such exercise. In the event that this Option is exercised in part, the Company at its expense will execute
and deliver a new Option of like tenor exercisable for the number of shares for which this Option may then be exercised.

4 .             No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the
exercise of this Option. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash
payment equal to the Exercise Price multiplied by such fraction.

5 .             Replacement of Option. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Option and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in
form  and  substance  to  the  Company  or,  in  the  case  of  mutilation,  on  surrender  and  cancellation  of  this  Option,  the  Company  at  its
expense shall execute and deliver, in lieu of this Option, a new Option of like tenor and amount.

6 .             Rights of Stockholder. Except as otherwise contemplated herein, the Holder shall not be entitled to vote or receive
dividends or be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of
a  stockholder  of  the  Company  or  any  right  to  vote  for  the  election  of  directors  or  upon  any  matter  submitted  to  stockholders  at  any
meeting  thereof,  or  to  give  or  withhold  consent  to  any  corporate  action  (whether  upon  any  recapitalization,  issuance  of  stock,
reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance or otherwise) or to
receive  notice  of  meetings,  or  to  receive  dividends  or  subscription  rights  or  otherwise  until  the  Option  shall  have  been  exercised  as
provided herein.

7.             Transfer of Option.

7 . 1 .     Non-Transferability.  This  Option  shall  not  be  assigned,  transferred,  pledged  or  hypothecated  in  any  way,  nor
subject  to  execution,  attachment  or  similar  process,  otherwise  than  by  will  or  by  the  laws  of  descent  and  distribution.  Any  attempted
assignment,  transfer,  pledge,  hypothecation  or  other  disposition  of  this  Option  contrary  to  the  provisions  hereof,  and  the  levy  of  an
execution, attachment, or similar process upon the Option, shall be null and void and without effect.

7 . 2 .          Compliance with Securities Laws; Restrictions on Transfers. In addition to restrictions on transfer of this

Option and Shares set forth in Section 7.1 above.

(a)     The Holder of this Option, by acceptance hereof, acknowledges that this Option and the Shares to be issued
upon exercise hereof are being acquired solely for the Holder's own account and not as a nominee for any other party, and for investment
(unless such shares are subject to resale pursuant to an effective prospectus), and that the Holder will not offer, sell or otherwise dispose

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
of any Shares to be issued upon exercise hereof except under circumstances that will not result in a violation of applicable federal and
state  securities  laws.  Upon  exercise  of  this  Option,  the  Holder  shall,  if  requested  by  the  Company,  confirm  in  writing,  in  a  form
satisfactory to the Company, that the Shares of Common Stock so purchased are being acquired solely for the Holder's own account and
not as a nominee for any other party, for investment (unless such shares are subject to resale pursuant to an effective prospectus), and
not with a view toward distribution or resale.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
(b)     Neither this Option nor any share of Common Stock issued upon exercise of this Option may be offered for
sale or sold, or otherwise transferred or sold in any transaction which would constitute a sale thereof within the meaning of the 1933 Act,
unless (i) such security has been registered for sale under the 1933 Act and registered or qualified under applicable state securities laws
relating  to  the  offer  an  sale  of  securities;  (ii)  exemptions  from  the  registration  requirements  of  the  1933  Act  and  the  registration  or
qualification  requirements  of  all  such  state  securities  laws  are  available  and  the  Company  shall  have  received  an  opinion  of  counsel
satisfactory to the Company that the proposed sale or other disposition of such securities may be effected without registration under the
1933  Act  and  would  not  result  in  any  violation  of  any  applicable  state  securities  laws  relating  to  the  registration  or  qualification  of
securities for sale, such counsel and such opinion to be satisfactory to the Company. The Holder of this Option, by acceptance hereof,
acknowledges that the Company has no obligation to file a registration statement with the Securities and Exchange Commission or any
state  securities  commission  to  register  the  issuance  of  the  Shares  upon  exercise  hereof  or  the  sale  or  transfer  of  the  Shares  after
issuance.

following form (in addition to any legend required by state securities laws).

(c)     All Shares issued upon exercise hereof shall be stamped or imprinted with a legend in substantially the

THE  SECURITIES  EVIDENCED  BY  THIS  CERTIFICATE  HAVE  NOT  BEEN  REGISTERED  UNDER  THE  SECURITIES  ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE  WITH  RULE  144,  OR  THE  COMPANY  RECEIVES  AN  OPINION  OF  COUNSEL  FOR  THE  HOLDER  OF
THESE  SECURITIES,  REASONABLY  SATISFACTORY  TO  THE  COMPANY,  STATING  THAT  SUCH  SALE,  TRANSFER,
ASSIGNMENT  OR  HYPOTHECATION 
IS  EXEMPT  FROM  THE  REGISTRATION  AND  PROSPECTUS  DELIVERY
REQUIREMENTS OF SUCH ACT.

(d)     Holder recognizes that investing in the Option and the Shares involves a high degree of risk, and Holder is in a
financial position to hold the Option and the Shares indefinitely and is able to bear the economic risk and withstand a complete loss of its
investment  in  the  Option  and  the  Shares.  The  Holder  is  a  sophisticated  investor  and  is  capable  of  evaluating  the  merits  and  risks  of
investing in the Company. The Holder has had an opportunity to discuss the Company's business, management and financial affairs with
the Company's management, has been given full and complete access to information concerning the Company, and has utilized such
access  to  its  satisfaction  for  the  purpose  of  obtaining  information  or  verifying  information  and  has  had  the  opportunity  to  inspect  the
Company's operation. Holder has had the opportunity to ask questions of, and receive answers from the management of the Company
(and any person acting on its behalf) concerning the Option and the Shares and the agreements and transactions contemplated hereby,
and to obtain any additional information as Holder may have requested in making its investment decision.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
(e)     Holder acknowledges and represents: (i) that he has been afforded the opportunity to review and is familiar with
the business prospects and finances of the Company and has based his decision to invest solely on the information contained therein
and has not been furnished with any other literature, prospectus or other information except as included in such reports; (ii) he is at least
21  years  of  age;  (iii)  he  has  adequate  means  of  providing  for  his  current  needs  and  personal  contingencies;  (iv)  he  has  no  need  for
liquidity  for  his  investment  in  the  Option  or  Shares;  (v)  he  maintains  his  domicile  and  is  not  a  transient  or  temporary  resident  at  the
address  on  the  books  and  records  of  the  Company;  (vi)  all  of  his  investments  and  commitments  to  non-liquid  assets  and  similar
investments are, after his acquisition of the Option and Shares, will be reasonable in relation to his net worth and current needs; (vii) he
understands that no federal or state agency has approved or disapproved the Option or Shares or made any finding or determination as
to the fairness of the Option and Common Stock for investment; and (viii) that the Company has made no representations, warranties, or
assurances  as  to  (A)  the  future  trading  value  of  the  Common  Stock,  (B)  whether  there  will  be  a  public  market  for  the  resale  of  the
Common  Stock  or  (C)  the  filing  of  a  registration  statement  with  the  Securities  and  Exchange  Commission  or  any  state  securities
commission to register the issuance of the Shares upon exercise hereof or the sale or transfer of the Shares after issuance.

8.             Reservation and Issuance of Stock; Payment of Taxes.

(a)     The Company covenants that during the term that this Option is exercisable, the Company will reserve from its
authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Shares upon the exercise of this
Option, and from time to time will take all steps necessary to amend its Certificate of Incorporation to provide sufficient reserves of shares
of Common Stock issuable upon the exercise of the Option.

(b)     The Company further covenants that all shares of Common Stock issuable upon the due exercise of this Option will
be free and clear from all taxes or liens, charges and security interests created by the Company with respect to the issuance thereof,
however,  the  Company  shall  not  be  obligated  or  liable  for  the  payment  of  any  taxes,  liens  or  charges  of  Holder,  or  any  other  party
contemplated by Section 7, incurred in connection with the issuance of this Option or the Common Stock upon the due exercise of this
Option. The Company agrees that its issuance of this Option shall constitute full authority to its officers who are charged with the duty of
executing stock certificates to execute and issue the necessary certificates for the shares of Common Stock upon the exercise of this
Option. The Common Stock issuable upon the due exercise of this Option, will, upon issuance in accordance with the terms hereof, be
duly authorized, validly issued, fully paid and non-assessable.

(c)     Upon exercise of the Option, the Company shall have the right to require the Holder to remit to the Company an
amount  sufficient  to  satisfy  federal,  state  and  local  tax  withholding  requirements  prior  to  the  delivery  of  any  certificate  for  Shares  of
Common  Stock  purchased  pursuant  to  the  Option,  if  in  the  opinion  of  counsel  to  the  Company  such  withholding  is  required  under
applicable tax laws.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
  
 
 
(d)          If  Holder  is  obligated  to  pay  the  Company  an  amount  required  to  be  withheld  under  applicable  tax  withholding
requirements may pay such amount (i) in cash; (ii) in the discretion of the Board of Directors of the Company, through the delivery to the
Company of previously-owned shares of Common Stock having an aggregate Fair Market Value equal to the tax obligation provided that
the previously owned shares delivered in satisfaction of the withholding obligations must have been held by the Holder for at least six (6)
months; (iii) in the discretion of the Board of Directors of the Company, through the withholding of Shares of Common Stock otherwise
issuable to the Holder in connection with the Option exercise; or (iv) in the discretion of the Board of Directors of the Company, through a
combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 8(d).

9.             Notices.

(a)     Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section 11
hereof, the Company shall issue a certificate signed by its Chief Financial Officer setting forth, in reasonable detail, the event requiring
the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and number
of shares purchasable hereunder after giving effect to such adjustment, and shall cause a copy of such certificate to be mailed (by first-
class mail, postage prepaid) to the Holder of this Option.

(b)     All notices, advices and communications under this Option shall be deemed to have been given, (i) in the case of
personal delivery, on the date of such delivery and (ii) in the case of mailing, on the third business day following the date of such mailing,
addressed as follows:

If to the Company:

BIO-key International, Inc.
3349 Highway 138
Building D, Suite A
Wall, NJ 07719

With a copy to:
Choate, Hall & Stewart
Two International Place
Boston, MA 02119
Attn.: Charles Johnson

and to the Holder:
Charles Romeo
237 Wickford Point Road 
North Kingstown, RI 02852

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
 
Either of the Company or the Holder may from time to time change the address to which notices to it are to be mailed hereunder

by notice in accordance with the provisions of this Paragraph 9.

10.           Amendments.

(a)          Any  term  of  this  Option  may  be  amended  with  the  written  consent  of  the  Company  and  the  Holder.  Any

amendment effected in accordance with this Section 10 shall be binding upon the Holder, each future holder and the Company.

(b)     No waivers of, or exceptions to, any term, condition or provision of this Option, in any one or more instances, shall

be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.

1 1 .           Adjustments. The number of Shares of Common Stock purchasable hereunder and the Exercise Price is subject to

adjustment from time to time upon the occurrence of certain events, as follows:

1 1 . 1 .     Reorganization,  Merger  or  Sale  of  Assets.  If  at  any  time  while  this  Option,  or  any  portion  thereof,  is
outstanding  and  unexpired  there  shall  be  (i)  a  reorganization  (other  than  a  combination,  reclassification,  exchange  or  subdivision  of
shares  otherwise  provided  for  herein);  or  (ii)  a  merger  or  consolidation  of  the  Company  in  which  the  shares  of  the  Company's  capital
stock  outstanding  immediately  prior  to  the  merger  are  converted  by  virtue  of  the  merger  into  other  property,  whether  in  the  form  of
securities, cash or otherwise, then, as a part of such reorganization, merger, or consolidation, lawful provision shall be made so that the
holder of this Option shall upon such reorganization, merger, or consolidation, have the right by exercising such Option, to purchase the
kind  and  number  of  shares  of  Common  Stock  or  other  securities  or  property  (including  cash)  otherwise  receivable  upon  such
reorganization, merger or consolidation by a holder of the number of shares of Common Stock that might have been purchased upon
exercise of such Option immediately prior to such reorganization, merger or consolidation. The foregoing provisions of this Section 11.1
shall similarly apply to successive reorganizations, consolidations or mergers. If the per-share consideration payable to the Holder hereof
for  shares  in  connection  with  any  such  transaction  is  in  a  form  other  than  cash  or  marketable  securities,  then  the  value  of  such
consideration  shall  be  determined  in  good  faith  by  the  Company's  Board  of  Directors.  In  all  events,  appropriate  adjustment  (as
determined  in  good  faith  by  the  Company's  Board  of  Directors)  shall  be  made  in  the  application  of  the  provisions  of  this  Option  with
respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Option shall be applicable after
that event, as near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this
Option.

11.2.     Reclassification. If the Company, at any time while this Option, or any portion thereof, remains outstanding and
unexpired, by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Option
exist  into  the  same  or  a  different  number  of  securities  of  any  other  class  or  classes,  this  Option  shall  thereafter  represent  the  right  to
acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that
were subject to the purchase rights under this Option immediately prior to such reclassification or other change and the Exercise Price
therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 11.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
 
1 1 . 3 .     Split,  Subdivision  or  Combination  of  Shares.  If  the  Company  at  any  time  while  this  Option,  or  any  portion
thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Option
exist, into a different number of securities of the same class, the Exercise Price and the number of shares issuable upon exercise of this
Option shall be proportionately adjusted.

1 1 . 4 .     Adjustments  for  Dividends  in  Stock  or  Other  Securities  or  Property.  If  while  this  Option,  or  any  portion
hereof, remains outstanding and unexpired the holders of the securities as to which purchase rights under this Option exist at the time
shall  have  received,  or,  on  or  after  the  record  date  fixed  for  the  determination  of  eligible  Stockholders,  shall  have  become  entitled  to
receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of
dividend,  then  and  in  each  case,  this  Option  shall  represent  the  right  to  acquire,  in  addition  to  the  number  of  shares  of  the  security
receivable  upon  exercise  of  this  Option,  and  without  payment  of  any  additional  consideration  therefor,  the  amount  of  such  other  or
additional  stock  or  other  securities  or  property  (other  than  cash)  of  the  Company  that  such  holder  would  hold  on  the  date  of  such
exercise had it been the holder of record of the security receivable upon exercise of this Option on the date hereof and had thereafter,
during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock,
other securities or property available by this Option as aforesaid during such period.

1 1 . 5     Good  Faith. The  Company  will  not,  by  any  voluntary  action,  avoid  or  seek  to  avoid  the  observance  or
performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the
carrying out of all the provisions of this Section 11 and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Holder of this Option against impairment.

1 2 .           Fundamental  Transaction.  For  purposes  of  this  Section  12,  a  "Fundamental  Transaction"  shall  mean  (i)  the
dissolution  or  liquidation  of  the  Company;  (ii)  a  merger,  reorganization  or  consolidation  in  which  the  Company  is  acquired  by  another
person  or  entity  (other  than  a  holding  company  formed  by  the  Company);  (iii)  the  sale  of  all  or  substantially  all  of  the  assets  of  the
Company to any person or persons; or (iv) the sale in a single transaction or a series of related transactions of voting stock representing
more than fifty percent (50%) of the voting power of all outstanding shares of the Company to any person or persons. In the event of a
Fundamental Transaction, this Option shall automatically become immediately exercisable in full, and shall be deemed to have attained
such  status  immediately  prior  to  the  Fundamental  Transaction.  Holder  shall  be  given  at  least  15  days  prior  written  notice  of  a
Fundamental  Transaction  and  shall  be  permitted  to  exercise  any  vested  Options  during  this  15  day  period  (including  those  Options
vesting  as  a  result  of  the  provisions  of  this  Section  12).  In  the  event  of  a  Fundamental  Transaction,  any  Options  which  are  neither
assumed or substituted for in connection with the Fundamental Transaction nor exercised as of the date of the Fundamental Transaction,
shall terminate and cease to be outstanding effective as of the date of the Fundamental Transaction, unless otherwise provided by the
Board of Directors of the Company.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
 
1 3 .           Severability. Whenever possible, each provision of this Option shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Option is held to be invalid, illegal or unenforceable in any respect under any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of
any  other  provision  of  this  Option  in  such  jurisdiction  or  affect  the  validity,  legality  or  enforceability  of  any  provision  in  any  other
jurisdiction,  but  this  Option  shall  be  reformed,  construed  and  enforced  in  such  jurisdiction  as  if  such  invalid,  illegal  or  unenforceable
provision had never been contained herein.

1 4 .           Governing Law. The corporate law of the State of Minnesota shall govern all issues and questions concerning the
relative  rights  of  the  Company  and  its  stockholders.  All  other  questions  concerning  the  construction,  validity,  interpretation  and
enforceability of this Option and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of
the State of Minnesota, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Minnesota
or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Minnesota.

1 5 .           Jurisdiction. The Holder and the Company agree to submit to personal jurisdiction and to waive any objection as to
venue in the federal or state courts of Minnesota. Service of process on the Company or the Holder in any action arising out of or relating
to this Option shall be effective if mailed to such party at the address listed in Section 9 hereof.

1 6 .          Arbitration. If a dispute arises as to interpretation of this Option, it shall be decided finally by three arbitrators in an
arbitration  proceeding  conforming  to  the  Rules  of  the  American  Arbitration  Association  applicable  to  commercial  arbitration.  The
arbitrators  shall  be  appointed  as  follows:  one  by  the  Company,  one  by  the  Holder  and  the  third  by  the  said  two  arbitrators,  or,  if  they
cannot agree, then the third arbitrator shall be appointed by the American Arbitration Association. The third arbitrator shall be chairman
of the panel and shall be impartial. The arbitration shall take place in Minneapolis, Minnesota. The decision of a majority of the arbitrators
shall be conclusively binding upon the parties and final, and such decision shall be enforceable as a judgment in any court of competent
jurisdiction. Each party shall pay the fees and expenses of the arbitrator appointed by it, its counsel and its witnesses. The parties shall
share equally the fees and expenses of the impartial arbitrator.

1 7 .           Corporate  Power;  Authorization;  Enforceable  Obligations.  The  execution,  delivery  and  performance  by  the
Company  of  this  Option:  (i)  are  within  the  Company’s  corporate  power;  (ii)  have  been  duly  authorized  by  all  necessary  or  proper
corporate action; (iii) are not in contravention of the Company’s certificate of incorporation or bylaws; (iv) will not violate in any material
respect,  any  law  or  regulation,  including  any  and  all  Federal  and  state  securities  laws,  or  any  order  or  decree  of  any  court  or
governmental instrumentality; and (v) will not, in any material respect, conflict with or result in the breach or termination of, or constitute a
default under any agreement or other material instrument to which the Company is a party or by which the Company is bound.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
  
 
 
1 8 .           Successors  and  Assigns. This  Option  shall  inure  to  the  benefit  of  and  be  binding  on  the  respective  successors,

assigns and legal representatives of the Holder and the Company.

IN WITNESS WHEREOF, the Company and Holder have caused this Option to be executed as of March 27, 2013, the Option

Issue Date.

BIO-key International, Inc.

By:

Name: Michael DePasquale 
Title: CEO

AGREED AND ACCEPTED:

Charles Romeo

______________________

Signature

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TO:  [_____________________________]

NOTICE OF EXERCISE

(1)     The undersigned hereby elects to purchase _______ shares of Common Stock of BIO-key  International,  Inc. pursuant  to
the  terms  of  the  attached  Option,  and  tenders  herewith  payment  of  the  purchase  price  for  such  shares  in  full  in  the  following  manner
(please check one of the following choices):

☐      In Cash

☐      Cashless exercise through a broker; or

☐      Delivery of previously owned shares.

(2)     In exercising this Option, the undersigned hereby confirms and acknowledges that the shares of Common Stock to be issued
upon conversion thereof are being acquired solely for the account of the undersigned and not as a nominee for any other party, and for
investment (unless such shares are subject to resale pursuant to an effective prospectus), and that the undersigned will not offer, sell or
otherwise dispose of any such shares of Common Stock except under circumstances that will not result in a violation of the Securities Act
of 1933, as amended, or any state securities laws.

(3)     Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned.

[____________________________]

(Date)

(Signature)

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE WITH RULE 144, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF
THESE SECURITIES, REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER,
ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SUCH ACT.

Exhibit 10.36

OPTION TO PURCHASE COMMON STOCK
OF
BIO-key International, Inc.
Void after March 27, 2020

This certifies that, for value received, John Schoenherr ("Holder"), is entitled, subject to the terms set forth below, to purchase
from BIO-key International, Inc., a Delaware corporation (the "Company"), shares of the common stock, $.0001 par value per share, of
the Company ("Common Stock"), as constituted on the date hereof (the "Option Issue Date"), with the Notice of Exercise attached hereto
duly executed, and simultaneous payment therefor in lawful money of the United States or as otherwise provided in Section 3 hereof, at
the  Exercise  Price  then  in  effect.  The  number,  character  and  Exercise  Price  of  the  shares  of  Common  Stock  issuable  upon  exercise
hereof are subject to adjustment as provided herein.

1 .           Term of Option. Subject to compliance with the vesting provisions identified at Section 2.3 hereof, this Option shall be
exercisable, in whole or in part, during the term commencing on the Option Issue Date and ending at 5:00 p.m. EST on March 27, 2020
(the "Option Expiration Date") and shall be void thereafter.

2.             Number of Shares, Exercise Price and Vesting Provisions.

2 . 1     Number of Shares. The number of shares of Common Stock which may be purchased pursuant to this Option

shall be 50,000 shares (the "Shares"), subject, however, to adjustment pursuant to Section 11 hereof.

2 . 2     Exercise Price. The Exercise Price at which this Option, or portion thereof, may be exercised shall be $0.17 per

Share, subject, however, to adjustment pursuant to Section 11 hereof.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
2.3     Vesting.      This Option shall vest in accordance with the following schedule:

(i)

(ii)

16,666 Shares shall vest on March 27, 2014;

16,666 Shares shall vest on March 27, 2015; and

(iii)

16,667 Shares shall vest on March 27, 2016.

3.             Exercise of Option.

3 . 1     Payment of Exercise Price.      Subject to the terms hereof, the purchase rights represented by this Option are
exercisable by the Holder in whole or in part, at any time, or from time to time, by the surrender of this Option and the Notice of Exercise
annexed hereto duly completed and executed on behalf of the Holder, at the office of the Company (or such other office or agency of the
Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company)
accompanied by payment of the Exercise Price in full (i) in cash or by bank or certified check for the Shares with respect to which this
Option is exercised; (ii) by delivery to the Company of shares of the Company's Common Stock having a Fair Market Value (as defined
below)  equal  to  the  aggregate  Exercise  Price  of  the  Shares  being  purchased  which  Holder  is  the  record  and  beneficial  owner  of  and
which  have  been  held  by  the  Holder  for  at  least  six  (6)  months;  (iii)  if  the  Shares  are  eligible  for  public  resale,  by  delivering  to  the
Company a Notice of Exercise together with an irrevocable direction to a broker-dealer registered under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), to sell a sufficient portion of the Shares and deliver the sales proceeds directly to the Company
to pay the Exercise Price; or (iv) by any combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 3.1.

3.2      Fair Market Value. If previously owned shares of Common Stock are tendered as payment of the Exercise Price,
the value of such shares shall be the "Fair Market Value" of such shares on the trading date immediately preceding the date of exercise.
For the purpose of this Agreement, the "Fair Market Value" shall be:

(a)     If the Common Stock is admitted to quotation on the National Association of Securities Dealers Automated
Quotation System ("NASDAQ"), the Fair Market Value on any given date shall be the average of the highest bid and lowest asked prices
of the Common Stock as reported for such date or, if no bid and asked prices were reported for such date, for the last day preceding such
date for which such prices were reported;

(b)     If the Common Stock is admitted to trading on a United States securities exchange or the NASDAQ National
Market  System,  the  Fair  Market  Value  on  any  date  shall  be  the  closing  price  reported  for  the  Common  Stock  on  such  exchange  or
system for such date or, if no sales were reported for such date, for the last day preceding such date for which a sale was reported;

2

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c)     If the Common Stock is traded in the over-the-counter market and not on any national securities exchange
nor in the NASDAQ Reporting System, the Fair Market Value shall be the average of the mean between the last bid and ask prices per
share, as reported by the National Quotation Bureau, Inc., or an equivalent generally accepted reporting service, or if not so reported, the
average  of  the  closing  bid  and  asked  prices  for  a  share  as  furnished  to  the  Company  by  any  member  of  the  National  Association  of
Securities Dealers, Inc., selected by the Company for that purpose; or

(d)     If the Fair Market Value of the Common Stock cannot be determined on the basis previously set forth in this
definition on the date that the Fair Market Value is to be determined, the Board of Directors of the Company shall in good faith determine
the Fair Market Value of the Common Stock on such date.

If the tender of previously owned shares would result in an issuance of a whole number of Shares and a fractional Share of Common
Stock, the value of such fractional share shall be paid to the Company in cash or by check by the Holder.

3.3     Termination of Employment; Death.

(a)     If Holder shall cease to be employed by the Company, all Options to which Holder is then entitled to exercise
may be exercised only within ninety (90) days after the termination of employment and prior to the Option Termination Date or, if such
termination was due to disability or retirement (as hereinafter defined), within one (1) year after termination of employment and prior to
the Option Termination Date. Notwithstanding the foregoing, in the event that any termination of employment shall be for Cause as that
term is defined in the Company’s 1999 Stock Option Plan, then this Option shall forthwith terminate.

(b)     If Holder shall die while employed by the Company and prior to the Option Termination Date, any Options
then exercisable may be exercised only within one (1) year after Holder's death, prior to the Option Termination Date and only by the
Holder's personal representative or persons entitled thereto under the Holder's will or the laws of descent and distribution.

(c)     This Option may not be exercised for more Shares (subject to adjustment as provided in Section 11 hereof)
after the termination of the Holder's employment or death, as the case may be, than the Holder was entitled to purchase thereunder at
the time of the termination of the Holder's employment or death.

3 . 4     Exercise  Date;  Delivery  of  Certificates.      This Option shall be deemed to have been exercised immediately
prior to the close of business on the date of its surrender for exercise as provided above, and Holder shall be treated for all purposes as
the holder of record of such Shares as of the close of business on such date. As promptly as practicable on or after such date and in any
event within ten (10) days thereafter, the Company at its expense shall issue and deliver to the Holder a certificate or certificates for the
number of Shares issuable upon such exercise. In the event that this Option is exercised in part, the Company at its expense will execute
and deliver a new Option of like tenor exercisable for the number of shares for which this Option may then be exercised.

3

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
4 .     No  Fractional  Shares  or  Scrip.  No  fractional  shares  or  scrip  representing  fractional  shares  shall  be  issued  upon  the
exercise of this Option. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash
payment equal to the Exercise Price multiplied by such fraction.

5 .     Replacement of Option. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Option and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in
form  and  substance  to  the  Company  or,  in  the  case  of  mutilation,  on  surrender  and  cancellation  of  this  Option,  the  Company  at  its
expense shall execute and deliver, in lieu of this Option, a new Option of like tenor and amount.

6 .     Rights  of  Stockholder.  Except  as  otherwise  contemplated  herein,  the  Holder  shall  not  be  entitled  to  vote  or  receive
dividends or be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of
a  stockholder  of  the  Company  or  any  right  to  vote  for  the  election  of  directors  or  upon  any  matter  submitted  to  stockholders  at  any
meeting  thereof,  or  to  give  or  withhold  consent  to  any  corporate  action  (whether  upon  any  recapitalization,  issuance  of  stock,
reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance or otherwise) or to
receive  notice  of  meetings,  or  to  receive  dividends  or  subscription  rights  or  otherwise  until  the  Option  shall  have  been  exercised  as
provided herein.

7.     Transfer of Option.

7.1.     Non-Transferability. This Option shall not be assigned, transferred, pledged or hypothecated in any way, nor subject
to execution, attachment or similar process, otherwise than by will or by the laws of descent and distribution. Any attempted assignment,
transfer,  pledge,  hypothecation  or  other  disposition  of  this  Option  contrary  to  the  provisions  hereof,  and  the  levy  of  an  execution,
attachment, or similar process upon the Option, shall be null and void and without effect.

7.2.          Compliance with Securities Laws; Restrictions on Transfers. In addition to restrictions on transfer of this

Option and Shares set forth in Section 7.1 above.

(a)     The Holder of this Option, by acceptance hereof, acknowledges that this Option and the Shares to be issued
upon exercise hereof are being acquired solely for the Holder's own account and not as a nominee for any other party, and for investment
(unless such shares are subject to resale pursuant to an effective prospectus), and that the Holder will not offer, sell or otherwise dispose
of any Shares to be issued upon exercise hereof except under circumstances that will not result in a violation of applicable federal and
state  securities  laws.  Upon  exercise  of  this  Option,  the  Holder  shall,  if  requested  by  the  Company,  confirm  in  writing,  in  a  form
satisfactory to the Company, that the Shares of Common Stock so purchased are being acquired solely for the Holder's own account and
not as a nominee for any other party, for investment (unless such shares are subject to resale pursuant to an effective prospectus), and
not with a view toward distribution or resale.

4

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
(b)     Neither this Option nor any share of Common Stock issued upon exercise of this Option may be offered for
sale or sold, or otherwise transferred or sold in any transaction which would constitute a sale thereof within the meaning of the 1933 Act,
unless (i) such security has been registered for sale under the 1933 Act and registered or qualified under applicable state securities laws
relating  to  the  offer  an  sale  of  securities;  (ii)  exemptions  from  the  registration  requirements  of  the  1933  Act  and  the  registration  or
qualification  requirements  of  all  such  state  securities  laws  are  available  and  the  Company  shall  have  received  an  opinion  of  counsel
satisfactory to the Company that the proposed sale or other disposition of such securities may be effected without registration under the
1933  Act  and  would  not  result  in  any  violation  of  any  applicable  state  securities  laws  relating  to  the  registration  or  qualification  of
securities for sale, such counsel and such opinion to be satisfactory to the Company. The Holder of this Option, by acceptance hereof,
acknowledges that the Company has no obligation to file a registration statement with the Securities and Exchange Commission or any
state  securities  commission  to  register  the  issuance  of  the  Shares  upon  exercise  hereof  or  the  sale  or  transfer  of  the  Shares  after
issuance.

following form (in addition to any legend required by state securities laws).

(c)     All Shares issued upon exercise hereof shall be stamped or imprinted with a legend in substantially the

THE  SECURITIES  EVIDENCED  BY  THIS  CERTIFICATE  HAVE  NOT  BEEN  REGISTERED  UNDER  THE  SECURITIES  ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE  WITH  RULE  144,  OR  THE  COMPANY  RECEIVES  AN  OPINION  OF  COUNSEL  FOR  THE  HOLDER  OF
THESE  SECURITIES,  REASONABLY  SATISFACTORY  TO  THE  COMPANY,  STATING  THAT  SUCH  SALE,  TRANSFER,
ASSIGNMENT  OR  HYPOTHECATION 
IS  EXEMPT  FROM  THE  REGISTRATION  AND  PROSPECTUS  DELIVERY
REQUIREMENTS OF SUCH ACT.

(d)     Holder recognizes that investing in the Option and the Shares involves a high degree of risk, and Holder is in a
financial position to hold the Option and the Shares indefinitely and is able to bear the economic risk and withstand a complete loss of its
investment  in  the  Option  and  the  Shares.  The  Holder  is  a  sophisticated  investor  and  is  capable  of  evaluating  the  merits  and  risks  of
investing in the Company. The Holder has had an opportunity to discuss the Company's business, management and financial affairs with
the Company's management, has been given full and complete access to information concerning the Company, and has utilized such
access  to  its  satisfaction  for  the  purpose  of  obtaining  information  or  verifying  information  and  has  had  the  opportunity  to  inspect  the
Company's operation. Holder has had the opportunity to ask questions of, and receive answers from the management of the Company
(and any person acting on its behalf) concerning the Option and the Shares and the agreements and transactions contemplated hereby,
and to obtain any additional information as Holder may have requested in making its investment decision.

5

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
(e)     Holder acknowledges and represents: (i) that he has been afforded the opportunity to review and is familiar with the
business prospects and finances of the Company and has based his decision to invest solely on the information contained therein and
has not been furnished with any other literature, prospectus or other information except as included in such reports; (ii) he is at least 21
years of age; (iii) he has adequate means of providing for his current needs and personal contingencies; (iv) he has no need for liquidity
for his investment in the Option or Shares; (v) he maintains his domicile and is not a transient or temporary resident at the address on the
books and records of the Company; (vi) all of his investments and commitments to non-liquid assets and similar investments are, after his
acquisition  of  the  Option  and  Shares,  will  be  reasonable  in  relation  to  his  net  worth  and  current  needs;  (vii)  he  understands  that  no
federal or state agency has approved or disapproved the Option or Shares or made any finding or determination as to the fairness of the
Option and Common Stock for investment; and (viii) that the Company has made no representations, warranties, or assurances as to (A)
the future trading value of the Common Stock, (B) whether there will be a public market for the resale of the Common Stock or (C) the
filing  of  a  registration  statement  with  the  Securities  and  Exchange  Commission  or  any  state  securities  commission  to  register  the
issuance of the Shares upon exercise hereof or the sale or transfer of the Shares after issuance.

8.     Reservation and Issuance of Stock; Payment of Taxes.

(a)          The  Company  covenants  that  during  the  term  that  this  Option  is  exercisable,  the  Company  will  reserve  from  its
authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Shares upon the exercise of this
Option, and from time to time will take all steps necessary to amend its Certificate of Incorporation to provide sufficient reserves of shares
of Common Stock issuable upon the exercise of the Option.

(b)     The Company further covenants that all shares of Common Stock issuable upon the due exercise of this Option will be
free  and  clear  from  all  taxes  or  liens,  charges  and  security  interests  created  by  the  Company  with  respect  to  the  issuance  thereof,
however,  the  Company  shall  not  be  obligated  or  liable  for  the  payment  of  any  taxes,  liens  or  charges  of  Holder,  or  any  other  party
contemplated by Section 7, incurred in connection with the issuance of this Option or the Common Stock upon the due exercise of this
Option. The Company agrees that its issuance of this Option shall constitute full authority to its officers who are charged with the duty of
executing stock certificates to execute and issue the necessary certificates for the shares of Common Stock upon the exercise of this
Option. The Common Stock issuable upon the due exercise of this Option, will, upon issuance in accordance with the terms hereof, be
duly authorized, validly issued, fully paid and non-assessable.

(c)          Upon  exercise  of  the  Option,  the  Company  shall  have  the  right  to  require  the  Holder  to  remit  to  the  Company  an
amount  sufficient  to  satisfy  federal,  state  and  local  tax  withholding  requirements  prior  to  the  delivery  of  any  certificate  for  Shares  of
Common  Stock  purchased  pursuant  to  the  Option,  if  in  the  opinion  of  counsel  to  the  Company  such  withholding  is  required  under
applicable tax laws.

6

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
(d)          If  Holder  is  obligated  to  pay  the  Company  an  amount  required  to  be  withheld  under  applicable  tax  withholding
requirements may pay such amount (i) in cash; (ii) in the discretion of the Board of Directors of the Company, through the delivery to the
Company of previously-owned shares of Common Stock having an aggregate Fair Market Value equal to the tax obligation provided that
the previously owned shares delivered in satisfaction of the withholding obligations must have been held by the Holder for at least six (6)
months; (iii) in the discretion of the Board of Directors of the Company, through the withholding of Shares of Common Stock otherwise
issuable to the Holder in connection with the Option exercise; or (iv) in the discretion of the Board of Directors of the Company, through a
combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 8(d).

9.     Notices.

(a)     Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section 11
hereof, the Company shall issue a certificate signed by its Chief Financial Officer setting forth, in reasonable detail, the event requiring
the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and number
of shares purchasable hereunder after giving effect to such adjustment, and shall cause a copy of such certificate to be mailed (by first-
class mail, postage prepaid) to the Holder of this Option.

(b)          All  notices,  advices  and  communications  under  this  Option  shall  be  deemed  to  have  been  given,  (i)  in  the  case  of
personal delivery, on the date of such delivery and (ii) in the case of mailing, on the third business day following the date of such mailing,
addressed as follows:

If to the Company:

BIO-key International, Inc.
3349 Highway 138
Building D, Suite A
Wall, NJ 07719

With a copy to:
Choate, Hall & Stewart
Two International Place
Boston, MA 02119
Attn.: Charles Johnson

and to the Holder:
John Schoenherr
One Berkshire Drive
Winchester, MA 01810 

7

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
Either of the Company or the Holder may from time to time change the address to which notices to it are to be mailed hereunder

by notice in accordance with the provisions of this Paragraph 9.

10.           Amendments.

(a)          Any  term  of  this  Option  may  be  amended  with  the  written  consent  of  the  Company  and  the  Holder.  Any

amendment effected in accordance with this Section 10 shall be binding upon the Holder, each future holder and the Company.

(b)     No waivers of, or exceptions to, any term, condition or provision of this Option, in any one or more instances, shall

be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.

1 1 .           Adjustments. The number of Shares of Common Stock purchasable hereunder and the Exercise Price is subject to

adjustment from time to time upon the occurrence of certain events, as follows:

1 1 . 1 .     Reorganization,  Merger  or  Sale  of  Assets.  If  at  any  time  while  this  Option,  or  any  portion  thereof,  is
outstanding  and  unexpired  there  shall  be  (i)  a  reorganization  (other  than  a  combination,  reclassification,  exchange  or  subdivision  of
shares  otherwise  provided  for  herein);  or  (ii)  a  merger  or  consolidation  of  the  Company  in  which  the  shares  of  the  Company's  capital
stock  outstanding  immediately  prior  to  the  merger  are  converted  by  virtue  of  the  merger  into  other  property,  whether  in  the  form  of
securities, cash or otherwise, then, as a part of such reorganization, merger, or consolidation, lawful provision shall be made so that the
holder of this Option shall upon such reorganization, merger, or consolidation, have the right by exercising such Option, to purchase the
kind  and  number  of  shares  of  Common  Stock  or  other  securities  or  property  (including  cash)  otherwise  receivable  upon  such
reorganization, merger or consolidation by a holder of the number of shares of Common Stock that might have been purchased upon
exercise of such Option immediately prior to such reorganization, merger or consolidation. The foregoing provisions of this Section 11.1
shall similarly apply to successive reorganizations, consolidations or mergers. If the per-share consideration payable to the Holder hereof
for  shares  in  connection  with  any  such  transaction  is  in  a  form  other  than  cash  or  marketable  securities,  then  the  value  of  such
consideration  shall  be  determined  in  good  faith  by  the  Company's  Board  of  Directors.  In  all  events,  appropriate  adjustment  (as
determined  in  good  faith  by  the  Company's  Board  of  Directors)  shall  be  made  in  the  application  of  the  provisions  of  this  Option  with
respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Option shall be applicable after
that event, as near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this
Option.

11.2.     Reclassification. If the Company, at any time while this Option, or any portion thereof, remains outstanding and
unexpired, by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Option
exist  into  the  same  or  a  different  number  of  securities  of  any  other  class  or  classes,  this  Option  shall  thereafter  represent  the  right  to
acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that
were subject to the purchase rights under this Option immediately prior to such reclassification or other change and the Exercise Price
therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 11.

8

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
1 1 . 3 .     Split,  Subdivision  or  Combination  of  Shares.  If  the  Company  at  any  time  while  this  Option,  or  any  portion
thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Option
exist, into a different number of securities of the same class, the Exercise Price and the number of shares issuable upon exercise of this
Option shall be proportionately adjusted.

1 1 . 4 .     Adjustments  for  Dividends  in  Stock  or  Other  Securities  or  Property.  If  while  this  Option,  or  any  portion
hereof, remains outstanding and unexpired the holders of the securities as to which purchase rights under this Option exist at the time
shall  have  received,  or,  on  or  after  the  record  date  fixed  for  the  determination  of  eligible  Stockholders,  shall  have  become  entitled  to
receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of
dividend,  then  and  in  each  case,  this  Option  shall  represent  the  right  to  acquire,  in  addition  to  the  number  of  shares  of  the  security
receivable  upon  exercise  of  this  Option,  and  without  payment  of  any  additional  consideration  therefor,  the  amount  of  such  other  or
additional  stock  or  other  securities  or  property  (other  than  cash)  of  the  Company  that  such  holder  would  hold  on  the  date  of  such
exercise had it been the holder of record of the security receivable upon exercise of this Option on the date hereof and had thereafter,
during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock,
other securities or property available by this Option as aforesaid during such period.

1 1 . 5      Good  Faith. The  Company  will  not,  by  any  voluntary  action,  avoid  or  seek  to  avoid  the  observance  or
performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the
carrying out of all the provisions of this Section 11 and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Holder of this Option against impairment.

12.     Fundamental Transaction. For purposes of this Section 12, a "Fundamental Transaction" shall mean (i) the dissolution
or liquidation of the Company; (ii) a merger, reorganization or consolidation in which the Company is acquired by another person or entity
(other than a holding company formed by the Company); (iii) the sale of all or substantially all of the assets of the Company to any person
or persons; or (iv) the sale in a single transaction or a series of related transactions of voting stock representing more than fifty percent
(50%) of the voting power of all outstanding shares of the Company to any person or persons. In the event of a Fundamental Transaction,
this  Option  shall  automatically  become  immediately  exercisable  in  full,  and  shall  be  deemed  to  have  attained  such  status  immediately
prior to the Fundamental Transaction. Holder shall be given at least 15 days prior written notice of a Fundamental Transaction and shall
be permitted to exercise any vested Options during this 15 day period (including those Options vesting as a result of the provisions of
this Section 12). In the event of a Fundamental Transaction, any Options which are neither assumed or substituted for in connection with
the Fundamental Transaction nor exercised as of the date of the Fundamental Transaction, shall terminate and cease to be outstanding
effective as of the date of the Fundamental Transaction, unless otherwise provided by the Board of Directors of the Company.

9

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
1 3 .       Severability. Whenever possible, each provision of this Option shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Option is held to be invalid, illegal or unenforceable in any respect under any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of
any  other  provision  of  this  Option  in  such  jurisdiction  or  affect  the  validity,  legality  or  enforceability  of  any  provision  in  any  other
jurisdiction,  but  this  Option  shall  be  reformed,  construed  and  enforced  in  such  jurisdiction  as  if  such  invalid,  illegal  or  unenforceable
provision had never been contained herein.

1 4 .       Governing Law.  The  corporate  law  of  the  State  of  Minnesota  shall  govern  all  issues  and  questions  concerning  the
relative  rights  of  the  Company  and  its  stockholders.  All  other  questions  concerning  the  construction,  validity,  interpretation  and
enforceability of this Option and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of
the State of Minnesota, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Minnesota
or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Minnesota.

1 5 .       Jurisdiction. The Holder and the Company agree to submit to personal jurisdiction and to waive any objection as to
venue in the federal or state courts of Minnesota. Service of process on the Company or the Holder in any action arising out of or relating
to this Option shall be effective if mailed to such party at the address listed in Section 9 hereof.

1 6 .       Arbitration. If a dispute arises as to interpretation of this Option, it shall be decided finally by three arbitrators in an
arbitration  proceeding  conforming  to  the  Rules  of  the  American  Arbitration  Association  applicable  to  commercial  arbitration.  The
arbitrators  shall  be  appointed  as  follows:  one  by  the  Company,  one  by  the  Holder  and  the  third  by  the  said  two  arbitrators,  or,  if  they
cannot agree, then the third arbitrator shall be appointed by the American Arbitration Association. The third arbitrator shall be chairman
of the panel and shall be impartial. The arbitration shall take place in Minneapolis, Minnesota. The decision of a majority of the arbitrators
shall be conclusively binding upon the parties and final, and such decision shall be enforceable as a judgment in any court of competent
jurisdiction. Each party shall pay the fees and expenses of the arbitrator appointed by it, its counsel and its witnesses. The parties shall
share equally the fees and expenses of the impartial arbitrator.

1 7 .       Corporate  Power;  Authorization;  Enforceable  Obligations.  The  execution,  delivery  and  performance  by  the
Company  of  this  Option:  (i)  are  within  the  Company’s  corporate  power;  (ii)  have  been  duly  authorized  by  all  necessary  or  proper
corporate action; (iii) are not in contravention of the Company’s certificate of incorporation or bylaws; (iv) will not violate in any material
respect,  any  law  or  regulation,  including  any  and  all  Federal  and  state  securities  laws,  or  any  order  or  decree  of  any  court  or
governmental instrumentality; and (v) will not, in any material respect, conflict with or result in the breach or termination of, or constitute a
default under any agreement or other material instrument to which the Company is a party or by which the Company is bound.

10

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
1 8 .       Successors  and  Assigns. This  Option  shall  inure  to  the  benefit  of  and  be  binding  on  the  respective  successors,

assigns and legal representatives of the Holder and the Company.

IN WITNESS WHEREOF, the Company and Holder have caused this Option to be executed as of March 27, 2013, the Option

Issue Date. 

AGREED AND ACCEPTED:

John Schoenherr

______________________

Signature

BIO-key International, Inc.

By:  

  Name:  Michael DePasquale
  Title:  CEO

11

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TO:   [_____________________________]

NOTICE OF EXERCISE

(1)     The undersigned hereby elects to purchase _______ shares of Common Stock of BIO-key International, Inc. pursuant to
the  terms  of  the  attached  Option,  and  tenders  herewith  payment  of  the  purchase  price  for  such  shares  in  full  in  the  following  manner
(please check one of the following choices):

 ☐    In Cash

 ☐    Cashless exercise through a broker; or

                 ☐    Delivery of previously owned shares.

(2)          In  exercising  this  Option,  the  undersigned  hereby  confirms  and  acknowledges  that  the  shares  of  Common  Stock  to  be
issued upon conversion thereof are being acquired solely for the account of the undersigned and not as a nominee for any other party,
and for investment (unless such shares are subject to resale pursuant to an effective prospectus), and that the undersigned will not offer,
sell  or  otherwise  dispose  of  any  such  shares  of  Common  Stock  except  under  circumstances  that  will  not  result  in  a  violation  of  the
Securities Act of 1933, as amended, or any state securities laws.

(3)     Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned. 

[

] 

(Date)    

(Signature)

12

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
                                                                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE WITH RULE 144, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF
THESE SECURITIES, REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER,
ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SUCH ACT.

Exhibit 10.37

OPTION TO PURCHASE COMMON STOCK
OF
BIO-key International, Inc.
Void after March 27, 2020

This  certifies  that,  for  value  received, Michael  DePasquale  ("Holder"),  is  entitled,  subject  to  the  terms  set  forth  below,  to
purchase from BIO-key International, Inc., a Delaware corporation (the "Company"), shares of the common stock, $.0001 par value per
share,  of  the  Company  ("Common  Stock"),  as  constituted  on  the  date  hereof  (the  "Option  Issue  Date"),  with  the  Notice  of  Exercise
attached  hereto  duly  executed,  and  simultaneous  payment  therefor  in  lawful  money  of  the  United  States  or  as  otherwise  provided  in
Section 3 hereof, at the Exercise Price then in effect. The number, character and Exercise Price of the shares of Common Stock issuable
upon exercise hereof are subject to adjustment as provided herein.

1 .     Term of Option.  Subject  to  compliance  with  the  vesting  provisions  identified  at  Section  2.3  hereof,  this  Option  shall  be
exercisable, in whole or in part, during the term commencing on the Option Issue Date and ending at 5:00 p.m. EST on March 27, 2020
(the "Option Expiration Date") and shall be void thereafter.

2.     Number of Shares, Exercise Price and Vesting Provisions.

2 . 1     Number of Shares. The number of shares of Common Stock which may be purchased pursuant to this Option

shall be 1,000,000 shares (the "Shares"), subject, however, to adjustment pursuant to Section 11 hereof.

2 . 2     Exercise Price. The Exercise Price at which this Option, or portion thereof, may be exercised shall be $0.17 per

Share, subject, however, to adjustment pursuant to Section 11 hereof. 

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
2.3     Vesting.      This Option shall vest in accordance with the following schedule:

(i)

(ii)

333,333 Shares shall vest on March 27, 2014;

333,333 Shares shall vest on March 27, 2015; and

(iii)

333,334 Shares shall vest on March 27, 2016.

3.     Exercise of Option.

3 . 1     Payment of Exercise Price.      Subject to the terms hereof, the purchase rights represented by this Option are
exercisable by the Holder in whole or in part, at any time, or from time to time, by the surrender of this Option and the Notice of Exercise
annexed hereto duly completed and executed on behalf of the Holder, at the office of the Company (or such other office or agency of the
Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company)
accompanied by payment of the Exercise Price in full (i) in cash or by bank or certified check for the Shares with respect to which this
Option is exercised; (ii) by delivery to the Company of shares of the Company's Common Stock having a Fair Market Value (as defined
below)  equal  to  the  aggregate  Exercise  Price  of  the  Shares  being  purchased  which  Holder  is  the  record  and  beneficial  owner  of  and
which  have  been  held  by  the  Holder  for  at  least  six  (6)  months;  (iii)  if  the  Shares  are  eligible  for  public  resale,  by  delivering  to  the
Company a Notice of Exercise together with an irrevocable direction to a broker-dealer registered under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), to sell a sufficient portion of the Shares and deliver the sales proceeds directly to the Company
to pay the Exercise Price; or (iv) by any combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 3.1.

3.2      Fair Market Value. If previously owned shares of Common Stock are tendered as payment of the Exercise Price,
the value of such shares shall be the "Fair Market Value" of such shares on the trading date immediately preceding the date of exercise.
For the purpose of this Agreement, the "Fair Market Value" shall be:

(a)     If the Common Stock is admitted to quotation on the National Association of Securities Dealers Automated
Quotation System ("NASDAQ"), the Fair Market Value on any given date shall be the average of the highest bid and lowest asked prices
of the Common Stock as reported for such date or, if no bid and asked prices were reported for such date, for the last day preceding such
date for which such prices were reported;

(b)          If  the  Common  Stock  is  admitted  to  trading  on  a  United  States  securities  exchange  or  the  NASDAQ
National Market System, the Fair Market Value on any date shall be the closing price reported for the Common Stock on such exchange
or system for such date or, if no sales were reported for such date, for the last day preceding such date for which a sale was reported;

2

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
(c)     If the Common Stock is traded in the over-the-counter market and not on any national securities exchange
nor in the NASDAQ Reporting System, the Fair Market Value shall be the average of the mean between the last bid and ask prices per
share, as reported by the National Quotation Bureau, Inc., or an equivalent generally accepted reporting service, or if not so reported, the
average  of  the  closing  bid  and  asked  prices  for  a  share  as  furnished  to  the  Company  by  any  member  of  the  National  Association  of
Securities Dealers, Inc., selected by the Company for that purpose; or

(d)     If the Fair Market Value of the Common Stock cannot be determined on the basis previously set forth in
this  definition  on  the  date  that  the  Fair  Market  Value  is  to  be  determined,  the  Board  of  Directors  of  the  Company  shall  in  good  faith
determine the Fair Market Value of the Common Stock on such date.

If the tender of previously owned shares would result in an issuance of a whole number of Shares and a fractional Share of Common
Stock, the value of such fractional share shall be paid to the Company in cash or by check by the Holder.

3.3     Termination of Employment; Death.

(a)     

If  Holder  shall  cease  to  be  employed  by  the  Company,  all  Options  to  which  Holder  is  then  entitled  to
exercise may be exercised only within ninety (90) days after the termination of employment and prior to the Option Termination Date or, if
such termination was due to disability or retirement (as hereinafter defined), within one (1) year after termination of employment and prior
to the Option Termination Date. Notwithstanding the foregoing, in the event that any termination of employment shall be for Cause as
that term is defined in the Company’s 1999 Stock Option Plan, then this Option shall forthwith terminate.

(b)     If Holder shall die while employed by the Company and prior to the Option Termination Date, any Options
then exercisable may be exercised only within one (1) year after Holder's death, prior to the Option Termination Date and only by the
Holder's personal representative or persons entitled thereto under the Holder's will or the laws of descent and distribution.

(c)     This Option may not be exercised for more Shares (subject to adjustment as provided in Section 11 hereof)
after the termination of the Holder's employment or death, as the case may be, than the Holder was entitled to purchase thereunder at
the time of the termination of the Holder's employment or death.

3 . 4     Exercise  Date;  Delivery  of  Certificates.      This Option shall be deemed to have been exercised immediately
prior to the close of business on the date of its surrender for exercise as provided above, and Holder shall be treated for all purposes as
the holder of record of such Shares as of the close of business on such date. As promptly as practicable on or after such date and in any
event within ten (10) days thereafter, the Company at its expense shall issue and deliver to the Holder a certificate or certificates for the
number of Shares issuable upon such exercise. In the event that this Option is exercised in part, the Company at its expense will execute
and deliver a new Option of like tenor exercisable for the number of shares for which this Option may then be exercised.

3

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
4 .     No  Fractional  Shares  or  Scrip.  No  fractional  shares  or  scrip  representing  fractional  shares  shall  be  issued  upon  the
exercise of this Option. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash
payment equal to the Exercise Price multiplied by such fraction.

5 .     Replacement of Option. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Option and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in
form  and  substance  to  the  Company  or,  in  the  case  of  mutilation,  on  surrender  and  cancellation  of  this  Option,  the  Company  at  its
expense shall execute and deliver, in lieu of this Option, a new Option of like tenor and amount.

6 .     Rights  of  Stockholder.  Except  as  otherwise  contemplated  herein,  the  Holder  shall  not  be  entitled  to  vote  or  receive
dividends or be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of
a  stockholder  of  the  Company  or  any  right  to  vote  for  the  election  of  directors  or  upon  any  matter  submitted  to  stockholders  at  any
meeting  thereof,  or  to  give  or  withhold  consent  to  any  corporate  action  (whether  upon  any  recapitalization,  issuance  of  stock,
reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance or otherwise) or to
receive  notice  of  meetings,  or  to  receive  dividends  or  subscription  rights  or  otherwise  until  the  Option  shall  have  been  exercised  as
provided herein.

7.     Transfer of Option.

7 . 1 .     Non-Transferability.  This  Option  shall  not  be  assigned,  transferred,  pledged  or  hypothecated  in  any  way,  nor
subject  to  execution,  attachment  or  similar  process,  otherwise  than  by  will  or  by  the  laws  of  descent  and  distribution.  Any  attempted
assignment,  transfer,  pledge,  hypothecation  or  other  disposition  of  this  Option  contrary  to  the  provisions  hereof,  and  the  levy  of  an
execution, attachment, or similar process upon the Option, shall be null and void and without effect.

7 . 2 .          Compliance with Securities Laws; Restrictions on Transfers. In addition to restrictions on transfer of this

Option and Shares set forth in Section 7.1 above.

(a)          The  Holder  of  this  Option,  by  acceptance  hereof,  acknowledges  that  this  Option  and  the  Shares  to  be
issued upon exercise hereof are being acquired solely for the Holder's own account and not as a nominee for any other party, and for
investment  (unless  such  shares  are  subject  to  resale  pursuant  to  an  effective  prospectus),  and  that  the  Holder  will  not  offer,  sell  or
otherwise  dispose  of  any  Shares  to  be  issued  upon  exercise  hereof  except  under  circumstances  that  will  not  result  in  a  violation  of
applicable  federal  and  state  securities  laws.  Upon  exercise  of  this  Option,  the  Holder  shall,  if  requested  by  the  Company,  confirm  in
writing, in a form satisfactory to the Company, that the Shares of Common Stock so purchased are being acquired solely for the Holder's
own account and not as a nominee for any other party, for investment (unless such shares are subject to resale pursuant to an effective
prospectus), and not with a view toward distribution or resale.

4

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
(b)     Neither this Option nor any share of Common Stock issued upon exercise of this Option may be offered for
sale or sold, or otherwise transferred or sold in any transaction which would constitute a sale thereof within the meaning of the 1933 Act,
unless (i) such security has been registered for sale under the 1933 Act and registered or qualified under applicable state securities laws
relating  to  the  offer  an  sale  of  securities;  (ii)  exemptions  from  the  registration  requirements  of  the  1933  Act  and  the  registration  or
qualification  requirements  of  all  such  state  securities  laws  are  available  and  the  Company  shall  have  received  an  opinion  of  counsel
satisfactory to the Company that the proposed sale or other disposition of such securities may be effected without registration under the
1933  Act  and  would  not  result  in  any  violation  of  any  applicable  state  securities  laws  relating  to  the  registration  or  qualification  of
securities for sale, such counsel and such opinion to be satisfactory to the Company. The Holder of this Option, by acceptance hereof,
acknowledges that the Company has no obligation to file a registration statement with the Securities and Exchange Commission or any
state  securities  commission  to  register  the  issuance  of  the  Shares  upon  exercise  hereof  or  the  sale  or  transfer  of  the  Shares  after
issuance.

following form (in addition to any legend required by state securities laws).

(c)     All Shares issued upon exercise hereof shall be stamped or imprinted with a legend in substantially the

THE  SECURITIES  EVIDENCED  BY  THIS  CERTIFICATE  HAVE  NOT  BEEN  REGISTERED  UNDER  THE  SECURITIES  ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE  WITH  RULE  144,  OR  THE  COMPANY  RECEIVES  AN  OPINION  OF  COUNSEL  FOR  THE  HOLDER  OF
THESE  SECURITIES,  REASONABLY  SATISFACTORY  TO  THE  COMPANY,  STATING  THAT  SUCH  SALE,  TRANSFER,
ASSIGNMENT  OR  HYPOTHECATION 
IS  EXEMPT  FROM  THE  REGISTRATION  AND  PROSPECTUS  DELIVERY
REQUIREMENTS OF SUCH ACT.

(d)     Holder recognizes that investing in the Option and the Shares involves a high degree of risk, and Holder is in a
financial position to hold the Option and the Shares indefinitely and is able to bear the economic risk and withstand a complete loss of its
investment  in  the  Option  and  the  Shares.  The  Holder  is  a  sophisticated  investor  and  is  capable  of  evaluating  the  merits  and  risks  of
investing in the Company. The Holder has had an opportunity to discuss the Company's business, management and financial affairs with
the Company's management, has been given full and complete access to information concerning the Company, and has utilized such
access  to  its  satisfaction  for  the  purpose  of  obtaining  information  or  verifying  information  and  has  had  the  opportunity  to  inspect  the
Company's operation. Holder has had the opportunity to ask questions of, and receive answers from the management of the Company
(and any person acting on its behalf) concerning the Option and the Shares and the agreements and transactions contemplated hereby,
and to obtain any additional information as Holder may have requested in making its investment decision.

5

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
(e)     Holder acknowledges and represents: (i) that he has been afforded the opportunity to review and is familiar with
the business prospects and finances of the Company and has based his decision to invest solely on the information contained therein
and has not been furnished with any other literature, prospectus or other information except as included in such reports; (ii) he is at least
21  years  of  age;  (iii)  he  has  adequate  means  of  providing  for  his  current  needs  and  personal  contingencies;  (iv)  he  has  no  need  for
liquidity  for  his  investment  in  the  Option  or  Shares;  (v)  he  maintains  his  domicile  and  is  not  a  transient  or  temporary  resident  at  the
address  on  the  books  and  records  of  the  Company;  (vi)  all  of  his  investments  and  commitments  to  non-liquid  assets  and  similar
investments are, after his acquisition of the Option and Shares, will be reasonable in relation to his net worth and current needs; (vii) he
understands that no federal or state agency has approved or disapproved the Option or Shares or made any finding or determination as
to the fairness of the Option and Common Stock for investment; and (viii) that the Company has made no representations, warranties, or
assurances  as  to  (A)  the  future  trading  value  of  the  Common  Stock,  (B)  whether  there  will  be  a  public  market  for  the  resale  of  the
Common  Stock  or  (C)  the  filing  of  a  registration  statement  with  the  Securities  and  Exchange  Commission  or  any  state  securities
commission to register the issuance of the Shares upon exercise hereof or the sale or transfer of the Shares after issuance.

8.     Reservation and Issuance of Stock; Payment of Taxes.

(a)     The Company covenants that during the term that this Option is exercisable, the Company will reserve from its
authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Shares upon the exercise of this
Option, and from time to time will take all steps necessary to amend its Certificate of Incorporation to provide sufficient reserves of shares
of Common Stock issuable upon the exercise of the Option.

(b)     The Company further covenants that all shares of Common Stock issuable upon the due exercise of this Option will
be free and clear from all taxes or liens, charges and security interests created by the Company with respect to the issuance thereof,
however,  the  Company  shall  not  be  obligated  or  liable  for  the  payment  of  any  taxes,  liens  or  charges  of  Holder,  or  any  other  party
contemplated by Section 7, incurred in connection with the issuance of this Option or the Common Stock upon the due exercise of this
Option. The Company agrees that its issuance of this Option shall constitute full authority to its officers who are charged with the duty of
executing stock certificates to execute and issue the necessary certificates for the shares of Common Stock upon the exercise of this
Option. The Common Stock issuable upon the due exercise of this Option, will, upon issuance in accordance with the terms hereof, be
duly authorized, validly issued, fully paid and non-assessable.

(c)     Upon exercise of the Option, the Company shall have the right to require the Holder to remit to the Company an
amount  sufficient  to  satisfy  federal,  state  and  local  tax  withholding  requirements  prior  to  the  delivery  of  any  certificate  for  Shares  of
Common  Stock  purchased  pursuant  to  the  Option,  if  in  the  opinion  of  counsel  to  the  Company  such  withholding  is  required  under
applicable tax laws.

6

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
  
 
(d)          If  Holder  is  obligated  to  pay  the  Company  an  amount  required  to  be  withheld  under  applicable  tax  withholding
requirements may pay such amount (i) in cash; (ii) in the discretion of the Board of Directors of the Company, through the delivery to the
Company of previously-owned shares of Common Stock having an aggregate Fair Market Value equal to the tax obligation provided that
the previously owned shares delivered in satisfaction of the withholding obligations must have been held by the Holder for at least six (6)
months; (iii) in the discretion of the Board of Directors of the Company, through the withholding of Shares of Common Stock otherwise
issuable to the Holder in connection with the Option exercise; or (iv) in the discretion of the Board of Directors of the Company, through a
combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 8(d).

9.     Notices.

(a)     Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section 11
hereof, the Company shall issue a certificate signed by its Chief Financial Officer setting forth, in reasonable detail, the event requiring
the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and number
of shares purchasable hereunder after giving effect to such adjustment, and shall cause a copy of such certificate to be mailed (by first-
class mail, postage prepaid) to the Holder of this Option.

(b)     All notices, advices and communications under this Option shall be deemed to have been given, (i) in the case of
personal delivery, on the date of such delivery and (ii) in the case of mailing, on the third business day following the date of such mailing,
addressed as follows:

If to the Company:

BIO-key International, Inc.
3349 Highway 138
Building D, Suite A
Wall, NJ 07719

With a copy to:
Choate, Hall & Stewart
Two International Place
Boston, MA 02119
Attn.: Charles Johnson

and to the Holder:
Michael DePasquale
704 Michael Drive
Tom’s River, NJ 08753

7

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
Either of the Company or the Holder may from time to time change the address to which notices to it are to be mailed hereunder

by notice in accordance with the provisions of this Paragraph 9.

10.     Amendments.

(a)          Any  term  of  this  Option  may  be  amended  with  the  written  consent  of  the  Company  and  the  Holder.  Any

amendment effected in accordance with this Section 10 shall be binding upon the Holder, each future holder and the Company.

(b)     No waivers of, or exceptions to, any term, condition or provision of this Option, in any one or more instances, shall

be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.

1 1 .     Adjustments.  The  number  of  Shares  of  Common  Stock  purchasable  hereunder  and  the  Exercise  Price  is  subject  to

adjustment from time to time upon the occurrence of certain events, as follows:

1 1 . 1 .     Reorganization,  Merger  or  Sale  of  Assets.  If  at  any  time  while  this  Option,  or  any  portion  thereof,  is
outstanding  and  unexpired  there  shall  be  (i)  a  reorganization  (other  than  a  combination,  reclassification,  exchange  or  subdivision  of
shares  otherwise  provided  for  herein);  or  (ii)  a  merger  or  consolidation  of  the  Company  in  which  the  shares  of  the  Company's  capital
stock  outstanding  immediately  prior  to  the  merger  are  converted  by  virtue  of  the  merger  into  other  property,  whether  in  the  form  of
securities, cash or otherwise, then, as a part of such reorganization, merger, or consolidation, lawful provision shall be made so that the
holder of this Option shall upon such reorganization, merger, or consolidation, have the right by exercising such Option, to purchase the
kind  and  number  of  shares  of  Common  Stock  or  other  securities  or  property  (including  cash)  otherwise  receivable  upon  such
reorganization, merger or consolidation by a holder of the number of shares of Common Stock that might have been purchased upon
exercise of such Option immediately prior to such reorganization, merger or consolidation. The foregoing provisions of this Section 11.1
shall similarly apply to successive reorganizations, consolidations or mergers. If the per-share consideration payable to the Holder hereof
for  shares  in  connection  with  any  such  transaction  is  in  a  form  other  than  cash  or  marketable  securities,  then  the  value  of  such
consideration  shall  be  determined  in  good  faith  by  the  Company's  Board  of  Directors.  In  all  events,  appropriate  adjustment  (as
determined  in  good  faith  by  the  Company's  Board  of  Directors)  shall  be  made  in  the  application  of  the  provisions  of  this  Option  with
respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Option shall be applicable after
that event, as near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this
Option.

11.2.     Reclassification. If the Company, at any time while this Option, or any portion thereof, remains outstanding and
unexpired, by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Option
exist  into  the  same  or  a  different  number  of  securities  of  any  other  class  or  classes,  this  Option  shall  thereafter  represent  the  right  to
acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that
were subject to the purchase rights under this Option immediately prior to such reclassification or other change and the Exercise Price
therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 11.

8

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
1 1 . 3 .     Split,  Subdivision  or  Combination  of  Shares.  If  the  Company  at  any  time  while  this  Option,  or  any  portion
thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Option
exist, into a different number of securities of the same class, the Exercise Price and the number of shares issuable upon exercise of this
Option shall be proportionately adjusted.

1 1 . 4 .     Adjustments  for  Dividends  in  Stock  or  Other  Securities  or  Property.  If  while  this  Option,  or  any  portion
hereof, remains outstanding and unexpired the holders of the securities as to which purchase rights under this Option exist at the time
shall  have  received,  or,  on  or  after  the  record  date  fixed  for  the  determination  of  eligible  Stockholders,  shall  have  become  entitled  to
receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of
dividend,  then  and  in  each  case,  this  Option  shall  represent  the  right  to  acquire,  in  addition  to  the  number  of  shares  of  the  security
receivable  upon  exercise  of  this  Option,  and  without  payment  of  any  additional  consideration  therefor,  the  amount  of  such  other  or
additional  stock  or  other  securities  or  property  (other  than  cash)  of  the  Company  that  such  holder  would  hold  on  the  date  of  such
exercise had it been the holder of record of the security receivable upon exercise of this Option on the date hereof and had thereafter,
during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock,
other securities or property available by this Option as aforesaid during such period.

1 1 . 5     Good  Faith. The  Company  will  not,  by  any  voluntary  action,  avoid  or  seek  to  avoid  the  observance  or
performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the
carrying out of all the provisions of this Section 11 and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Holder of this Option against impairment.

12.     Fundamental Transaction. For purposes of this Section 12, a "Fundamental Transaction" shall mean (i) the dissolution or
liquidation of the Company; (ii) a merger, reorganization or consolidation in which the Company is acquired by another person or entity
(other than a holding company formed by the Company); (iii) the sale of all or substantially all of the assets of the Company to any person
or persons; or (iv) the sale in a single transaction or a series of related transactions of voting stock representing more than fifty percent
(50%) of the voting power of all outstanding shares of the Company to any person or persons. In the event of a Fundamental Transaction,
this  Option  shall  automatically  become  immediately  exercisable  in  full,  and  shall  be  deemed  to  have  attained  such  status  immediately
prior to the Fundamental Transaction. Holder shall be given at least 15 days prior written notice of a Fundamental Transaction and shall
be permitted to exercise any vested Options during this 15 day period (including those Options vesting as a result of the provisions of
this Section 12). In the event of a Fundamental Transaction, any Options which are neither assumed or substituted for in connection with
the Fundamental Transaction nor exercised as of the date of the Fundamental Transaction, shall terminate and cease to be outstanding
effective as of the date of the Fundamental Transaction, unless otherwise provided by the Board of Directors of the Company.

9

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
  
 
13.     Severability. Whenever possible, each provision of this Option shall be interpreted in such manner as to be effective and
valid  under  applicable  law,  but  if  any  provision  of  this  Option  is  held  to  be  invalid,  illegal  or  unenforceable  in  any  respect  under  any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of
any  other  provision  of  this  Option  in  such  jurisdiction  or  affect  the  validity,  legality  or  enforceability  of  any  provision  in  any  other
jurisdiction,  but  this  Option  shall  be  reformed,  construed  and  enforced  in  such  jurisdiction  as  if  such  invalid,  illegal  or  unenforceable
provision had never been contained herein.

14.     Governing Law. The corporate law of the State of Minnesota shall govern all issues and questions concerning the relative
rights of the Company and its stockholders. All other questions concerning the construction, validity, interpretation and enforceability of
this  Option  and  the  exhibits  and  schedules  hereto  shall  be  governed  by,  and  construed  in  accordance  with,  the  laws  of  the  State  of
Minnesota, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Minnesota or any other
jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Minnesota.

15.     Jurisdiction. The Holder and the Company agree to submit to personal jurisdiction and to waive any objection as to venue
in the federal or state courts of Minnesota. Service of process on the Company or the Holder in any action arising out of or relating to this
Option shall be effective if mailed to such party at the address listed in Section 9 hereof.

1 6 .     Arbitration.  If  a  dispute  arises  as  to  interpretation  of  this  Option,  it  shall  be  decided  finally  by  three  arbitrators  in  an
arbitration  proceeding  conforming  to  the  Rules  of  the  American  Arbitration  Association  applicable  to  commercial  arbitration.  The
arbitrators  shall  be  appointed  as  follows:  one  by  the  Company,  one  by  the  Holder  and  the  third  by  the  said  two  arbitrators,  or,  if  they
cannot agree, then the third arbitrator shall be appointed by the American Arbitration Association. The third arbitrator shall be chairman
of the panel and shall be impartial. The arbitration shall take place in Minneapolis, Minnesota. The decision of a majority of the arbitrators
shall be conclusively binding upon the parties and final, and such decision shall be enforceable as a judgment in any court of competent
jurisdiction. Each party shall pay the fees and expenses of the arbitrator appointed by it, its counsel and its witnesses. The parties shall
share equally the fees and expenses of the impartial arbitrator.

1 7 .     Corporate Power; Authorization; Enforceable Obligations. The execution, delivery and performance by the Company
of this Option: (i) are within the Company’s corporate power; (ii) have been duly authorized by all necessary or proper corporate action;
(iii) are not in contravention of the Company’s certificate of incorporation or bylaws; (iv) will not violate in any material respect, any law or
regulation, including any and all Federal and state securities laws, or any order or decree of any court or governmental instrumentality;
and (v) will not, in any material respect, conflict with or result in the breach or termination of, or constitute a default under any agreement
or other material instrument to which the Company is a party or by which the Company is bound.

10

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
18.     Successors and Assigns. This Option shall inure to the benefit of and be binding on the respective successors, assigns

and legal representatives of the Holder and the Company.

IN WITNESS WHEREOF, the Company and Holder have caused this Option to be executed as of March 27, 2013, the Option

Issue Date.

AGREED AND ACCEPTED:  

Michael DePasquale  

Signature

BIO-key International, Inc.  

By:  

Name: Cecilia Welch  
Title: CFO  

11

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
TO: [_____________________________]

NOTICE OF EXERCISE

(1)     The undersigned hereby elects to purchase _______ shares of Common Stock of BIO-key International, Inc. pursuant to
the  terms  of  the  attached  Option,  and  tenders  herewith  payment  of  the  purchase  price  for  such  shares  in  full  in  the  following  manner
(please check one of the following choices):

☐     In Cash

☐     Cashless exercise through a broker; or

☐     Delivery of previously owned shares.

(2)          In  exercising  this  Option,  the  undersigned  hereby  confirms  and  acknowledges  that  the  shares  of  Common  Stock  to  be
issued upon conversion thereof are being acquired solely for the account of the undersigned and not as a nominee for any other party,
and for investment (unless such shares are subject to resale pursuant to an effective prospectus), and that the undersigned will not offer,
sell  or  otherwise  dispose  of  any  such  shares  of  Common  Stock  except  under  circumstances  that  will  not  result  in  a  violation  of  the
Securities Act of 1933, as amended, or any state securities laws.

(3)     Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned.

[

] 

(Date)    

(Signature)

12

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE WITH RULE 144, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF
THESE SECURITIES, REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER,
ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SUCH ACT.

Exhibit 10.38

OPTION TO PURCHASE COMMON STOCK
OF
BIO-key International, Inc.
Void after March 27, 2020

This certifies that, for value received, Jeff May ("Holder"), is entitled, subject to the terms set forth below, to purchase from BIO-
key  International,  Inc.,  a  Delaware  corporation  (the  "Company"),  shares  of  the  common  stock,  $.0001  par  value  per  share,  of  the
Company ("Common Stock"), as constituted on the date hereof (the "Option Issue Date"), with the Notice of Exercise attached hereto
duly executed, and simultaneous payment therefor in lawful money of the United States or as otherwise provided in Section 3 hereof, at
the  Exercise  Price  then  in  effect.  The  number,  character  and  Exercise  Price  of  the  shares  of  Common  Stock  issuable  upon  exercise
hereof are subject to adjustment as provided herein.

1.            Term of Option.  Subject to compliance with the vesting provisions identified at Section 2.3 hereof, this Option shall be
exercisable, in whole or in part, during the term commencing on the Option Issue Date and ending at 5:00 p.m. EST on March 27, 2020
(the "Option Expiration Date") and shall be void thereafter.

2.             Number of Shares, Exercise Price and Vesting Provisions.

2 . 1         Number of Shares. The number of shares of Common Stock which may be purchased pursuant to this Option

shall be 50,000 shares (the "Shares"), subject, however, to adjustment pursuant to Section 11 hereof.

2 . 2          Exercise Price. The Exercise Price at which this Option, or portion thereof, may be exercised shall be $0.17

per Share, subject, however, to adjustment pursuant to Section 11 hereof.

1

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
2.3          Vesting.    This Option shall vest in accordance with the following schedule:

(i)

16,666 Shares shall vest on March 27, 2014;

(ii)

16,666 Shares shall vest on March 27, 2015; and

(iii)

16,667 Shares shall vest on March 27, 2016.

3.           Exercise of Option.

3 . 1          Payment of Exercise Price.      Subject to the terms hereof, the purchase rights represented by this Option
are  exercisable  by  the  Holder  in  whole  or  in  part,  at  any  time,  or  from  time  to  time,  by  the  surrender  of  this  Option  and  the  Notice  of
Exercise  annexed  hereto  duly  completed  and  executed  on  behalf  of  the  Holder,  at  the  office  of  the  Company  (or  such  other  office  or
agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the
Company) accompanied by payment of the Exercise Price in full (i) in cash or by bank or certified check for the Shares with respect to
which this Option is exercised; (ii) by delivery to the Company of shares of the Company's Common Stock having a Fair Market Value
(as defined below) equal to the aggregate Exercise Price of the Shares being purchased which Holder is the record and beneficial owner
of and which have been held by the Holder for at least six (6) months; (iii) if the Shares are eligible for public resale, by delivering to the
Company a Notice of Exercise together with an irrevocable direction to a broker-dealer registered under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), to sell a sufficient portion of the Shares and deliver the sales proceeds directly to the Company
to pay the Exercise Price; or (iv) by any combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 3.1.

3 . 2           Fair Market Value.  If previously owned shares of Common Stock are tendered as payment of the Exercise
Price, the value of such shares shall be the "Fair Market Value" of such shares on the trading date immediately preceding the date of
exercise. For the purpose of this Agreement, the "Fair Market Value" shall be:

(a)                If  the  Common  Stock  is  admitted  to  quotation  on  the  National  Association  of  Securities  Dealers
Automated Quotation System ("NASDAQ"), the Fair Market Value on any given date shall be the average of the highest bid and lowest
asked prices of the Common Stock as reported for such date or, if no bid and asked prices were reported for such date, for the last day
preceding such date for which such prices were reported;

(b)                If  the  Common  Stock  is  admitted  to  trading  on  a  United  States  securities  exchange  or  the  NASDAQ
National Market System, the Fair Market Value on any date shall be the closing price reported for the Common Stock on such exchange
or system for such date or, if no sales were reported for such date, for the last day preceding such date for which a sale was reported;

2

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c)                If  the  Common  Stock  is  traded  in  the  over-the-counter  market  and  not  on  any  national  securities
exchange nor in the NASDAQ Reporting System, the Fair Market Value shall be the average of the mean between the last bid and ask
prices per share, as reported by the National Quotation Bureau, Inc., or an equivalent generally accepted reporting service, or if not so
reported,  the  average  of  the  closing  bid  and  asked  prices  for  a  share  as  furnished  to  the  Company  by  any  member  of  the  National
Association of Securities Dealers, Inc., selected by the Company for that purpose; or

(d)        If the Fair Market Value of the Common Stock cannot be determined on the basis previously set forth in
this  definition  on  the  date  that  the  Fair  Market  Value  is  to  be  determined,  the  Board  of  Directors  of  the  Company  shall  in  good  faith
determine the Fair Market Value of the Common Stock on such date.

If the tender of previously owned shares would result in an issuance of a whole number of Shares and a fractional Share of Common
Stock, the value of such fractional share shall be paid to the Company in cash or by check by the Holder.

3.3          Termination of Employment; Death.

(a)        

If Holder shall cease to be employed by the Company, all Options to which Holder is then entitled to
exercise may be exercised only within ninety (90) days after the termination of employment and prior to the Option Termination Date or, if
such termination was due to disability or retirement (as hereinafter defined), within one (1) year after termination of employment and prior
to the Option Termination Date. Notwithstanding the foregoing, in the event that any termination of employment shall be for Cause as
that term is defined in the Company’s 1999 Stock Option Plan, then this Option shall forthwith terminate.

(b)                If  Holder  shall  die  while  employed  by  the  Company  and  prior  to  the  Option  Termination  Date,  any
Options then exercisable may be exercised only within one (1) year after Holder's death, prior to the Option Termination Date and only by
the Holder's personal representative or persons entitled thereto under the Holder's will or the laws of descent and distribution.

(c)                This  Option  may  not  be  exercised  for  more  Shares  (subject  to  adjustment  as  provided  in  Section  11
hereof)  after  the  termination  of  the  Holder's  employment  or  death,  as  the  case  may  be,  than  the  Holder  was  entitled  to  purchase
thereunder at the time of the termination of the Holder's employment or death.

3.4           Exercise Date; Delivery of Certificates.      This Option shall be deemed to have been exercised immediately
prior to the close of business on the date of its surrender for exercise as provided above, and Holder shall be treated for all purposes as
the holder of record of such Shares as of the close of business on such date. As promptly as practicable on or after such date and in any
event within ten (10) days thereafter, the Company at its expense shall issue and deliver to the Holder a certificate or certificates for the
number of Shares issuable upon such exercise. In the event that this Option is exercised in part, the Company at its expense will execute
and deliver a new Option of like tenor exercisable for the number of shares for which this Option may then be exercised.

3

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
4 .           No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the
exercise of this Option. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash
payment equal to the Exercise Price multiplied by such fraction.

5 .           Replacement of Option. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Option and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in
form  and  substance  to  the  Company  or,  in  the  case  of  mutilation,  on  surrender  and  cancellation  of  this  Option,  the  Company  at  its
expense shall execute and deliver, in lieu of this Option, a new Option of like tenor and amount.

6 .           Rights of Stockholder. Except as otherwise contemplated herein, the Holder shall not be entitled to vote or receive
dividends or be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of
a  stockholder  of  the  Company  or  any  right  to  vote  for  the  election  of  directors  or  upon  any  matter  submitted  to  stockholders  at  any
meeting  thereof,  or  to  give  or  withhold  consent  to  any  corporate  action  (whether  upon  any  recapitalization,  issuance  of  stock,
reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance or otherwise) or to
receive  notice  of  meetings,  or  to  receive  dividends  or  subscription  rights  or  otherwise  until  the  Option  shall  have  been  exercised  as
provided herein.

7.            Transfer of Option.

7 . 1 .        Non-Transferability. This Option shall not be assigned, transferred, pledged or hypothecated in any way, nor
subject  to  execution,  attachment  or  similar  process,  otherwise  than  by  will  or  by  the  laws  of  descent  and  distribution.  Any  attempted
assignment,  transfer,  pledge,  hypothecation  or  other  disposition  of  this  Option  contrary  to  the  provisions  hereof,  and  the  levy  of  an
execution, attachment, or similar process upon the Option, shall be null and void and without effect.

7.2.           Compliance with Securities Laws; Restrictions on Transfers.  In addition to restrictions on transfer of this

Option and Shares set forth in Section 7.1 above.

(a)        The Holder of this Option, by acceptance hereof, acknowledges that this Option and the Shares to be
issued upon exercise hereof are being acquired solely for the Holder's own account and not as a nominee for any other party, and for
investment  (unless  such  shares  are  subject  to  resale  pursuant  to  an  effective  prospectus),  and  that  the  Holder  will  not  offer,  sell  or
otherwise  dispose  of  any  Shares  to  be  issued  upon  exercise  hereof  except  under  circumstances  that  will  not  result  in  a  violation  of
applicable  federal  and  state  securities  laws.  Upon  exercise  of  this  Option,  the  Holder  shall,  if  requested  by  the  Company,  confirm  in
writing, in a form satisfactory to the Company, that the Shares of Common Stock so purchased are being acquired solely for the Holder's
own account and not as a nominee for any other party, for investment (unless such shares are subject to resale pursuant to an effective
prospectus), and not with a view toward distribution or resale.

4

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
(b)        Neither this Option nor any share of Common Stock issued upon exercise of this Option may be offered
for sale or sold, or otherwise transferred or sold in any transaction which would constitute a sale thereof within the meaning of the 1933
Act, unless (i) such security has been registered for sale under the 1933 Act and registered or qualified under applicable state securities
laws relating to the offer an sale of securities; (ii) exemptions from the registration requirements of the 1933 Act and the registration or
qualification  requirements  of  all  such  state  securities  laws  are  available  and  the  Company  shall  have  received  an  opinion  of  counsel
satisfactory to the Company that the proposed sale or other disposition of such securities may be effected without registration under the
1933  Act  and  would  not  result  in  any  violation  of  any  applicable  state  securities  laws  relating  to  the  registration  or  qualification  of
securities for sale, such counsel and such opinion to be satisfactory to the Company. The Holder of this Option, by acceptance hereof,
acknowledges that the Company has no obligation to file a registration statement with the Securities and Exchange Commission or any
state  securities  commission  to  register  the  issuance  of  the  Shares  upon  exercise  hereof  or  the  sale  or  transfer  of  the  Shares  after
issuance.

following form (in addition to any legend required by state securities laws).

(c)        All Shares issued upon exercise hereof shall be stamped or imprinted with a legend in substantially the

THE  SECURITIES  EVIDENCED  BY  THIS  CERTIFICATE  HAVE  NOT  BEEN  REGISTERED  UNDER  THE  SECURITIES  ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE  WITH  RULE  144,  OR  THE  COMPANY  RECEIVES  AN  OPINION  OF  COUNSEL  FOR  THE  HOLDER  OF
THESE  SECURITIES,  REASONABLY  SATISFACTORY  TO  THE  COMPANY,  STATING  THAT  SUCH  SALE,  TRANSFER,
ASSIGNMENT  OR  HYPOTHECATION 
IS  EXEMPT  FROM  THE  REGISTRATION  AND  PROSPECTUS  DELIVERY
REQUIREMENTS OF SUCH ACT.

(d)          Holder recognizes that investing in the Option and the Shares involves a high degree of risk, and Holder is in a
financial position to hold the Option and the Shares indefinitely and is able to bear the economic risk and withstand a complete loss of its
investment  in  the  Option  and  the  Shares.  The  Holder  is  a  sophisticated  investor  and  is  capable  of  evaluating  the  merits  and  risks  of
investing in the Company. The Holder has had an opportunity to discuss the Company's business, management and financial affairs with
the Company's management, has been given full and complete access to information concerning the Company, and has utilized such
access  to  its  satisfaction  for  the  purpose  of  obtaining  information  or  verifying  information  and  has  had  the  opportunity  to  inspect  the
Company's operation. Holder has had the opportunity to ask questions of, and receive answers from the management of the Company
(and any person acting on its behalf) concerning the Option and the Shares and the agreements and transactions contemplated hereby,
and to obtain any additional information as Holder may have requested in making its investment decision.

5

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
(e)          Holder acknowledges and represents: (i) that he has been afforded the opportunity to review and is familiar with
the business prospects and finances of the Company and has based his decision to invest solely on the information contained therein
and has not been furnished with any other literature, prospectus or other information except as included in such reports; (ii) he is at least
21  years  of  age;  (iii)  he  has  adequate  means  of  providing  for  his  current  needs  and  personal  contingencies;  (iv)  he  has  no  need  for
liquidity  for  his  investment  in  the  Option  or  Shares;  (v)  he  maintains  his  domicile  and  is  not  a  transient  or  temporary  resident  at  the
address  on  the  books  and  records  of  the  Company;  (vi)  all  of  his  investments  and  commitments  to  non-liquid  assets  and  similar
investments are, after his acquisition of the Option and Shares, will be reasonable in relation to his net worth and current needs; (vii) he
understands that no federal or state agency has approved or disapproved the Option or Shares or made any finding or determination as
to the fairness of the Option and Common Stock for investment; and (viii) that the Company has made no representations, warranties, or
assurances  as  to  (A)  the  future  trading  value  of  the  Common  Stock,  (B)  whether  there  will  be  a  public  market  for  the  resale  of  the
Common  Stock  or  (C)  the  filing  of  a  registration  statement  with  the  Securities  and  Exchange  Commission  or  any  state  securities
commission to register the issuance of the Shares upon exercise hereof or the sale or transfer of the Shares after issuance.

8.             Reservation and Issuance of Stock; Payment of Taxes.

(a)          The Company covenants that during the term that this Option is exercisable, the Company will reserve from its
authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Shares upon the exercise of this
Option, and from time to time will take all steps necessary to amend its Certificate of Incorporation to provide sufficient reserves of shares
of Common Stock issuable upon the exercise of the Option.

(b)          The Company further covenants that all shares of Common Stock issuable upon the due exercise of this Option
will be free and clear from all taxes or liens, charges and security interests created by the Company with respect to the issuance thereof,
however,  the  Company  shall  not  be  obligated  or  liable  for  the  payment  of  any  taxes,  liens  or  charges  of  Holder,  or  any  other  party
contemplated by Section 7, incurred in connection with the issuance of this Option or the Common Stock upon the due exercise of this
Option. The Company agrees that its issuance of this Option shall constitute full authority to its officers who are charged with the duty of
executing stock certificates to execute and issue the necessary certificates for the shares of Common Stock upon the exercise of this
Option. The Common Stock issuable upon the due exercise of this Option, will, upon issuance in accordance with the terms hereof, be
duly authorized, validly issued, fully paid and non-assessable.

(c)          Upon exercise of the Option, the Company shall have the right to require the Holder to remit to the Company an
amount  sufficient  to  satisfy  federal,  state  and  local  tax  withholding  requirements  prior  to  the  delivery  of  any  certificate  for  Shares  of
Common  Stock  purchased  pursuant  to  the  Option,  if  in  the  opinion  of  counsel  to  the  Company  such  withholding  is  required  under
applicable tax laws.

6

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
(d)          If Holder is obligated to pay the Company an amount required to be withheld under applicable tax withholding
requirements may pay such amount (i) in cash; (ii) in the discretion of the Board of Directors of the Company, through the delivery to the
Company of previously-owned shares of Common Stock having an aggregate Fair Market Value equal to the tax obligation provided that
the previously owned shares delivered in satisfaction of the withholding obligations must have been held by the Holder for at least six (6)
months; (iii) in the discretion of the Board of Directors of the Company, through the withholding of Shares of Common Stock otherwise
issuable to the Holder in connection with the Option exercise; or (iv) in the discretion of the Board of Directors of the Company, through a
combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 8(d).

9.             Notices.

(a)          Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section
11  hereof,  the  Company  shall  issue  a  certificate  signed  by  its  Chief  Financial  Officer  setting  forth,  in  reasonable  detail,  the  event
requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price
and  number  of  shares  purchasable  hereunder  after  giving  effect  to  such  adjustment,  and  shall  cause  a  copy  of  such  certificate  to  be
mailed (by first-class mail, postage prepaid) to the Holder of this Option.

(b)          All notices, advices and communications under this Option shall be deemed to have been given, (i) in the case
of  personal  delivery,  on  the  date  of  such  delivery  and  (ii)  in  the  case  of  mailing,  on  the  third  business  day  following  the  date  of  such
mailing, addressed as follows:

If to the Company:

BIO-key International, Inc.
3349 Highway 138
Building D, Suite A
Wall, NJ 07719

With a copy to:
Choate, Hall & Stewart
Two International Place
Boston, MA 02119
Attn.: Charles Johnson

and to the Holder:
Jeff May
20 Gideons Point Road  
Tonka Bay MN 55331

7

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
Either of the Company or the Holder may from time to time change the address to which notices to it are to be mailed hereunder

by notice in accordance with the provisions of this Paragraph 9.

10.           Amendments.

(a)                    Any  term  of  this  Option  may  be  amended  with  the  written  consent  of  the  Company  and  the  Holder.  Any

amendment effected in accordance with this Section 10 shall be binding upon the Holder, each future holder and the Company.

(b)          No waivers of, or exceptions to, any term, condition or provision of this Option, in any one or more instances,

shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.

1 1 .           Adjustments. The number of Shares of Common Stock purchasable hereunder and the Exercise Price is subject to

adjustment from time to time upon the occurrence of certain events, as follows:

1 1 . 1 .        Reorganization,  Merger  or  Sale  of  Assets.  If  at  any  time  while  this  Option,  or  any  portion  thereof,  is
outstanding  and  unexpired  there  shall  be  (i)  a  reorganization  (other  than  a  combination,  reclassification,  exchange  or  subdivision  of
shares  otherwise  provided  for  herein);  or  (ii)  a  merger  or  consolidation  of  the  Company  in  which  the  shares  of  the  Company's  capital
stock  outstanding  immediately  prior  to  the  merger  are  converted  by  virtue  of  the  merger  into  other  property,  whether  in  the  form  of
securities, cash or otherwise, then, as a part of such reorganization, merger, or consolidation, lawful provision shall be made so that the
holder of this Option shall upon such reorganization, merger, or consolidation, have the right by exercising such Option, to purchase the
kind  and  number  of  shares  of  Common  Stock  or  other  securities  or  property  (including  cash)  otherwise  receivable  upon  such
reorganization, merger or consolidation by a holder of the number of shares of Common Stock that might have been purchased upon
exercise of such Option immediately prior to such reorganization, merger or consolidation. The foregoing provisions of this Section 11.1
shall similarly apply to successive reorganizations, consolidations or mergers. If the per-share consideration payable to the Holder hereof
for  shares  in  connection  with  any  such  transaction  is  in  a  form  other  than  cash  or  marketable  securities,  then  the  value  of  such
consideration  shall  be  determined  in  good  faith  by  the  Company's  Board  of  Directors.  In  all  events,  appropriate  adjustment  (as
determined  in  good  faith  by  the  Company's  Board  of  Directors)  shall  be  made  in  the  application  of  the  provisions  of  this  Option  with
respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Option shall be applicable after
that event, as near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this
Option.

11.2.      Reclassification. If the Company, at any time while this Option, or any portion thereof, remains outstanding and
unexpired, by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Option
exist  into  the  same  or  a  different  number  of  securities  of  any  other  class  or  classes,  this  Option  shall  thereafter  represent  the  right  to
acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that
were subject to the purchase rights under this Option immediately prior to such reclassification or other change and the Exercise Price
therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 11.

8

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
1 1 . 3 .        Split, Subdivision or Combination of Shares. If the Company at any time while this Option, or any portion
thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Option
exist, into a different number of securities of the same class, the Exercise Price and the number of shares issuable upon exercise of this
Option shall be proportionately adjusted.

1 1 . 4 .         Adjustments for Dividends in Stock or Other Securities or Property. If while this Option, or any portion
hereof, remains outstanding and unexpired the holders of the securities as to which purchase rights under this Option exist at the time
shall  have  received,  or,  on  or  after  the  record  date  fixed  for  the  determination  of  eligible  Stockholders,  shall  have  become  entitled  to
receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of
dividend,  then  and  in  each  case,  this  Option  shall  represent  the  right  to  acquire,  in  addition  to  the  number  of  shares  of  the  security
receivable  upon  exercise  of  this  Option,  and  without  payment  of  any  additional  consideration  therefor,  the  amount  of  such  other  or
additional  stock  or  other  securities  or  property  (other  than  cash)  of  the  Company  that  such  holder  would  hold  on  the  date  of  such
exercise had it been the holder of record of the security receivable upon exercise of this Option on the date hereof and had thereafter,
during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock,
other securities or property available by this Option as aforesaid during such period.

1 1 . 5         Good  Faith. The  Company  will  not,  by  any  voluntary  action,  avoid  or  seek  to  avoid  the  observance  or
performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the
carrying out of all the provisions of this Section 11 and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Holder of this Option against impairment.

1 2 .        Fundamental  Transaction.        For  purposes  of  this  Section  12,  a  "Fundamental  Transaction"  shall  mean  (i)  the
dissolution  or  liquidation  of  the  Company;  (ii)  a  merger,  reorganization  or  consolidation  in  which  the  Company  is  acquired  by  another
person  or  entity  (other  than  a  holding  company  formed  by  the  Company);  (iii)  the  sale  of  all  or  substantially  all  of  the  assets  of  the
Company to any person or persons; or (iv) the sale in a single transaction or a series of related transactions of voting stock representing
more than fifty percent (50%) of the voting power of all outstanding shares of the Company to any person or persons. In the event of a
Fundamental Transaction, this Option shall automatically become immediately exercisable in full, and shall be deemed to have attained
such  status  immediately  prior  to  the  Fundamental  Transaction.  Holder  shall  be  given  at  least  15  days  prior  written  notice  of  a
Fundamental  Transaction  and  shall  be  permitted  to  exercise  any  vested  Options  during  this  15  day  period  (including  those  Options
vesting  as  a  result  of  the  provisions  of  this  Section  12).  In  the  event  of  a  Fundamental  Transaction,  any  Options  which  are  neither
assumed or substituted for in connection with the Fundamental Transaction nor exercised as of the date of the Fundamental Transaction,
shall terminate and cease to be outstanding effective as of the date of the Fundamental Transaction, unless otherwise provided by the
Board of Directors of the Company.

9

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
1 3 .         Severability. Whenever possible, each provision of this Option shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Option is held to be invalid, illegal or unenforceable in any respect under any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of
any  other  provision  of  this  Option  in  such  jurisdiction  or  affect  the  validity,  legality  or  enforceability  of  any  provision  in  any  other
jurisdiction,  but  this  Option  shall  be  reformed,  construed  and  enforced  in  such  jurisdiction  as  if  such  invalid,  illegal  or  unenforceable
provision had never been contained herein.

1 4 .         Governing Law.  The  corporate  law  of  the  State  of  Minnesota  shall  govern  all  issues  and  questions  concerning  the
relative  rights  of  the  Company  and  its  stockholders.  All  other  questions  concerning  the  construction,  validity,  interpretation  and
enforceability of this Option and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of
the State of Minnesota, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Minnesota
or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Minnesota.

1 5 .         Jurisdiction. The Holder and the Company agree to submit to personal jurisdiction and to waive any objection as to
venue in the federal or state courts of Minnesota. Service of process on the Company or the Holder in any action arising out of or relating
to this Option shall be effective if mailed to such party at the address listed in Section 9 hereof.

1 6 .         Arbitration.   If a dispute arises as to interpretation of this Option, it shall be decided finally by three arbitrators in an
arbitration  proceeding  conforming  to  the  Rules  of  the  American  Arbitration  Association  applicable  to  commercial  arbitration.  The
arbitrators  shall  be  appointed  as  follows:  one  by  the  Company,  one  by  the  Holder  and  the  third  by  the  said  two  arbitrators,  or,  if  they
cannot agree, then the third arbitrator shall be appointed by the American Arbitration Association. The third arbitrator shall be chairman
of the panel and shall be impartial. The arbitration shall take place in Minneapolis, Minnesota. The decision of a majority of the arbitrators
shall be conclusively binding upon the parties and final, and such decision shall be enforceable as a judgment in any court of competent
jurisdiction. Each party shall pay the fees and expenses of the arbitrator appointed by it, its counsel and its witnesses. The parties shall
share equally the fees and expenses of the impartial arbitrator.

1 7 .         Corporate  Power;  Authorization;  Enforceable  Obligations.    The  execution,  delivery  and  performance  by  the
Company  of  this  Option:  (i)  are  within  the  Company’s  corporate  power;  (ii)  have  been  duly  authorized  by  all  necessary  or  proper
corporate action; (iii) are not in contravention of the Company’s certificate of incorporation or bylaws; (iv) will not violate in any material
respect,  any  law  or  regulation,  including  any  and  all  Federal  and  state  securities  laws,  or  any  order  or  decree  of  any  court  or
governmental instrumentality; and (v) will not, in any material respect, conflict with or result in the breach or termination of, or constitute a
default under any agreement or other material instrument to which the Company is a party or by which the Company is bound.

10

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
1 8 .         Successors  and  Assigns. This  Option  shall  inure  to  the  benefit  of  and  be  binding  on  the  respective  successors,

assigns and legal representatives of the Holder and the Company.

IN WITNESS WHEREOF, the Company and Holder have caused this Option to be executed as of March 27, 2013, the Option

Issue Date.

AGREED AND ACCEPTED:

Jeff May

______________________

Signature

BIO-key International, Inc.

By:  

  Name:  Michael DePasquale
  Title:  CEO

11

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
TO: [_____________________________]

NOTICE OF EXERCISE

(1)        The undersigned hereby elects to purchase _______ shares of Common Stock of BIO-key International, Inc. pursuant
to the terms of the attached Option, and tenders herewith payment of the purchase price for such shares in full in the following manner
(please check one of the following choices):

☐         In Cash

☐         Cashless exercise through a broker; or

☐         Delivery of previously owned shares.

(2)         In exercising this Option, the undersigned hereby confirms and acknowledges that the shares of Common Stock to be
issued upon conversion thereof are being acquired solely for the account of the undersigned and not as a nominee for any other party,
and for investment (unless such shares are subject to resale pursuant to an effective prospectus), and that the undersigned will not offer,
sell  or  otherwise  dispose  of  any  such  shares  of  Common  Stock  except  under  circumstances  that  will  not  result  in  a  violation  of  the
Securities Act of 1933, as amended, or any state securities laws.

(3)         Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned. 

[

] 

(Date)    

(Signature)

12

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE WITH RULE 144, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF
THESE SECURITIES, REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER,
ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SUCH ACT.

Exhibit 10.39

OPTION TO PURCHASE COMMON STOCK
OF
BIO-key International, Inc.
Void after March 27, 2020

This certifies that, for value received, Thomas Colatosti ("Holder"), is entitled, subject to the terms set forth below, to purchase
from BIO-key International, Inc., a Delaware corporation (the "Company"), shares of the common stock, $.0001 par value per share, of
the Company ("Common Stock"), as constituted on the date hereof (the "Option Issue Date"), with the Notice of Exercise attached hereto
duly executed, and simultaneous payment therefor in lawful money of the United States or as otherwise provided in Section 3 hereof, at
the  Exercise  Price  then  in  effect.  The  number,  character  and  Exercise  Price  of  the  shares  of  Common  Stock  issuable  upon  exercise
hereof are subject to adjustment as provided herein.

1 .     Term of Option.  Subject  to  compliance  with  the  vesting  provisions  identified  at  Section  2.3  hereof,  this  Option  shall  be
exercisable, in whole or in part, during the term commencing on the Option Issue Date and ending at 5:00 p.m. EST on March 27, 2020
(the "Option Expiration Date") and shall be void thereafter.

2.     Number of Shares, Exercise Price and Vesting Provisions.

2 . 1     Number of Shares. The number of shares of Common Stock which may be purchased pursuant to this Option

shall be 50,000 shares (the "Shares"), subject, however, to adjustment pursuant to Section 11 hereof.

2 . 2     Exercise Price. The Exercise Price at which this Option, or portion thereof, may be exercised shall be $0.17 per

Share, subject, however, to adjustment pursuant to Section 11 hereof. 

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
2.3     Vesting.      This Option shall vest in accordance with the following schedule:

(i)

(ii)

16,666 Shares shall vest on March 27, 2014;

16,666 Shares shall vest on March 27, 2015; and

(iii)

16,667 Shares shall vest on March 27, 2016.

3.     Exercise of Option.

3 . 1     Payment of Exercise Price.      Subject to the terms hereof, the purchase rights represented by this Option are
exercisable by the Holder in whole or in part, at any time, or from time to time, by the surrender of this Option and the Notice of Exercise
annexed hereto duly completed and executed on behalf of the Holder, at the office of the Company (or such other office or agency of the
Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company)
accompanied by payment of the Exercise Price in full (i) in cash or by bank or certified check for the Shares with respect to which this
Option is exercised; (ii) by delivery to the Company of shares of the Company's Common Stock having a Fair Market Value (as defined
below)  equal  to  the  aggregate  Exercise  Price  of  the  Shares  being  purchased  which  Holder  is  the  record  and  beneficial  owner  of  and
which  have  been  held  by  the  Holder  for  at  least  six  (6)  months;  (iii)  if  the  Shares  are  eligible  for  public  resale,  by  delivering  to  the
Company a Notice of Exercise together with an irrevocable direction to a broker-dealer registered under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), to sell a sufficient portion of the Shares and deliver the sales proceeds directly to the Company
to pay the Exercise Price; or (iv) by any combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 3.1.

3.2      Fair Market Value. If previously owned shares of Common Stock are tendered as payment of the Exercise Price,
the value of such shares shall be the "Fair Market Value" of such shares on the trading date immediately preceding the date of exercise.
For the purpose of this Agreement, the "Fair Market Value" shall be:

(a)     If the Common Stock is admitted to quotation on the National Association of Securities Dealers Automated
Quotation System ("NASDAQ"), the Fair Market Value on any given date shall be the average of the highest bid and lowest asked prices
of the Common Stock as reported for such date or, if no bid and asked prices were reported for such date, for the last day preceding such
date for which such prices were reported;

(b)          If  the  Common  Stock  is  admitted  to  trading  on  a  United  States  securities  exchange  or  the  NASDAQ
National Market System, the Fair Market Value on any date shall be the closing price reported for the Common Stock on such exchange
or system for such date or, if no sales were reported for such date, for the last day preceding such date for which a sale was reported;

2

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
(c)     If the Common Stock is traded in the over-the-counter market and not on any national securities exchange
nor in the NASDAQ Reporting System, the Fair Market Value shall be the average of the mean between the last bid and ask prices per
share, as reported by the National Quotation Bureau, Inc., or an equivalent generally accepted reporting service, or if not so reported, the
average  of  the  closing  bid  and  asked  prices  for  a  share  as  furnished  to  the  Company  by  any  member  of  the  National  Association  of
Securities Dealers, Inc., selected by the Company for that purpose; or

(d)     If the Fair Market Value of the Common Stock cannot be determined on the basis previously set forth in
this  definition  on  the  date  that  the  Fair  Market  Value  is  to  be  determined,  the  Board  of  Directors  of  the  Company  shall  in  good  faith
determine the Fair Market Value of the Common Stock on such date.

If the tender of previously owned shares would result in an issuance of a whole number of Shares and a fractional Share of Common
Stock, the value of such fractional share shall be paid to the Company in cash or by check by the Holder.

3.3     Termination of Employment; Death.

(a)     

If  Holder  shall  cease  to  be  employed  by  the  Company,  all  Options  to  which  Holder  is  then  entitled  to
exercise may be exercised only within ninety (90) days after the termination of employment and prior to the Option Termination Date or, if
such termination was due to disability or retirement (as hereinafter defined), within one (1) year after termination of employment and prior
to the Option Termination Date. Notwithstanding the foregoing, in the event that any termination of employment shall be for Cause as
that term is defined in the Company’s 1999 Stock Option Plan, then this Option shall forthwith terminate.

(b)     If Holder shall die while employed by the Company and prior to the Option Termination Date, any Options
then exercisable may be exercised only within one (1) year after Holder's death, prior to the Option Termination Date and only by the
Holder's personal representative or persons entitled thereto under the Holder's will or the laws of descent and distribution.

(c)     This Option may not be exercised for more Shares (subject to adjustment as provided in Section 11 hereof)
after the termination of the Holder's employment or death, as the case may be, than the Holder was entitled to purchase thereunder at
the time of the termination of the Holder's employment or death.

3 . 4     Exercise  Date;  Delivery  of  Certificates.      This Option shall be deemed to have been exercised immediately
prior to the close of business on the date of its surrender for exercise as provided above, and Holder shall be treated for all purposes as
the holder of record of such Shares as of the close of business on such date. As promptly as practicable on or after such date and in any
event within ten (10) days thereafter, the Company at its expense shall issue and deliver to the Holder a certificate or certificates for the
number of Shares issuable upon such exercise. In the event that this Option is exercised in part, the Company at its expense will execute
and deliver a new Option of like tenor exercisable for the number of shares for which this Option may then be exercised.

3

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
4 .     No  Fractional  Shares  or  Scrip.  No  fractional  shares  or  scrip  representing  fractional  shares  shall  be  issued  upon  the
exercise of this Option. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash
payment equal to the Exercise Price multiplied by such fraction.

5 .     Replacement of Option. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Option and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in
form  and  substance  to  the  Company  or,  in  the  case  of  mutilation,  on  surrender  and  cancellation  of  this  Option,  the  Company  at  its
expense shall execute and deliver, in lieu of this Option, a new Option of like tenor and amount.

6 .     Rights  of  Stockholder.  Except  as  otherwise  contemplated  herein,  the  Holder  shall  not  be  entitled  to  vote  or  receive
dividends or be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of
a  stockholder  of  the  Company  or  any  right  to  vote  for  the  election  of  directors  or  upon  any  matter  submitted  to  stockholders  at  any
meeting  thereof,  or  to  give  or  withhold  consent  to  any  corporate  action  (whether  upon  any  recapitalization,  issuance  of  stock,
reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance or otherwise) or to
receive  notice  of  meetings,  or  to  receive  dividends  or  subscription  rights  or  otherwise  until  the  Option  shall  have  been  exercised  as
provided herein.

7.     Transfer of Option.

7 . 1 .     Non-Transferability.  This  Option  shall  not  be  assigned,  transferred,  pledged  or  hypothecated  in  any  way,  nor
subject  to  execution,  attachment  or  similar  process,  otherwise  than  by  will  or  by  the  laws  of  descent  and  distribution.  Any  attempted
assignment,  transfer,  pledge,  hypothecation  or  other  disposition  of  this  Option  contrary  to  the  provisions  hereof,  and  the  levy  of  an
execution, attachment, or similar process upon the Option, shall be null and void and without effect.

7 . 2 .          Compliance with Securities Laws; Restrictions on Transfers. In addition to restrictions on transfer of this

Option and Shares set forth in Section 7.1 above.

(a)          The  Holder  of  this  Option,  by  acceptance  hereof,  acknowledges  that  this  Option  and  the  Shares  to  be
issued upon exercise hereof are being acquired solely for the Holder's own account and not as a nominee for any other party, and for
investment  (unless  such  shares  are  subject  to  resale  pursuant  to  an  effective  prospectus),  and  that  the  Holder  will  not  offer,  sell  or
otherwise  dispose  of  any  Shares  to  be  issued  upon  exercise  hereof  except  under  circumstances  that  will  not  result  in  a  violation  of
applicable  federal  and  state  securities  laws.  Upon  exercise  of  this  Option,  the  Holder  shall,  if  requested  by  the  Company,  confirm  in
writing, in a form satisfactory to the Company, that the Shares of Common Stock so purchased are being acquired solely for the Holder's
own account and not as a nominee for any other party, for investment (unless such shares are subject to resale pursuant to an effective
prospectus), and not with a view toward distribution or resale.

4

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
(b)     Neither this Option nor any share of Common Stock issued upon exercise of this Option may be offered for
sale or sold, or otherwise transferred or sold in any transaction which would constitute a sale thereof within the meaning of the 1933 Act,
unless (i) such security has been registered for sale under the 1933 Act and registered or qualified under applicable state securities laws
relating  to  the  offer  an  sale  of  securities;  (ii)  exemptions  from  the  registration  requirements  of  the  1933  Act  and  the  registration  or
qualification  requirements  of  all  such  state  securities  laws  are  available  and  the  Company  shall  have  received  an  opinion  of  counsel
satisfactory to the Company that the proposed sale or other disposition of such securities may be effected without registration under the
1933  Act  and  would  not  result  in  any  violation  of  any  applicable  state  securities  laws  relating  to  the  registration  or  qualification  of
securities for sale, such counsel and such opinion to be satisfactory to the Company. The Holder of this Option, by acceptance hereof,
acknowledges that the Company has no obligation to file a registration statement with the Securities and Exchange Commission or any
state  securities  commission  to  register  the  issuance  of  the  Shares  upon  exercise  hereof  or  the  sale  or  transfer  of  the  Shares  after
issuance.

following form (in addition to any legend required by state securities laws).

(c)     All Shares issued upon exercise hereof shall be stamped or imprinted with a legend in substantially the

THE  SECURITIES  EVIDENCED  BY  THIS  CERTIFICATE  HAVE  NOT  BEEN  REGISTERED  UNDER  THE  SECURITIES  ACT
OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN
ACCORDANCE  WITH  RULE  144,  OR  THE  COMPANY  RECEIVES  AN  OPINION  OF  COUNSEL  FOR  THE  HOLDER  OF
THESE  SECURITIES,  REASONABLY  SATISFACTORY  TO  THE  COMPANY,  STATING  THAT  SUCH  SALE,  TRANSFER,
ASSIGNMENT  OR  HYPOTHECATION 
IS  EXEMPT  FROM  THE  REGISTRATION  AND  PROSPECTUS  DELIVERY
REQUIREMENTS OF SUCH ACT.

(d)     Holder recognizes that investing in the Option and the Shares involves a high degree of risk, and Holder is
in a financial position to hold the Option and the Shares indefinitely and is able to bear the economic risk and withstand a complete loss
of its investment in the Option and the Shares. The Holder is a sophisticated investor and is capable of evaluating the merits and risks of
investing in the Company. The Holder has had an opportunity to discuss the Company's business, management and financial affairs with
the Company's management, has been given full and complete access to information concerning the Company, and has utilized such
access  to  its  satisfaction  for  the  purpose  of  obtaining  information  or  verifying  information  and  has  had  the  opportunity  to  inspect  the
Company's operation. Holder has had the opportunity to ask questions of, and receive answers from the management of the Company
(and any person acting on its behalf) concerning the Option and the Shares and the agreements and transactions contemplated hereby,
and to obtain any additional information as Holder may have requested in making its investment decision.

5

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
(e)     Holder acknowledges and represents: (i) that he has been afforded the opportunity to review and is familiar
with  the  business  prospects  and  finances  of  the  Company  and  has  based  his  decision  to  invest  solely  on  the  information  contained
therein and has not been furnished with any other literature, prospectus or other information except as included in such reports; (ii) he is
at least 21 years of age; (iii) he has adequate means of providing for his current needs and personal contingencies; (iv) he has no need
for liquidity for his investment in the Option or Shares; (v) he maintains his domicile and is not a transient or temporary resident at the
address  on  the  books  and  records  of  the  Company;  (vi)  all  of  his  investments  and  commitments  to  non-liquid  assets  and  similar
investments are, after his acquisition of the Option and Shares, will be reasonable in relation to his net worth and current needs; (vii) he
understands that no federal or state agency has approved or disapproved the Option or Shares or made any finding or determination as
to the fairness of the Option and Common Stock for investment; and (viii) that the Company has made no representations, warranties, or
assurances  as  to  (A)  the  future  trading  value  of  the  Common  Stock,  (B)  whether  there  will  be  a  public  market  for  the  resale  of  the
Common  Stock  or  (C)  the  filing  of  a  registration  statement  with  the  Securities  and  Exchange  Commission  or  any  state  securities
commission to register the issuance of the Shares upon exercise hereof or the sale or transfer of the Shares after issuance.

8.     Reservation and Issuance of Stock; Payment of Taxes.

(a)     The Company covenants that during the term that this Option is exercisable, the Company will reserve from its
authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Shares upon the exercise of this
Option, and from time to time will take all steps necessary to amend its Certificate of Incorporation to provide sufficient reserves of shares
of Common Stock issuable upon the exercise of the Option.

(b)     The Company further covenants that all shares of Common Stock issuable upon the due exercise of this Option will
be free and clear from all taxes or liens, charges and security interests created by the Company with respect to the issuance thereof,
however,  the  Company  shall  not  be  obligated  or  liable  for  the  payment  of  any  taxes,  liens  or  charges  of  Holder,  or  any  other  party
contemplated by Section 7, incurred in connection with the issuance of this Option or the Common Stock upon the due exercise of this
Option. The Company agrees that its issuance of this Option shall constitute full authority to its officers who are charged with the duty of
executing stock certificates to execute and issue the necessary certificates for the shares of Common Stock upon the exercise of this
Option. The Common Stock issuable upon the due exercise of this Option, will, upon issuance in accordance with the terms hereof, be
duly authorized, validly issued, fully paid and non-assessable.

(c)     Upon exercise of the Option, the Company shall have the right to require the Holder to remit to the Company an
amount  sufficient  to  satisfy  federal,  state  and  local  tax  withholding  requirements  prior  to  the  delivery  of  any  certificate  for  Shares  of
Common  Stock  purchased  pursuant  to  the  Option,  if  in  the  opinion  of  counsel  to  the  Company  such  withholding  is  required  under
applicable tax laws.

6

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
  
 
(d)          If  Holder  is  obligated  to  pay  the  Company  an  amount  required  to  be  withheld  under  applicable  tax  withholding
requirements may pay such amount (i) in cash; (ii) in the discretion of the Board of Directors of the Company, through the delivery to the
Company of previously-owned shares of Common Stock having an aggregate Fair Market Value equal to the tax obligation provided that
the previously owned shares delivered in satisfaction of the withholding obligations must have been held by the Holder for at least six (6)
months; (iii) in the discretion of the Board of Directors of the Company, through the withholding of Shares of Common Stock otherwise
issuable to the Holder in connection with the Option exercise; or (iv) in the discretion of the Board of Directors of the Company, through a
combination of the procedures set forth in subsections (i), (ii) and (iii) of this Section 8(d).

9.     Notices.

(a)     Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section 11
hereof, the Company shall issue a certificate signed by its Chief Financial Officer setting forth, in reasonable detail, the event requiring
the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and number
of shares purchasable hereunder after giving effect to such adjustment, and shall cause a copy of such certificate to be mailed (by first-
class mail, postage prepaid) to the Holder of this Option.

(b)     All notices, advices and communications under this Option shall be deemed to have been given, (i) in the case of
personal delivery, on the date of such delivery and (ii) in the case of mailing, on the third business day following the date of such mailing,
addressed as follows:

If to the Company:

BIO-key International, Inc.
3349 Hwy 138
BLDG D, Suite A
Wall, NJ 07719

With a copy to:
Choate, Hall & Stewart
Two International Place
Boston, MA 02119
Attn.: Charles Johnson

and to the Holder:
Thomas Colatosti
188 East Emerson Road  
Lexington, MA 02420

7

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
Either of the Company or the Holder may from time to time change the address to which notices to it are to be mailed hereunder

by notice in accordance with the provisions of this Paragraph 9.

10.     Amendments.

(a)          Any  term  of  this  Option  may  be  amended  with  the  written  consent  of  the  Company  and  the  Holder.  Any

amendment effected in accordance with this Section 10 shall be binding upon the Holder, each future holder and the Company.

(b)     No waivers of, or exceptions to, any term, condition or provision of this Option, in any one or more instances, shall

be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.

1 1 .     Adjustments.  The  number  of  Shares  of  Common  Stock  purchasable  hereunder  and  the  Exercise  Price  is  subject  to

adjustment from time to time upon the occurrence of certain events, as follows:

1 1 . 1 .     Reorganization,  Merger  or  Sale  of  Assets.  If  at  any  time  while  this  Option,  or  any  portion  thereof,  is
outstanding  and  unexpired  there  shall  be  (i)  a  reorganization  (other  than  a  combination,  reclassification,  exchange  or  subdivision  of
shares  otherwise  provided  for  herein);  or  (ii)  a  merger  or  consolidation  of  the  Company  in  which  the  shares  of  the  Company's  capital
stock  outstanding  immediately  prior  to  the  merger  are  converted  by  virtue  of  the  merger  into  other  property,  whether  in  the  form  of
securities, cash or otherwise, then, as a part of such reorganization, merger, or consolidation, lawful provision shall be made so that the
holder of this Option shall upon such reorganization, merger, or consolidation, have the right by exercising such Option, to purchase the
kind  and  number  of  shares  of  Common  Stock  or  other  securities  or  property  (including  cash)  otherwise  receivable  upon  such
reorganization, merger or consolidation by a holder of the number of shares of Common Stock that might have been purchased upon
exercise of such Option immediately prior to such reorganization, merger or consolidation. The foregoing provisions of this Section 11.1
shall similarly apply to successive reorganizations, consolidations or mergers. If the per-share consideration payable to the Holder hereof
for  shares  in  connection  with  any  such  transaction  is  in  a  form  other  than  cash  or  marketable  securities,  then  the  value  of  such
consideration  shall  be  determined  in  good  faith  by  the  Company's  Board  of  Directors.  In  all  events,  appropriate  adjustment  (as
determined  in  good  faith  by  the  Company's  Board  of  Directors)  shall  be  made  in  the  application  of  the  provisions  of  this  Option  with
respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Option shall be applicable after
that event, as near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this
Option.

11.2.     Reclassification. If the Company, at any time while this Option, or any portion thereof, remains outstanding and
unexpired, by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Option
exist  into  the  same  or  a  different  number  of  securities  of  any  other  class  or  classes,  this  Option  shall  thereafter  represent  the  right  to
acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that
were subject to the purchase rights under this Option immediately prior to such reclassification or other change and the Exercise Price
therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 11.

8

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
1 1 . 3 .     Split,  Subdivision  or  Combination  of  Shares.  If  the  Company  at  any  time  while  this  Option,  or  any  portion
thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Option
exist, into a different number of securities of the same class, the Exercise Price and the number of shares issuable upon exercise of this
Option shall be proportionately adjusted.

1 1 . 4 .     Adjustments  for  Dividends  in  Stock  or  Other  Securities  or  Property.  If  while  this  Option,  or  any  portion
hereof, remains outstanding and unexpired the holders of the securities as to which purchase rights under this Option exist at the time
shall  have  received,  or,  on  or  after  the  record  date  fixed  for  the  determination  of  eligible  Stockholders,  shall  have  become  entitled  to
receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of
dividend,  then  and  in  each  case,  this  Option  shall  represent  the  right  to  acquire,  in  addition  to  the  number  of  shares  of  the  security
receivable  upon  exercise  of  this  Option,  and  without  payment  of  any  additional  consideration  therefor,  the  amount  of  such  other  or
additional  stock  or  other  securities  or  property  (other  than  cash)  of  the  Company  that  such  holder  would  hold  on  the  date  of  such
exercise had it been the holder of record of the security receivable upon exercise of this Option on the date hereof and had thereafter,
during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock,
other securities or property available by this Option as aforesaid during such period.

1 1 . 5     Good  Faith. The  Company  will  not,  by  any  voluntary  action,  avoid  or  seek  to  avoid  the  observance  or
performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the
carrying out of all the provisions of this Section 11 and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Holder of this Option against impairment.

12.     Fundamental Transaction. For purposes of this Section 12, a "Fundamental Transaction" shall mean (i) the dissolution or
liquidation of the Company; (ii) a merger, reorganization or consolidation in which the Company is acquired by another person or entity
(other than a holding company formed by the Company); (iii) the sale of all or substantially all of the assets of the Company to any person
or persons; or (iv) the sale in a single transaction or a series of related transactions of voting stock representing more than fifty percent
(50%) of the voting power of all outstanding shares of the Company to any person or persons. In the event of a Fundamental Transaction,
this  Option  shall  automatically  become  immediately  exercisable  in  full,  and  shall  be  deemed  to  have  attained  such  status  immediately
prior to the Fundamental Transaction. Holder shall be given at least 15 days prior written notice of a Fundamental Transaction and shall
be permitted to exercise any vested Options during this 15 day period (including those Options vesting as a result of the provisions of
this Section 12). In the event of a Fundamental Transaction, any Options which are neither assumed or substituted for in connection with
the Fundamental Transaction nor exercised as of the date of the Fundamental Transaction, shall terminate and cease to be outstanding
effective as of the date of the Fundamental Transaction, unless otherwise provided by the Board of Directors of the Company.

 9

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
13.     Severability. Whenever possible, each provision of this Option shall be interpreted in such manner as to be effective and
valid  under  applicable  law,  but  if  any  provision  of  this  Option  is  held  to  be  invalid,  illegal  or  unenforceable  in  any  respect  under  any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of
any  other  provision  of  this  Option  in  such  jurisdiction  or  affect  the  validity,  legality  or  enforceability  of  any  provision  in  any  other
jurisdiction,  but  this  Option  shall  be  reformed,  construed  and  enforced  in  such  jurisdiction  as  if  such  invalid,  illegal  or  unenforceable
provision had never been contained herein.

14.     Governing Law. The corporate law of the State of Minnesota shall govern all issues and questions concerning the relative
rights of the Company and its stockholders. All other questions concerning the construction, validity, interpretation and enforceability of
this  Option  and  the  exhibits  and  schedules  hereto  shall  be  governed  by,  and  construed  in  accordance  with,  the  laws  of  the  State  of
Minnesota, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Minnesota or any other
jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Minnesota.

15.     Jurisdiction. The Holder and the Company agree to submit to personal jurisdiction and to waive any objection as to venue
in the federal or state courts of Minnesota. Service of process on the Company or the Holder in any action arising out of or relating to this
Option shall be effective if mailed to such party at the address listed in Section 9 hereof.

1 6 .     Arbitration.  If  a  dispute  arises  as  to  interpretation  of  this  Option,  it  shall  be  decided  finally  by  three  arbitrators  in  an
arbitration  proceeding  conforming  to  the  Rules  of  the  American  Arbitration  Association  applicable  to  commercial  arbitration.  The
arbitrators  shall  be  appointed  as  follows:  one  by  the  Company,  one  by  the  Holder  and  the  third  by  the  said  two  arbitrators,  or,  if  they
cannot agree, then the third arbitrator shall be appointed by the American Arbitration Association. The third arbitrator shall be chairman
of the panel and shall be impartial. The arbitration shall take place in Minneapolis, Minnesota. The decision of a majority of the arbitrators
shall be conclusively binding upon the parties and final, and such decision shall be enforceable as a judgment in any court of competent
jurisdiction. Each party shall pay the fees and expenses of the arbitrator appointed by it, its counsel and its witnesses. The parties shall
share equally the fees and expenses of the impartial arbitrator.

1 7 .     Corporate Power; Authorization; Enforceable Obligations. The execution, delivery and performance by the Company
of this Option: (i) are within the Company’s corporate power; (ii) have been duly authorized by all necessary or proper corporate action;
(iii) are not in contravention of the Company’s certificate of incorporation or bylaws; (iv) will not violate in any material respect, any law or
regulation, including any and all Federal and state securities laws, or any order or decree of any court or governmental instrumentality;
and (v) will not, in any material respect, conflict with or result in the breach or termination of, or constitute a default under any agreement
or other material instrument to which the Company is a party or by which the Company is bound.

10

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
   
 
 
 
  
 
18.     Successors and Assigns. This Option shall inure to the benefit of and be binding on the respective successors, assigns

and legal representatives of the Holder and the Company.

IN WITNESS WHEREOF, the Company and Holder have caused this Option to be executed as of March 27, 2013, the Option

Issue Date.

AGREED AND ACCEPTED:  

Thomas Colatosti

Signature

BIO-key International, Inc.  

By:  

Name: Michael DePasquale
Title: CEO  

11

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
TO: [_____________________________]

NOTICE OF EXERCISE

(1)     The undersigned hereby elects to purchase _______ shares of Common Stock of BIO-key International, Inc. pursuant to
the  terms  of  the  attached  Option,  and  tenders  herewith  payment  of  the  purchase  price  for  such  shares  in  full  in  the  following  manner
(please check one of the following choices):

☐     In Cash

☐     Cashless exercise through a broker; or

☐     Delivery of previously owned shares.

(2)          In  exercising  this  Option,  the  undersigned  hereby  confirms  and  acknowledges  that  the  shares  of  Common  Stock  to  be
issued upon conversion thereof are being acquired solely for the account of the undersigned and not as a nominee for any other party,
and for investment (unless such shares are subject to resale pursuant to an effective prospectus), and that the undersigned will not offer,
sell  or  otherwise  dispose  of  any  such  shares  of  Common  Stock  except  under  circumstances  that  will  not  result  in  a  violation  of  the
Securities Act of 1933, as amended, or any state securities laws.

(3)     Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned.

[

] 

(Date)    

(Signature)

12

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit 10.40

MIRA LACOUS
 Optionee     

BIO-KEY INTERNATIONAL, INC.

NON-QUALIFIED STOCK OPTION AGREEMENT
UNDER THE
BIO-KEY INTERNATIONAL, INC.
2004 STOCK INCENTIVE PLAN

This Agreement is made as of the date set forth on Schedule A hereto (the “Grant Date”) by and between Bio-key

International, Inc., a Delaware corporation (the “Corporation”), and the person named on Schedule A hereto (the “Optionee”).

WHEREAS, Optionee is an employee of the Corporation and the Corporation considers it desirable and in its best

interest that Optionee be given an incentive to advance the interests of the Corporation by granting the Optionee an option to purchase
shares of common stock of the Corporation (the “Common Stock”);

NOW, THEREFORE, the parties hereto, intending to be legally bound, hereby agree that as of the Grant Date, the

Corporation hereby grants Optionee an option to purchase from it, upon and subject to the terms and conditions set forth in the
Corporation’s 2004 Stock Incentive Plan, as amended from time to time (the “Plan”), a copy of which is attached hereto, that number of
shares of the authorized and unissued Common Stock of the Corporation as is set forth on Schedule A hereto.

1.     Terms of Stock Option. The option to purchase Common Stock granted hereby (the “Option”) is subject to the

terms, conditions, and covenants set forth in the Plan as well as the following:

(a)

(b)

(c)

(d)

This Option shall constitute a Non-Qualified Stock Option which is not intended to qualify under Section
422 of the Internal Revenue Code of 1986, as amended;

The per share exercise price for the shares subject to the Option is set forth on Schedule A hereto;

The Option shall vest in accordance with the vesting schedule set forth on Schedule A hereto; and

No portion of the Option may be exercised more than seven (7) years from the Grant Date.

2.     Payment of Exercise Price. The Option may be exercised, in part or in whole, only by written request to the

Corporation accompanied by payment of the exercise price in full either: (i) in cash for the shares with respect to which it is exercised; (ii)
if the shares underlying the option are registered under the Securities Act, by delivering to the Corporation a notice of exercise with an
irrevocable direction to a broker-dealer registered under the Securities Exchange Act of 1934, as amended, to sell a sufficient portion of
the shares and deliver the sale proceeds directly to the Corporation to pay the exercise price; or (iii) by delivering previously owned
shares of Common Stock or a combination of shares and cash having an aggregate Fair Market Value (as defined in the Plan) equal to
the exercise price of the shares being purchased; provided, however, that shares of Common Stock delivered by the Optionee may be
accepted as full or partial payment of the exercise price for any exercise of the Option hereunder only if the shares have been held by the
Optionee for at least six (6) months.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.     Miscellaneous.

(a)

(b)

(c)

This Agreement is binding upon the parties hereto and their respective heirs, personal representatives,
successors and assigns.

This Agreement will be governed and interpreted in accordance with the laws of the State of Delaware,
and may be executed in more than one counterpart, each of which shall constitute an original document.

No alterations, amendments, changes or additions to this agreement will be binding upon the
Corporation unless reduced to writing and signed by the Corporation.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
In witness whereof, the parties have executed this Agreement as of the Grant Date.

BIO KEY INTERNATIONAL, INC.

By:

Michael DePasquale

Title: Chief Executive Officer

OPTIONEE  

MIRA LACOUS

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule A

1. Optionee: MIRA LACOUS

2. Grant Date: March 27, 2013

3. Number of Shares of Common Stock covered by the Option: 125,000

4. Exercise Price (which is not less than the Fair Market Value (as defined in the Plan) of Common Stock on the Grant Date): $0.17

5. The Option shall vest in accordance with the following schedule:

(i)

(ii)

41,666 shares shall vest on March 27, 2014; and

41,666 shares shall vest on March 27, 2015; and

(iii)

41,667 shares shall vest on March 27, 2016

6. Expiration Date: March 26, 2020

Initials of Authorized  
Officer of BIO KEY INTERNATIONAL, INC.  

Optionee’s Initials  

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit 10.41

CECILIA WELCH
 Optionee     

BIO-KEY INTERNATIONAL, INC.

NON-QUALIFIED STOCK OPTION AGREEMENT
UNDER THE
BIO-KEY INTERNATIONAL, INC.
2004 STOCK INCENTIVE PLAN

This Agreement is made as of the date set forth on Schedule A hereto (the “Grant Date”) by and between Bio-key

International, Inc., a Delaware corporation (the “Corporation”), and the person named on Schedule A hereto (the “Optionee”).

WHEREAS, Optionee is an employee of the Corporation and the Corporation considers it desirable and in its best

interest that Optionee be given an incentive to advance the interests of the Corporation by granting the Optionee an option to purchase
shares of common stock of the Corporation (the “Common Stock”);

NOW, THEREFORE, the parties hereto, intending to be legally bound, hereby agree that as of the Grant Date, the

Corporation hereby grants Optionee an option to purchase from it, upon and subject to the terms and conditions set forth in the
Corporation’s 2004 Stock Incentive Plan, as amended from time to time (the “Plan”), a copy of which is attached hereto, that number of
shares of the authorized and unissued Common Stock of the Corporation as is set forth on Schedule A hereto.

1.          Terms of Stock Option. The option to purchase Common Stock granted hereby (the “Option”) is subject to the

terms, conditions, and covenants set forth in the Plan as well as the following:

(a)

This Option shall constitute a Non-Qualified Stock Option which is not intended to qualify under Section 422 of
the Internal Revenue Code of 1986, as amended;

(b)

The per share exercise price for the shares subject to the Option is set forth on Schedule A hereto;

(c)

The Option shall vest in accordance with the vesting schedule set forth on Schedule A hereto; and

(d) No portion of the Option may be exercised more than seven (7) years from the Grant Date.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
2.          Payment of Exercise Price. The Option may be exercised, in part or in whole, only by written request to the

Corporation accompanied by payment of the exercise price in full either: (i) in cash for the shares with respect to which it is exercised; (ii)
if the shares underlying the option are registered under the Securities Act, by delivering to the Corporation a notice of exercise with an
irrevocable direction to a broker-dealer registered under the Securities Exchange Act of 1934, as amended, to sell a sufficient portion of
the shares and deliver the sale proceeds directly to the Corporation to pay the exercise price; or (iii) by delivering previously owned
shares of Common Stock or a combination of shares and cash having an aggregate Fair Market Value (as defined in the Plan) equal to
the exercise price of the shares being purchased; provided, however, that shares of Common Stock delivered by the Optionee may be
accepted as full or partial payment of the exercise price for any exercise of the Option hereunder only if the shares have been held by the
Optionee for at least six (6) months.

3.          Miscellaneous.

(a)

(b)

This Agreement is binding upon the parties hereto and their respective heirs, personal representatives,
successors and assigns.

This Agreement will be governed and interpreted in accordance with the laws of the State of Delaware, and
may be executed in more than one counterpart, each of which shall constitute an original document.

(c) No alterations, amendments, changes or additions to this agreement will be binding upon the Corporation

unless reduced to writing and signed by the Corporation.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
In witness whereof, the parties have executed this Agreement as of the Grant Date.

BIO KEY INTERNATIONAL, INC.

By:                                                                                       
                            Michael DePasquale

Title: Chief Executive Officer                                         

OPTIONEE

CECILIA WELCH

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
                                                                                             
 
 
 
Schedule A

1.   Optionee: CECILIA WELCH

2.   Grant Date: March 27, 2013

3.   Number of Shares of Common Stock covered by the Option: 150,000

4.   Exercise Price (which is not less than the Fair Market Value (as defined in the Plan) of Common Stock on the Grant Date): $0.17

5.   The Option shall vest in accordance with the following schedule:

(i)

(ii)

50,000 shares shall vest on March 27, 2014; and

50,000 shares shall vest on March 27, 2015; and

(iii)

50,000 shares shall vest on March 27, 2016

6. Expiration Date: March 26, 2020

Initials of Authorized
Officer of BIO KEY INTERNATIONAL, INC.

_______________
Optionee’s Initials

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                  
 
 
 
 
EMPLOYMENT AGREEMENT

Exhibit 10.42

THIS AGREEMENT (the "Agreement") dated May 15, 2013 by and between BIO-Key International, Inc., a Delaware corporation
with its principal place of business at 3349 Highway 138, Building D, Suite A, Wall NJ 07719 (the "Company") and Cecilia Welch, at P.O.
Box 588, Dunstable, MA 01827 (the "Executive").

WITNESSETH:

WHEREAS,  the  Company  desires  to  secure  the  employment  of  the  Executive  in  accordance  with  the  provisions  of  this

Agreement; and

WHEREAS, the Executive desires and is willing to be employed by the Company in accordance herewith.

NOW THEREFORE,  in  consideration  of  the  premises  and  mutual  covenants  contained  herein,  and  other  good  and  valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be legally bound hereby, the parties hereto
agree as follows:

1.     Employment Term. This Agreement shall remain in force and effect for a term commencing on the Effective Date hereof and
expiring  on  the  first  anniversary  hereof  (the  "Initial  Term"),  or  until  the  employment  relationship  is  terminated  pursuant  to  Section  4
hereof. Upon the expiration of the Initial Term, this Agreement will be renewed automatically for successive one year periods (each, a
"Renewal  Term"),  unless  sooner  terminated  in  accordance  with  the  provisions  of  Section  4  or  unless  Company  gives  written  notice  of
non-renewal at least two (2) months prior to the date on which the Executive's employment would otherwise end.

2.     Duties; Exclusive Services and Best Efforts.

(a) Duties. Executive shall hold the position of Vice President Chief Financial Officer, and shall have such responsibilities, duties
and authority consistent with such position as may from time to time be determined by the Company’s Chief Executive Officer
(“CEO”) and Board of Directors (“BOD”). The Executive shall report to the BOD and CEO.

( b )    Exclusive  Services  and  Best  Efforts.  The  Executive  agrees  to  devote  his  best  efforts,  energies  and  skill  to  the  faithful,
competent  and  diligent  discharge  of  the  duties  and  responsibilities  attributable  to  his  position,  and  to  this  end,  will  devote  his  fulltime
attention  to  the  business  and  affairs  of  the  Company.  The  Executive  also  agrees  that  he  shall  not  take  personal  advantage  of  any
business opportunities that arise during his employment that may benefit the Company. All material facts regarding such opportunities
must be promptly reported to the Company's CEO for its consideration.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
  
 
 
3 .      Compensation. On and after the commencement of Executive's employment, the Executive shall receive, for all services

rendered to the Company hereunder, the following:

(a)     Base Salary. The Executive shall be paid a base annual salary equal to One Hundred Forty Four Thousand

($144,000). The Executive's annual base salary shall be payable in equal installments in accordance with the Company's general salary
payment policies but no less frequently than monthly.

(b)     Benefits Plans. The Executive shall be eligible to participate in any and all employee welfare and health benefit plans
(including,  but  not  limited  to,  life  insurance,  health,  medical  and  dental  plans)  and  other  employee  benefit  plans,  which  may  be
established by the Company from time to time for the benefit of other Company employees of comparable status. The Executive shall be
required to comply with the conditions attendant to coverage by such preceding plans and policies and shall comply with and be eligible
for benefits only in accordance with the terms and conditions of such plans as they may be amended from time to time. Nothing in this
Agreement shall be construed as requiring the Company to establish or continue any particular benefit plan in discharge of its obligations
under this Agreement.

(c)     Vacation. The Executive shall be eligible for four (4) weeks of paid vacation each year of his employment hereunder.
The Executive shall be permitted to carry over and accrue unused vacation time for a period of up to two years. Except as required by
applicable law, in no event shall the Executive be entitled to receive any cash compensation in lieu of unused vacation time.

( d )     Expenses.  Subject  to  and  in  accordance  with  the  Company's  policies  and  procedures,  and,  upon  presentation  of
itemized accounts, the Executive shall be reimbursed by the Company for reasonable and necessary business-related expenses, which
expenses are incurred by the Executive on behalf of the Company.

(e)     Deductions from Salary and Benefits. The Company will withhold from any salary or benefits payable to the Executive

all federal, state, local, and other taxes and other amounts as required by law, rule or regulation.

4 .      Termination. This Agreement may be terminated by either the Executive or the Company at any time, subject only to the

provisions of this Section 4.

(a)     Voluntary Termination. If Executive terminates his own employment, the Company shall be released from any and all
further obligations under this Agreement, except that the Company shall be obligated to pay Executive his salary and benefits owing to
Executive  through  the  effective  date  of  termination.  Executive  shall  also  be  entitled  to  any  reimbursement  owed  in  accordance  with
Section 3(g). Executive's obligations under Sections 5, 7, 8 and 9 hereof and shall survive the termination of Executive's employment,
and Executive shall remain bound thereby.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
 
( b )     Death.  This  Agreement  shall  terminate  on  the  date  of  the  Executive's  death,  in  which  event  salary,  benefits,  and

reimbursable expenses owing to the Executive through the date of the Executive's death shall be paid to his estate.

(c)     Disability. If, during the term of this Agreement, in the opinion of the Company, the Executive, because of physical or
mental illness or incapacity or disability, shall become unable to perform, with or without reasonable accommodation, substantially all of
the duties and services required of him under this Agreement for a period one hundred eighty (180) days during any twelve-month period,
the Company may, upon at least ten (10) days prior written notice given at any time after the expiration of such one hundred eighty (180)
day  period,  notify  the  Executive  of  its  intention  to  terminate  this  Agreement  as  of  the  date  set  forth  in  the  notice.  In  case  of  such
termination,  the  Executive  shall  be  entitled  to  receive  salary,  benefits, and  reimbursable  expenses  owing  to  the  Executive  through  the
date of termination. The Company shall have no further obligation or liability to the Executive. The Executive's obligations under Sections
5, 7 8 and 9 hereof shall survive the termination of Executive's employment, and Executive shall remain bound thereby.

( d )     Termination by Employer for Cause. This Agreement may be terminated by the Company for "Cause" at any time.
Upon such termination for “Cause”, the Company shall be released from any and all further obligations under this Agreement, except that
the Company shall be obligated to pay the Executive his salary and benefits owing to the Executive through the effective date of such
termination.  The  Executive  shall  also  be  entitled  to  any  reimbursement  owed  in  accordance  with  Section  3(g).  The  Executive's
obligations  under  Sections  5,  7,  8  and  9  hereof  shall  survive  the  termination  of  Executive's  employment,  and  Executive  shall  remain
bound thereby.

Cause.     "Cause" for Termination shall mean the following conduct of the Executive:

weeks after receiving written notice thereof;

(i)     Breach of any material provision of this Employment Agreement by the Executive if not cured within two (2)

(ii)     Misconduct as an employee of the Company, including but not limited to, misappropriating funds or property of
the Company; any attempt to obtain any personal profit from any transaction in which the Executive has an interest that is adverse to the
Company; any breach of the duty of loyalty and fidelity to the Company; or any other act or omission of the Executive which substantially
impairs the Company's ability to conduct its ordinary business in its usual manner;

Agreement if not cured within two (2) weeks after receiving notice thereof;

(iii)          Material  neglect  or  refusal  to  perform  the  duties  assigned  to  the  Executive  pursuant  to  this  Employment

(iv)     Conviction of a felony or plea of guilty or nolo contendere to a felony;

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
  
 
 
(v)     Acts of dishonesty or moral turpitude by the Executive that are detrimental to the Company or any other act or
omission which subjects the Company or any of its affiliates to public disrespect, scandal, or ridicule, or that causes the Company to be in
violation  of  governmental  regulations  that  subjects  the  Company  either  to  sanctions  by  governmental  authority  or  to  civil  liability  to  its
employees or third parties; and

required in the performance of the Executive's duties.

(vi)          Disclosure  or  use  of  confidential  information  of  the  Company,  other  than  as  specifically  authorized  and

(e)     Termination by Company Without Cause. Upon termination of this Agreement without Cause, the Company shall be
released from any and all further obligations under this Agreement, except that the Executive shall continue to be paid or provided, as
applicable,  in  the  same  manner  as  before  termination,  and  for  a  period  of  time  equal  to  the  greater  of  (i)  six  (6)  months;  and  (ii)  that
number of months remaining until the end of the Term, if, and only if, the Executive signs a valid general release of all claims against the
Company,  its  affiliates,  subsidiaries,  officers,  directors  and  agents,  in  a  form  provided  by  the  Company.  The  Company  shall  have  no
further  obligation  or  liability  to  the  Executive.  The  Executive's  obligations  under  Sections  5,  7,  8  and  9  hereof  and  shall  survive  the
termination  of  the  Executive's  employment,  regardless  of  the  circumstances  of  any  such  termination,  and  the  Executive  shall  remain
bound thereby.

( f )     Termination  by  Mutual  Agreement.  This  Agreement  may  be  terminated  at  any  time  by  mutual  agreement  of  the

Executive and the Company.

5.      Non-Competition and Business Opportunities.

( a )     Non-Competition.  The  Executive  understands  that  the  Company  (for  this  purpose,  Company  shall  include  all
subsidiaries and affiliates of the Company) is in the business of (i) developing and licensing finger print identification technologies, and
distributing  products  incorporating  such  technologies  to  original  equipment  manufacturers,  systems  integrators,  application  developers
and end users; and (ii) developing, licensing and/or selling software, products and services, including wireless solutions, and providing
technology support and services to the law enforcement and public safety markets. The Executive agrees that during the period of his
employment hereunder and for a period of one (1) year thereafter, the Executive will not directly or indirectly: (i) market, sell or perform
services  such  as  are  offered  or  conducted  by  the  Company  during  the  period  of  his  employment,  to  any  customer  or  client  of  the
Company  or  "Prospective  Customer"  or  client  of  the  Company;  or  (ii)  engage,  directly  or  indirectly,  whether  as  principal  or  as  agent,
officer,  director,  employee,  consultant,  shareholder,  or  otherwise,  alone  or  in  association  with  any  other  person,  corporation  or  other
entity, in any "Competing Business". For the purpose of this Agreement, "Prospective Customer" shall mean any person with whom the
Company has engaged in any discussion or negotiation regarding the use of the Company's products or services. For purposes of this
Section 5(a), the term "shareholder" shall exclude any interest owned by Employer in a public company to the extent the Employer owns
less  than  five  percent  (5%)  of  any  such  company's  outstanding  common  stock.  For  the  further  purposes  of  this  Agreement,  the  term
"Competing  Business"  shall  mean  any  person,  corporation  or  other  entity  (X)  developing  and/or  licensing  finger  print  identification
technologies  or  distributing  products  incorporating  such  technologies,  (Y),  developing,  licensing  or  selling  software,  products  and
services, including wireless solutions, or providing technology support or services to the law enforcement and public safety markets within
the  United  States  or  (Z)  offering  or  developing  products  or  services  in  competition  with  products  or  services  offered  by,  or  being
developed by the Company at the time of the termination of Executive’s employment with the Company. Due to the nature of the markets
served and the technology and products to be developed and marketed by the Company which are intended to be available on a national
basis, the restrictions set forth in this Section 5(a) cannot be limited to a specific geographic area within the United States.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
(b)     Business Opportunities. The Executive agrees that during the period of his employment hereunder, the Executive will
not  take  personal  advantage  of  any  business  opportunities  that  are  similar  or  substantially  similar  to  the  business  of  the  Company.  In
addition, all material facts regarding any such business opportunities must be promptly and fully disclosed by the Executive to the CEO
as  soon  as  the  Executive  becomes  aware  of  any  opportunity,  and  in  no  event  later  than  forty-eight  (48)  hours  after  learning  of  such
opportunity.  Business  opportunities  covered  by  this  Section  5(b)  shall  include,  but  are  not  limited  to,  opportunities  relating  to  the
development  and  licensing  of  finger  print  identification  technologies  or  the  distribution  of  products  incorporating  such  technologies  to
original equipment manufacturers and end users.

( c )     Non-Solicitation. The Executive agrees that during the period of employment hereunder and for a period of one (1)
year  thereafter,  the  Executive  will  not  request  or  otherwise  attempt  to  induce  or  influence,  directly  or  indirectly,  any  present  customer,
distributor or supplier, or Prospective Customer, distributor or supplier, of the Company, or other persons sharing a business relationship
with  the  Company  to  cancel,  to  limit  or  postpone  their  business  with  the  Company,  or  otherwise  take  action  which  might  be  to  the
material disadvantage of the Company. The Executive agrees that during the period of employment hereunder and for a period of one (1)
year thereafter, Executive will not hire or solicit for employment, directly or indirectly, or induce or actively attempt to influence, hire or
solicit, any employee, agent, officer, director, contractor, consultant or other business associate of the Company to terminate his or her
employment or discontinue such person's consultant, contractor or other business association with the Company.

( d )     Scope. The parties hereto agree that, due to the nature of the Company's business, the duration and scope of the
non-competition and non-solicitation provisions set forth above are reasonable. In the event that any court determines that the duration or
the geographic scope, or both, are unreasonable and that such provisions are to that extent unenforceable, the parties hereto agree that
such  provisions  shall  remain  in  full  force  and  effect  for  the  greatest  time  period  and  in  the  greatest  area  that  would  not  render  it
unenforceable.  The  parties  intend  that  the  non-competition  and  non-solicitation  provisions  herein  shall  be  deemed  to  be  a  series  of
separate covenants, one for each and every county of each and every state of the United States of America and each and every political
subdivision of each and every country outside the United States of America where this provision is intended to be effective. The Executive
agrees  that  damages  are  an  inadequate  remedy  for  any  breach  of  such  provisions  and  that  the  Company,  shall,  whether  or  not  it  is
pursuing any potential remedies at law, be entitled to seek in any court of competent jurisdiction, equitable relief in the form of preliminary
and permanent injunctions without bond or other security upon any actual or threatened breach of either of these competition provisions.
If the Executive shall violate this Section 5, the duration of this Section 5 automatically shall be extended as against the Executive for a
period  equal  to  the  period  during  which  the  Executive  shall  have  been  in  violation  of  this  Section  5.  The  covenants  contained  in  this
Section 5 are deemed to be material and the Company is entering into this Agreement relying on such covenants.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
6 .        Representations and Warranties of the Executive.  The  Executive,  hereby  represents  and  warrants  to  the  Company  as
follows: (i) The Executive has the legal capacity and  unrestricted  right  to  execute  and  deliver  this  Agreement  and  to  perform  all  of  his
obligations  hereunder;  (ii)  the  execution  and  delivery  of  this  Agreement  by  the  Executive  and  the  performance  of  his  obligations
hereunder  will  not  violate  or  be  in  conflict  with  any  fiduciary  or  other  duty,  instrument,  agreement,  document,  arrangement,  or  other
understanding  to  which  Executive  is  a  party  or  by  which  he  is  or  may  be  bound  or  subject;  and  (iii)  except  as  set  forth  in  Exhibit  B
attached  hereto,  the  Executive  is  not  a  party  to  any  instrument,  agreement,  document,  arrangement,  including,  but  not  limited  to,
invention  assignment  agreement,  confidential  information  agreement,  non-competition  agreement,  non-solicitation  agreement,  or  other
understanding with any person (other than the Company) requiring or restricting the use or disclosure of any confidential information or
the provision of any employment, consulting or other services.

7 .     Disclosure  of  Innovations;  Assignment  of  Ownership  of  Innovations;  Protection  of  Confidential  Information.  Executive
hereby represents and warrants to the Company that Executive understands that the Company is in the business of (i) developing and
licensing  finger  print  identification  technologies,  and  distributing  products  incorporating  such  technologies,  to  original  equipment
manufacturers, systems integrators, application developers and end users; and (ii) developing, licensing and/or selling software, products
and  services,  including  wireless  solutions,  and  providing  technology  support  and  services  to  the  law  enforcement  and  public  safety
markets,  and  that  Executive  may  have  access  to  or  acquire  information  with  respect  to  Confidential  Information  (as  defined  below),
including software, processes and methods, development tools, scientific, technical and/or business innovations.

( a )     Disclosure  of  Innovations.  Executive  agrees  to  disclose  in  writing  to  the  Company  all  inventions,
improvements and other innovations of any kind that Executive may make, conceive, develop or reduce to practice, alone or jointly with
others,  during  the  term  of  Executive's  employment  with  the  Company,  whether  or  not  such  inventions,  improvements  or  other
innovations are related to and grow out of Executive's work for the Company and whether or not they are eligible for patent, copyright,
trademark,  trade  secret  or  other  legal  protection  ("Innovations").  Examples  of  Innovations  shall  include,  but  are  not  limited  to,
discoveries,  research,  inventions,  formulas,  techniques,  processes,  know-how,  marketing  plans,  new  product  plans,  production
processes, advertising, packaging and marketing techniques and improvements to computer hardware or software.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
  
 
 
( b )     Assignment  of  Ownership  of  Innovations.  Executive  agrees  that  all  Innovations  will  be  the  sole  and
exclusive property of the Company and Executive hereby assigns all of Executive's rights, title or interest in the Innovations and in all
related patents, copyrights, trademarks, trade secrets, rights of priority and other proprietary rights to the Company. At the Company's
request and expense, during and after the period of Executive's employment with the Company, Executive will assist and cooperate with
the  Company  in  all  respects  and  will  execute  documents,  and,  subject  to  Executive's  reasonable  availability,  give  testimony  and  take
further  acts  requested  by  the  Company  to  obtain,  maintain,  perfect  and  enforce  for  the  Company  patent,  copyright,  trademark,  trade
secret  and  other  legal  protection  for  the  Innovations.  Executive  hereby  appoints  an  authorized  officer  of  the  Company  as  Executive's
attorney-in-fact to execute documents on his behalf for this purpose. Executive has attached hereto as Exhibit C a list of Innovations as of
the date hereof which belong to Executive and which are not assigned to the Company hereunder (the "Prior Innovations"), or, if no such
list is attached, Executive represents that there are no Prior Innovations.

( c )     Protection of Confidential Information of the Company. Executive understands that Executive's work as
an employee of the Company creates a relationship of trust and confidence between Executive and the Company. During and after the
period  of  Executive's  employment  with  the  Company,  Executive  will  not  use  or  disclose  or  allow  anyone  else  to  use  or  disclose  any
"Confidential Information" (as defined below) relating to the Company, its products, services, suppliers or customers except as may be
necessary  in  the  performance  of  Executive's  work  for  the  Company  or  as  may  be  specifically  authorized  in  advance  by  appropriate
officers  of  the  Company.  "Confidential  Information"  shall  include,  but  not  be  limited  to,  information  consisting  of  research  and
development,  patents,  trademarks  and  copyrights  and  applications  thereto,  technical  information,  computer  programs,  software,
methodologies, innovations, software tools, know-how, knowledge, designs, drawings, specifications, concepts, data, reports, processes,
techniques, documentation, pricing, marketing plans, customer and prospect lists, trade secrets, financial information, salaries, business
affairs,  suppliers,  profits,  markets,  sales  strategies,  forecasts,  Executive  information  and  any  other  information  not  available  to  the
general public, whether written or oral, which Executive knows or has reason to know the Company would like to treat as confidential for
any purpose, such as maintaining a competitive advantage or avoiding undesirable publicity. Executive will keep Confidential Information
secret and will not allow any unauthorized use of the same, whether or not any document containing it is marked as confidential. These
restrictions, however, will not apply to Confidential Information that has become known to the public generally through no fault or breach
of Executive's or that the Company regularly gives to third parties without restriction on use or disclosure.

8.      Work Made For Hire; Disclosure of Works and Inventions/Assignment of Patents.

( a )     Work  Made  For  Hire.  Executive  further  recognizes  and  understands  that  Executive's  duties  at  the  Company  may
include  the  preparation  of  materials,  including  without  limitation  written  or  graphic  materials,  and  that  any  such  materials  conceived  or
written by Executive shall be done as "work made for hire" as defined and used in the Copyright Act of 1976, 17 U.S.C. §§ 1 et seq. In
the event of publication of such materials, Executive understands that since the work is a "work made for hire", the Company will solely
retain and own all rights in said materials, including right of copyright. In the event that any of such works shall be deemed by a court of
competent jurisdiction not to be a "work made for hire," this Agreement shall operate as an irrevocable assignment by Executive to the
Company  of  all  right,  title  and  interest  in  and  to  such  works,  including,  without  limitation,  all  worldwide  copyright  interests  therein,  in
perpetuity.  The  fact  that  such  copyrightable  works  are  created  by  Executive  outside  of  the  Company's  facilities  or  other  than  during
Executive's  working  hours  with  the  Company  shall  not  diminish  the  Company's  right  with  respect  to  such  works  which  otherwise  fall
within  this  paragraph.  Executive  agrees  to  execute  and  deliver  to  the  Company  such  further  instruments  or  documents  as  may  be
requested by the Company in order to effectuate the purposes of this paragraph.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
( b )     Disclosure  of  Works  and  Inventions/Assignment  of  Patents.  In  consideration  of  the  promises  set  forth  herein,
Executive agrees to disclose promptly to the Company, or to such person whom the Company may expressly designate for this specific
purpose (its "Designee"), any and all works, inventions, discoveries and improvements authored, conceived or made by Executive during
the period of employment and related to the business or activities of the Company, and Executive hereby assigns and agrees to assign
all of Executive's interest in the foregoing to the Company or to its Designee. Executive agrees that, whenever he is requested to do so
by  the  Company,  Executive  shall  execute  any  and  all  applications,  assignments  or  other  instruments  which  the  Company  shall  deem
necessary  to  apply  for  and  obtain  Letters  Patent  or  Copyrights  of  the  United  States  or  any  foreign  country  or  to  otherwise  protect  the
Company's interest therein. Such obligations shall continue beyond the termination or nonrenewal of Executive's employment or service
with respect to any works, inventions, discoveries and/or improvements that are authored, conceived of, or made by Executive during the
period of Executive's employment or service, and shall be binding upon Executive's successors, assigns, executors, heirs, administrators
or other legal representatives.

9 .      Company Property. All records, files, lists, including computer generated lists, drawings, documents, software, documents,
equipment,  models,  binaries,  object  modules,  libraries,  source  code  and  similar  items  relating  to  the  Company's  business  that  the
Executive  shall  prepare  or  receive  from  the  Company  and  all  Confidential  Information  shall  remain  the  Company's  sole  and  exclusive
property  ("Company  Business  Property").  Upon  termination  of  this  Agreement,  the  Executive  shall  promptly  return  to  the  Company  all
property of the Company in his possession, including Company Business Property. The Executive further represents that he will not copy
or cause to be copied, print out, or cause to be printed out any Company Business Property other than as specifically authorized and
required  in  the  performance  of  the  Executive's  duties.  The  Executive  additionally  represents  that,  upon  termination  of  his  employment
with the Company, he will not retain in his possession any such Company Business Property.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
10.    Cooperation. The Executive and Company agree that during the term of Executive’s employment they shall, at the request
of the other Party, render all assistance and perform all lawful acts that each Party considers necessary or advisable in connection with
any litigation involving either Party or any director, officer, employee, shareholder, agent, representative, consultant, client, or vendor of
the Company.

11.    Employment Dispute Settlement Procedure/Waiver of Rights.

(a)     The Executive and the Company each agree that, in the event either party (or its representatives, successors or assigns)
brings  an  action  in  a  court  of  competent  jurisdiction  relating  to  the  Executive's  recruitment,  employment  with,  or  termination  of
employment from the Company, each party in such action agrees to waive his, her or its right to a trial by jury, and further agrees that no
demand, request or motion will be made for trial by jury.

(b)     The parties hereto further agree that, in the event that either seeks relief in a court of competent jurisdiction for a dispute
covered  by  this  Agreement,  any  other  Agreement  between  the  Executive  and  the  Company  or  which  relates  to  the  Executive’s
recruitment,  employment  with,  or  termination  of  employment  from  the  Company,  the  defendant  or  third-party  defendant  in  such  action
may, at any time within sixty (60) days of the service of the complaint, third-party complaint or cross-claim upon such party, at his, her or
its  option,  require  all  or  part  of  the  dispute  to  be  arbitrated  by  one  arbitrator  in  accordance  with  the  rules  of  the  American  Arbitration
Association. The parties agree that the option to arbitrate any dispute is governed by the Federal Arbitration Act. The parties understand
and agree that, if the other party exercises his, her or its option, any dispute arbitrated will be heard solely by the arbitrator, and not by a
court. Judgment upon the award rendered, however, may be entered in any court of competent jurisdiction. The cost of such arbitration
shall be borne equally by the parties.

(c)          This  dispute  resolution  agreement  will  cover  all  matters  directly  or  indirectly  related  to  the  Executive's  recruitment,
employment  or  termination  of  employment  by  the  Company;  including,  but  not  limited  to,  claims  involving  laws  against  discrimination
whether  brought  under  federal  and/or  state  law  and/or  local  law,  and/or  claims  involving  co-employees  but  excluding  Worker's
Compensation Claims. Nothing contained in this Section 11 shall limit the right of the Company to enforce by court injunction or other
equitable relief the Executive's obligations under Sections 5, 7, 8 and 9 hereof.

The right to a trial, and to a trial by jury, is of value.

THE  EXECUTIVE  MAY  WISH  TO  CONSULT  AN  ATTORNEY  PRIOR  TO  SIGNING  THIS
AGREEMENT. IF SO, THE EXECUTIVE SHOULD TAKE A COPY OF THIS AGREEMENT WITH HIM.
HOWEVER, THE EXECUTIVE WILL NOT BE OFFERED EMPLOYMENT UNTIL THIS AGREEMENT IS
SIGNED AND RETURNED TO EMPLOYER.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
12.    Choice of Law and Jurisdiction. This Agreement shall be construed, interpreted and the rights of the parties determined in
accordance  with  the  laws  of  the  State  of  Massachusetts.  Each  of  the  parties  hereto  hereby  irrevocably  consents  and  submits  to  the
exclusive  jurisdiction  of  the  state  courts  of  the  State  of  Massachusetts,  and  of  the  United  States  District  Court  for  the  District  of
Massachusetts in connection with any suit, action, or other proceeding concerning this Agreement or enforcement of Sections 5, 7, 8 and
9 hereof. The Executive waives and agrees not to assert any defense that the court lacks jurisdiction, venue is improper, inconvenient
forum  or  otherwise.  The  Executive  waives  the  right  to  a  jury  trial  and  agrees  to  accept  service  of  process  by  certified  mail  at  the
Executive's last known address.

1 3 .    Successors  and  Assigns.  Neither  this  Agreement,  nor  any  of  the  Executive's  rights,  powers,  duties  or  obligations
hereunder, may be assigned by the Executive. This Agreement shall be binding upon and inure to the benefit of the Executive and his
heirs and legal representatives and the Company and its successors. Successors of the Company shall include, without limitation, any
company  or  companies,  individuals,  groups,  associations,  partnerships,  firm,  venture  or  other  entity  or  party  acquiring,  directly  or
indirectly, all or substantially all of the assets of the Company, whether by merger, consolidation, purchase, lease or otherwise. Any such
successor referred to in this paragraph shall thereafter be deemed "the Company" for the purpose hereof. All covenants and restrictions
upon the Executive hereunder, including, but not limited to Sections 5, 7, 8 and 9 hereof, are specifically assignable by the Company.

1 4 .    Waiver.  Any  waiver  or  consent  from  the  Company  with  respect  to  any  term  or  provision  of  this  Agreement  or  any  other
aspect of the Executive's conduct or employment shall be effective only in the specific instance and for the specific purpose for which
given and shall not be deemed, regardless of frequency given, to be a further or continuing waiver or consent. The failure or delay of the
Company at any time or times to require performance of, or to exercise any of its powers, rights or remedies with respect to any term or
provision of this Agreement or any other aspect of the Executive's conduct or employment in no manner (except as otherwise expressly
provided herein) shall affect the Company's right at a later time to enforce any such term or provision.

15.    Notices. All notices, requests, demands, and other communications hereunder must be in writing and shall be deemed to
have  been  duly  given  if  delivered  by  hand  or  mailed  within  the  continental  United  States  by  first  class,  registered  mail,  return  receipt
requested, postage and registry fees prepaid, to the applicable party and addressed as follows:

(a)       If to the Company:

Bio-key International, Inc.
3349 Highway 138, Building D, Suite A
Wall, NJ 07719
Attn: CEO

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
 
(b)       If to the Executive:
Cecilia Welch
P.O. Box 588
Dunstable, MA 01827

16.       Construction of Agreement.

(a)     Severability. In the event that any one or more of the provisions of this Agreement shall be held to be invalid, illegal

or unenforceable, the validity, legality or enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

( b )     Headings.  The  descriptive  headings  of  the  several  paragraphs  of  this  Agreement  are  inserted  for  convenience  of

reference only and shall not constitute a part of this Agreement.

1 7 .    Entire  Agreement  and  Amendments.  This  Agreement,  including  all  Exhibits  which  shall  form  parts  hereof,  contains  the
entire agreement of the parties concerning the Executive's employment and all promises, representations, understandings, arrangements
and  prior  agreements  on  such  subject  are  merged  herein  and  superseded  hereby.  The  provisions  of  this  Agreement  may  not  be
amended,  modified,  repealed,  waived,  extended  or  discharged  except  by  an  agreement  in  writing  signed  by  the  party  against  whom
enforcement  of  any  amendment,  modification,  repeal,  waiver,  extension  or  discharge  is  sought.  No  person  acting  other  than  the  CEO
shall  have  authority  on  behalf  of  the  Company  to  agree  to  amend,  modify,  repeal,  waive,  extend  or  discharge  any  provision  of  this
Agreement or anything in reference thereto or to exercise any of the Company's rights to terminate or to fail to extend this Agreement.

18.    Survival. The Executive's obligations under Paragraphs 5, 7, 8 and 9 shall survive and continue pursuant to the terms and

conditions of this Agreement following specific termination.

1 9 .    Understanding. The  Executive  represents  and  agrees  that  he  fully  understands  his  rights  to  discuss  all  aspects  of  this
Agreement  with  his  private  attorney,  that  to  the  extent  he  desires,  he  availed  himself  of  this  right,  that  he  has  carefully  read  and  fully
understands  all  of  the  provisions  of  this  Agreement,  that  he  is  competent  to  execute  this  Agreement,  that  his  decision  to  execute  this
Agreement has not been obtained by any duress and that he freely and voluntarily enters into this Agreement, and that he has read this
document in its entirety and fully understands the meaning, intent, and consequences of this Agreement.

20.    Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original,

and all of which together shall constitute one and the same instrument.

21.    Injunctive Relief. The Executive hereby agrees and acknowledges that in the event of a breach or threatened breach of this
Agreement  by  the  Executive,  the  Company  may  suffer  irreparable  harm  and  monetary  damages  alone  would  not  adequately
compensate the Company. Accordingly, the Company will therefore be entitled to injunctive relief to enforce this Agreement.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
IN WITNESS WHEREOF, the Company has caused this Agreement to be executed and attested by its duly authorized officers,

and the Executive has set his hand, all as of the day and year first above written.

BIO-KEY INTERNATIONAL, INC.

By:  

  Name: Michael W. DePasquale
Title: Chief Executive Officer

EXECUTIVE

Cecilia Welch

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THIRD AMENDMENT TO LEASE AGREEMENT

Exhibit 10.43

This Third Amendment to Lease Agreement (this “Third Amendment”) made as of this __ day of June, 2013 by and between

Victor AOP, Inc., as Landlord, and BIO-key International, Inc., as Tenant.

WHEREAS:

A.     Landlord and Tenant are parties to a certain lease dated June 2, 2004 as amended by a First Amendment to Lease dated in

August, 2004 and Second Amendment and Lease dated January, 2009 (collectively, the “Lease”) respecting 4,179 gross square feet of
floor space (the “Premises”) in Allaire Office Park, Building D, Route 138, Wall Township, New Jersey; and

B.     The term of the Lease expires on September 30, 2014; and

C.     The Landlord and Tenant wish do relocate the office to Building A, Suite 102 representing 4517 gross square feet in the

Allaire Office Park.

D.     The expected date of this move will be at or near October 1, 2013, with a date certain agreement signed upon occupancy.

E.     Landlord and Tenant mutually desire to extend the term of the Lease for five (5) years, subject to and in accordance with the

terms of this Third Amendment.

NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the parties agree as

follows:

1. The term of the Lease is hereby renewed commencing as of September 1, 2013 and terminating on August 30, 2018 (the

“Renewal Term”).

2. During the Renewal Term all terms and conditions of the Lease shall remain the same, except that:

a. During the initial year of the Renewal Term (September 1, 2013) the Base Rent shall be at the rate of $103,891.00 per
annum, payable in monthly installments of $8657.58 in accordance with the terms of the Lease. The rent will be subject
to an annual increase of 3% commencing September 1, 2014 and each year thereafter.

3. Landlord shall be required to perform work in the Premises in order for the Renewal Term to occur. Landlord and Tenant will

mutually agree on the floor plan of the new space, a sketch of which is attached to this addendum.

4. For purposes of this Third Amendment, capitalized terms used herein shall have the same meanings ascribed to them in the

Lease, unless otherwise defined herein.

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
5. Article 12.1 and 13.1 of the original lease agreement are amended to have landlord responsible for all utility charges to the

premises. Article 13.2 is amended to have landlord responsible for all water charges to the premises.

6. The preamble to this Third Amendment is incorporated by reference into the body of this Third Amendment.

7. Except as modified by this Third Amendment, the Lease, and all the covenants, agreements, terms, provisions and conditions
thereof shall remain in full force and effect and are hereby ratified and affirmed. The covenants, agreements, terms, provisions
and conditions contained in the Lease as amended by this Third Amendment shall bind and inure to the benefit of the parties
hereto and their respective successors and assigns. In the event of any conflict between the terms contained in this Third
Amendment to Lease and the Lease, the terms herein contained shall supersede and control the obligations and liabilities of the
parties.

IN WITNESS WHEREOF, the parties hereto have hereunto set their hands and seals and caused these presents to be properly

signed by authorized signatories as of the day and year Second above written.

ATTEST OR WITNESS:   

VICTOR AOP, INC., Landlord  

ATTEST OR WITNESS:

BIO-KEY INTERNATIONAL, INC., Tenant  

By:   

RAN KOROLIK, Vice President

By:   
  Michael DePasquale, President

-2-

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIRST AMENDMENT TO LEASE AGREEMENT

Exhibit 10.44

THIS  FIRST  AMENDMENT  TO  LEASE  AGREEMENT  (hereinafter  referred  to  as  the  “Amendment”)  is  made  this  ____  day  of
September, 2013, by and between BRE/DP MN LLC, a Delaware limited liability company (“Landlord”), and BIO-KEY INTERNATIONAL,
INC., a Delaware corporation (“Tenant”).

WITNESSETH:

WHEREAS,  Landlord  and  Tenant  are  party  to  that  certain  Lease,  dated  as  of  May  4,  2009  (the  “Lease”,  as  may  be  further
amended or modified from time to time), pursuant to which Landlord leases to Tenant certain premises consisting of approximately 5,544
rentable square feet with a common address of 1301 Corporate Center Drive, Suite 165, Eagan, Minnesota 55121, as more particularly
described  in  the  Lease  (the  “Premises”),  and  located  in  the  Project  commonly  known  as  Eagandale  Business  Campus  I.  Capitalized
terms used herein but not otherwise defined shall have the meanings ascribed thereto in the Lease.

WHEREAS, the Term is scheduled to expire on August 31, 2014 and Landlord and Tenant desire to extend the existing Term for
an  additional  forty-eight  (48)  full  calendar  months  from  such  expiration  date  and  to  amend  the  terms  and  conditions  of  the  Lease  as
hereinafter provided.

AGREEMENT:

NOW,  THEREFORE,  in  consideration  of  ten  dollars  ($10.00)  and  other  good  and  valuable  consideration,  the  receipt  and
sufficiency  of  which  are  hereby  acknowledged  by  the  parties,  and  the  mutual  covenants  set  forth  herein,  the  parties  hereto  agree  as
follows:

1 .     Extension of Term. The Term is hereby extended for a period of forty-eight (48) full calendar months, commencing as of
September 1, 2014 (the “Extended Term Commencement Date”) and expiring on August 31, 2018 (the “Extended Term”). From and after
the date hereof, the “Term” shall be deemed to include the Extended Term.

2 .     Rent Schedule. The Annual Rent and Monthly Installment of Rent for the Premises payable by Tenant to Landlord during

the Extended Term is as follows:

Period

Annual Rent

From

Through

Monthly
Installment of Rent

9/01/2014
9/01/2015
9/01/2016
9/01/2017

8/31/2015
8/31/2016
8/31/2017
8/31/2018

$35,481.60
$36,036.00
$37,144.80
$38,808.00

$2,956.80
$3,003.00
$3,095.40
$3,234.00

Except as otherwise set forth in this Amendment, all other terms and conditions with respect to the payment of Monthly
Installment  of  Rent,  Taxes,  Expenses,  or  any  other  sums  due  and  payable  by  Tenant  under  the  Lease  shall  remain  as  set  forth
thereunder.

3.     AS-IS Condition. Tenant hereby acknowledges and agrees that it has accepted the Premises as of the date hereof, and will
accept  the  Premises  as  of  the  Extended  Term  Commencement  Date,  in  AS-IS,  WHERE-IS  condition  without  any  representation  or
warranty of any kind made by Landlord in favor of Tenant.

4 .     Insurance  and  Waiver  of  Subrogation.  Effective  solely  with  respect  to  the  period  from  and  after  the  Extended  Term

Commencement Date, Sections 11 and 12 of the Lease are hereby amended and restated in their entirety as follows:

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
“ 1 1 .     Insurance.  Tenant,  at  its  sole  cost  and  expense,  shall  maintain  during  the  Term  the  following  insurance:  (1)
commercial  general  liability  insurance  applicable  to  the  Premises  and  its  appurtenances  providing,  on  an  occurrence
basis, a minimum combined single limit of $1,000,000 primary per occurrence and $2,000,000 annual aggregate; and in
the  event  property  of  Tenant’s  invitees  or  customers  are  kept  in,  or  about  the,  Premises,  Tenant  shall  maintain
warehouser’s legal liability or bailee customers insurance for the full value of the property of such invitees or customers
as  determined  by  the  warehouse  contract  between  Tenant  and  its  customer;  (2)  special  cause  of  loss  form  property
insurance  covering  the  full  replacement  cost  of  all  property  and  improvements  installed  or  placed  in  the  Premises  by
Tenant,  and  shall  include  coverage  for  damage  or  other  loss  caused  by  fire  or  other  peril,  including  vandalism  and
malicious mischief, theft, water damage of any type, including sprinkler leakage or stoppage of pipes, and explosion, and
providing business interruption coverage for a period of one year; (3) workers’ compensation insurance as required by
the state in which the Premises is located and in amounts as may be required by applicable statute and shall include a
waiver  of  subrogation  in  favor  of  Landlord;  (4)  employers  liability  insurance  of  at  least  $1,000,000;  (5)  business
automobile liability insurance having a combined single limit of not less than $1,000,000 per occurrence insuring Tenant
against liability arising out of the ownership maintenance or use of any owned, hired or nonowned automobiles; and (6)
an  umbrella  liability  policy  or  excess  liability  policy  having  a  limit  of  not  less  than  $3,000,000,  which  policy  shall  be  in
“following form” and shall provide that if the underlying aggregate is exhausted, the excess coverage will drop down as
primary insurance. Such umbrella liability policy or excess liability policy shall include coverage for additional insureds.
Any company writing any of Tenant’s insurance shall have an A.M. Best rating of not less than A-VIII and provide primary
coverage  to  Landlord  (any  policy  issued  to  Landlord  providing  duplicate  or  similar  coverage  shall  be  deemed  excess
over Tenant’s policies). All commercial general liability and, if applicable, warehouser’s legal liability or bailee customers
insurance policies shall (a) name Tenant as a named insured and Landlord, its property manager, and other designees of
Landlord as the interest of such designees shall appear, as additional insureds; and (b) be primary insurance as to all
claims  thereunder  and  provide  that  any  insurance  carried  by  Landlord  is  excess  and  non-contributing  with  Tenant’s
insurance.  The  limits  and  types  of  insurance  maintained  by  Tenant  shall  not  limit  Tenant’s  liability  under  this  Lease.
Tenant shall provide Landlord with certificates of such insurance as required under this Lease prior to the Extended Term
Commencement Date and thereafter upon renewals at least 15 days prior to the expiration of the insurance coverage.
Such certificates shall be on forms currently designated “ACORD 25” (Certificate of Liability Insurance) and “ACORD 28”
(Evidence of Commercial Property Insurance) or the equivalent. Attached to the ACORD 25 (or equivalent) there shall be
an  endorsement  naming  Landlord,  its  property  manager,  and  other  designees  of  Landlord  as  additional  insureds,  and
attached  to  the  ACORD  28  (or  equivalent)  there  shall  be  an  endorsement  designating  Landlord  as  a  loss  payee  with
respect  to  Tenant’s  property  insurance  on  any  Tenant-Insured  improvements  and  trade  fixtures,  and  each  such
endorsement shall be binding on Tenant’s insurance company. Acceptance by Landlord of delivery of any certificates of
insurance does not constitute approval or agreement by Landlord that the insurance requirements of this section have
been  met,  and  failure  of  Landlord  to  identify  a  deficiency  from  evidence  provided  will  not  be  construed  as  a  waiver  of
Tenant’s  obligation  to  maintain  such  insurance.  In  the  event  any  of  the  insurance  policies  required  to  be  carried  by
Tenant under this Lease shall be cancelled prior to the expiration date of such policy, or if Tenant receives notice of any
cancellation  of  such  insurance  policies  from  the  insurer  prior  to  the  expiration  date  of  such  policy,  Tenant  shall:  (i)
immediately  deliver  notice  to  Landlord  that  such  insurance  has  been,  or  is  to  be,  cancelled,  (ii)  shall  promptly  replace
such insurance policy in order to assure no lapse of coverage shall occur, and (iii) shall deliver to Landlord a certificate of
insurance for such policy.”

“ 1 2 .     Waiver of Subrogation.  The  special  cause  of  loss  form  property  insurance  obtained  by  Landlord  and  Tenant
shall  include  a  waiver  of  subrogation  by  the  insurers  of  all  rights  based  upon  an  assignment  from  its  insured,  against
Landlord or Tenant, their officers, directors, employees, managers, agents, invitees and contractors, in connection with
any  loss  or  damage  thereby  insured  against.  Neither  party  nor  its  officers,  directors,  employees,  managers,  agents,
invitees or contractors shall be liable to the other for loss or damage caused by any risk coverable by special cause of
loss  form  property  insurance,  and  each  party  waives  any  claims  against  the  other  party,  and  its  officers,  directors,
employees,  managers,  agents,  invitees  and  contractors  for  such  loss  or  damage.  The  failure  of  a  party  to  insure  its
property shall not void this waiver. Landlord and its agents, employees and contractors shall not be liable for, and Tenant
hereby  waives  all  claims  against  such  parties  for  losses  resulting  from  an  interruption  of  Tenant’s  business,  or  any
person claiming through Tenant, resulting from any accident or occurrence in or upon the Premises or the Project from
any  cause  whatsoever,  including  without  limitation,  damage  caused  in  whole  or  in  part,  directly  or  indirectly,  by  the
negligence  of  Landlord  or  its  agents,  employees  or  contractors,  except  to  the  extent  such  claim  arises  from  the  gross
negligence or willful misconduct of Landlord and its agents, employees and contractors.”

2

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
  
 
5 .     Notices. Landlord’s Address set forth on the References Pages to the Lease (as may have been otherwise modified from

time to time during the Term) is hereby deleted in its entirety and replaced with the following:

LANDLORD’S ADDRESS:

With a copy to:

c/o IndCor Properties
2 N. Riverside Plaza, Suite 2350
Chicago, IL 60606
Attention: Lease Administration

c/o IndCor Properties
7887 E. Belleview Avenue, Suite 325
Denver, CO 80111
Attention: Charles E. Sullivan

6.     Limitation of Landlord’s Liability. Section 40 of the Lease shall be amended and restated in its entirety as follows:

“ 4 0 .     Limitation  of  Landlord’s  Liability.  All  obligations  of  Landlord  under  this  Lease  will  be  binding  upon  Landlord
only during the period of its ownership of the Premises and not thereafter. The term "Landlord" in this Lease shall mean
only the owner, for the time being of the Premises, and in the event of the transfer by such owner of its interest in the
Premises, such owner shall thereupon be released and discharged from all obligations of Landlord thereafter accruing,
but such obligations shall be binding during the Term upon each new owner for the duration of such owner’s ownership.
Any liability of Landlord under this Lease shall be limited solely to its interest in the Building, and in no event shall any
personal liability be asserted against Landlord in connection with this Lease nor shall any recourse be had to any other
property or assets of Landlord. Any obligation or liability whatsoever of Landlord which may arise at any time under this
Lease  or  any  obligation  or  liability  which  may  be  incurred  by  it  pursuant  to  any  other  instrument,  transaction,  or
undertaking contemplated hereby shall not be personally binding upon, nor shall resort for the enforcement thereof be
had  to  the  property  of,  its  trustees,  directors,  shareholders,  officers,  employees  or  agents,  regardless  of  whether  such
obligation or liability is in the nature of contract, tort, or otherwise.”

7.     Additional Change. Section 38 of the Lease is hereby deemed null and void and of no further force and effect.

8.     Roof. Notwithstanding anything to the contrary in the Lease, Landlord may elect, in its sole discretion and from time to time,
to install (or permit the installation of) telecommunication equipment, solar equipment and panels, and any other equipment for any other
uses on the roof of the Premises.

9.     OFAC. Tenant hereby represents and warrants that, to the best of its knowledge, neither Tenant, nor any persons or entities
holding any legal or beneficial interest whatsoever in Tenant, are (i) the target of any sanctions program that is established by Executive
Order of the President or published by the Office of Foreign Assets Control, U.S. Department of the Treasury (“OFAC”); (ii) designated by
the President or OFAC pursuant to the Trading with the Enemy Act, 50 U.S.C. App. § 5, the International Emergency Economic Powers
Act, 50 U.S.C. §§ 1701-06, the Patriot Act, Public Law 107-56, Executive Order 13224 (September 23, 2001) or any Executive Order of
the  President  issued  pursuant  to  such  statutes;  or  (iii)  named  on  the  following  list  that  is  published  by  OFAC:  “List  of  Specially
Designated Nationals and Blocked Persons.” If the foregoing representation is untrue at any time during the Term, an Event of Default
will be deemed to have occurred, without the necessity of notice to the defaulting party.

3

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
10.     Tenant’s Broker. Tenant represents and warrants that it has dealt with no broker, agent or other person in connection with
this  transaction  and  that  no  broker,  agent  or  other  person  brought  about  this  transaction  other  than  AREA  Corporate  Real  Estate
Advisors.  Tenant  agrees  to  indemnify  and  hold  Landlord  harmless  from  and  against  any  claims  by  any  other  broker,  agent  or  other
person claiming a commission or other form of compensation by virtue of having dealt with Tenant with regard to this leasing transaction.

1 1 .     No  Offer.  Submission  of  this  Amendment  by  Landlord  is  not  an  offer  to  enter  into  this  Amendment,  but  rather  is  a
solicitation for such an offer by Tenant. Landlord shall not be bound by this Amendment until Landlord and Tenant have fully executed
and delivered this Amendment.

12.     Authority. Tenant represents and warrants to Landlord that Tenant has been and is qualified to do business in the state in
which the Premises is located, that the entity has the full right and authority to enter into this Amendment, and that all persons signing on
behalf of the entity were authorized to do so by appropriate actions.

13.     Severability. If any clause or provision of this Amendment is illegal, invalid or unenforceable under present or future laws,
then and in that event, it is the intention of the parties hereto that the remainder of this Amendment shall not be affected thereby. It is also
the  intention  of  the  parties  to  this  Amendment  that  in  lieu  of  each  clause  or  provision  of  this  Amendment  that  is  illegal,  invalid  or
unenforceable,  there  be  added,  as  a  part  of  this  Amendment,  a  clause  or  provision  as  similar  in  terms  to  such  illegal,  invalid  or
unenforceable clause or provision as may be possible and be legal, valid and enforceable.

1 4 .     Counterparts and Delivery.  The  Amendment  may  be  executed  in  any  number  of  counterparts,  each  of  which  shall  be
deemed  to  be  an  original,  and  all  of  such  counterparts  shall  constitute  one  Amendment.  Execution  copies  of  the  Amendment  may  be
delivered  by  facsimile  or  email,  and  the  parties  hereto  agree  to  accept  and  be  bound  by  facsimile  signatures  or  scanned  signatures
transmitted  via  email  hereto,  which  signatures  shall  be  considered  as  original  signatures  with  the  transmitted  Amendment  having  the
binding  effect  as  an  original  signature  on  an  original  document.  Notwithstanding  the  foregoing,  Tenant  shall,  upon  Landlord’s  request,
deliver  original  copies  of  the  Amendment  to  Landlord  at  the  address  set  forth  in  such  request.  Neither  party  may  raise  the  use  of  a
facsimile machine or scanned document or the fact that any signature was transmitted through the use of a facsimile machine or email
as a defense to the enforcement of the Amendment.

15.     Conflict; Ratification. Insofar as the specific terms and provisions of this Amendment purport to amend or modify or are in
conflict  with  the  specific  terms,  provisions  and  exhibits  of  the  Lease,  the  terms  and  provisions  of  this  Amendment  shall  govern  and
control. Landlord and Tenant hereby agree that (a) this Amendment is incorporated into and made a part of the Lease, (b) any and all
references  to  the  Lease  hereinafter  shall  include  this  Amendment,  and  (c)  the  Lease,  and  all  terms,  conditions  and  provisions  of  the
Lease, are in full force and effect as of the date hereof, except as expressly modified and amended hereinabove.

[Signature Page Follows]

4

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
 
 
 
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly authorized, executed and delivered as of

the day and year first set forth above.

TENANT:

LANDLORD:

BIO-KEY INTERNATIONAL, INC., a Delaware corporation

BRE/DP MN LLC, a Delaware limited liability company

By:
Name: 
Title:

By:
Name:
Title:

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference into the registration statement of BIO-key International, Inc. on Form S-8 (file no. 333-
137414) of our report dated March 31, 2014 relating to the financial statements which appear in this Form 10-K for the year ended
December 31, 2013.

Exhibit 23.1

/s/ / Rotenberg Meril Solomon Bertiger & Guttilla, P.C.
ROTENBERG MERIL SOLOMON BERTIGER & GUTTILLA, P.C.
Saddle Brook, New Jersey
March 31, 2014

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

  
 
 
 
 
  
  
  
 
 
 
 
Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael W. DePasquale, certify that:

1.

2.

3.

4.

I have reviewed this annual report on Form 10-K of BIO-key International, Inc. (the “Company”);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this
report;

The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f) for the Company and have:

(a)

(b)

(c)

(d)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under
our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and

Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the
Company’s most recent fiscal quarter (the company’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting;

5.

The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the
equivalent functions):

(a)

(b)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial
information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the
Company’s internal control over financial reporting.

Date: March 31, 2014
/s/ MICHAEL W. DEPASQUALE
Michael W. DePasquale
Chief Executive Officer

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
 
 
 
 
 
  
 
  
 
  
 
  
 
 
  
 
  
 
  
  
  
  
 
 
 
Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Cecilia Welch, certify that:

1.

2.

3.

4.

I have reviewed this annual report on Form 10-K of BIO-key International, Inc. (the “Company”);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this
report;

The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f) for the Company and have:

(a)

(b)

(c)

(d)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under
our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and

Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the
Company’s most recent fiscal quarter (the company’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting;

5.

The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the
equivalent functions):

(a)

(b)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial
information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the
Company’s internal control over financial reporting.

Date: March 31, 2014
/s/  CECILIA WELCH
Cecilia Welch
Chief Financial Officer

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

  
 
 
 
 
 
 
 
  
 
  
 
  
 
  
 
 
  
 
  
 
  
  
  
  
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 Exhibit 32.1

In connection with the Annual Report of BIO-key International, Inc. (the “Company”) on Form 10-K for the period ended

December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael W. DePasquale,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The
Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)

(2)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and result of
operations of the Company.

BIO-KEY INTERNATIONAL, INC.

By:

/s/  MICHAEL W. DEPASQUALE
Michael W. DePasquale
Chief Executive Officer

Date: March 31, 2014

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.

 
 
 
  
 
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.2

In connection with the Annual Report of BIO-key International, Inc. (the “Company”) on Form 10-K for the period ended

December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Cecilia Welch, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-
Oxley Act of 2002, that, to my knowledge:

(1)

(2)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and result of
operations of the Company.

BIO-KEY INTERNATIONAL, INC.

By:

/s/ CECILIA WELCH
Cecilia Welch
Chief Financial Officer

Date: March 31, 2014

EDGAR Stream is a copyright of Issuer Direct Corporation, all rights reserved.